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Eph Receptors (Eph) belong to the largest group of receptor tyrosine kinases. Upon binding 
their membrane-tethered ligands, the ephrins, they regulate a great number of physiological 
processes including axon guidance and synapse formation. A unique feature of the Eph-
ephrin interaction is the induction of bidirectional signalling into both Eph (forward) and 
ephrin (reverse) expressing cells. In this manner Ephs and ephrins can trigger repulsive 
guidance responses in a bidirectional manner. 
An important step in Eph-ephrin signal transduction is the removal of Eph-ephrin 
complexes from the cell surface to turn the initial contact between two opposing cells into 
repulsion. This can be achieved by trans-endocytosis of Eph-ephrin complexes, during 
which the entire receptor-ligand complex including patches of cell membrane is taken up 
by either cell. The molecular mechanisms regulating this process, especially in the reverse 
direction, are poorly understood. Previous studies have often relied on stimulation with 
soluble proteins, which may differ greatly from a more physiologically relevant, cell-
contact-mediated interaction of membrane-tethered Ephs and ephrins. Therefore this study 
sought to determine the key players in Eph-ephrin reverse endocytosis using a functional 
assay that depends on cell-cell contact. I conducted a systematic analysis of the Rho 
GTPase subfamilies (Rac, Rho, Cdc42) to decipher their respective involvement in 
different modes of Eph-ephrin endocytosis (forward/reverse, soluble/cell-cell). This study 
revealed that the Rac subfamily of GTPases (Rac1, Rac3, RhoG) is required for EphB 
trans-endocytosis from the EphB-expressing cell into the opposing ephrinB+ cell, but not 
for endocytosis of a soluble EphB protein. In addition to the experiments in human cell 
lines, co-culture of primary murine neurons with EphB-expressing cells implicated the 
same Rac-dependent mechanism for Eph-ephrin trans-endocytosis in a physiologically 
relevant setting. While I found no regulatory role for Rho GTPases of the Cdc42 subfamily 
(Cdc42, RhoQ and RhoU), knockdown of RhoA subfamily members (RhoA, RhoB) led to 
an increase in endocytosis of soluble EphB2 into ephrinB+ cells, but no change in EphB 
trans-endocytosis. An image-based siRNA screen of the Rho family guanine exchange 
factors (GEFs) and GTPase activating proteins (GAPs) revealed the Rac-specific GEF 
Tiam2 as a key upstream regulator of Rac in EphB trans-endocytosis upon EphB-ephrinB 
IX 
engagement of two opposing cells. Furthermore the closely related Tiam1 is also required 
for trans-endocytosis in some cellular contexts. Analogously to the specific requirement of 
Rac activity in EphB trans-endocytosis, Tiam family proteins are dispensable for 
endocytosis of soluble EphB2 into ephrinB+ cells.  
In summary, the work presented here provides new insights into the molecular regulation 
of Eph-ephrin endocytosis, which is relevant in physiological contexts, and outlines 
significant differences between endocytosis mediated by cell contact and endocytosis after 
stimulation with soluble proteins. 
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1 Introduction 
An important step in evolution was the occurrence of multicellular life forms, since 
organisms consisting of more than one cell have the significant advantage of being able to 
divide the numerous tasks necessary for survival and procreation between different 
specialised cell types. However, with the transition to multicellularity come new 
challenges. In order to co-ordinate their behaviour and functions, multicellular organisms 
not only need to interact with cues from the external world, but the various cells also need 
to be able to communicate with each other to regulate their activities. This is especially 
true in order to achieve a meaningful organisation of cells within a multicellular organism. 
A process which requires the spatial distribution of specific cell types to be tightly 
regulated commencing from the development of the organism. While this task already 
requires an astonishing level of complexity, even in simple organisms such as algae, 
sponges or jellyfish, the complexity scales up even more when considering the 
development of the vertebrate nervous system. Here, billions of neurons need to form up 
to a thousand synaptic connections each onto their correct partner cells, which in some 
cases need to cover distances of several meters, for example, in the spinal cord of giraffes 
(Kandel 2013).  
To communicate successfully with surrounding cells and the external world, cells have 
developed an intricate system of sensory proteins, which enables them to sense, process 
and convert signals coming from outside sources. These external cues can come in a great 
variety of forms, ranging from soluble molecules over elements of the extracellular matrix 
to molecules bound on the membranes of other cells. With a few exceptions, such as 
intracellular hormone receptors, sensory proteins of the cells are receptors that are present 
on the surface of the cell membrane. Given the diversity of possible interactors, these 
receptors also appear in multiple forms, all with their specific ligands and a specific 
intracellular machinery connected to translate the signal into the cell (Alberts 2015). These 
signalling events triggered by the activation of the receptor through its ligand can be very 
direct, such as changing membrane permeability for certain ions, or involve a whole 
cascade of intracellular signalling molecules. Accordingly, the cellular response can be 
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short-term, for example changing its morphology through rearrangement of the 
cytoskeleton, or long-term, as in the case of changes in gene expression. 
There are three main families of cell surface receptors. The first are ligand-gated ion 
channels, which increase membrane permeability for certain ions after activation through 
their ligand. They are especially important in the nervous system, where, for example, 
glutamate-gated cation channels such as α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) or N-methyl-D-aspartate (NMDA) are important for the 
signal transduction at synapses. Upon binding of the ligand, the G-protein dissociates from 
the receptor and separates into its subunits, which in turn act on different signalling 
molecules in the cell. The third large group of receptors are the enzyme-linked receptors, 
which in most cases contain only a single transmembrane domain. Many of the enzyme-
linked receptors are protein kinases, which exert their function through the phosphorylation 
of target proteins, thus altering their biochemical properties. Among the enzyme-linked 
receptors, the Receptor-Tyrosine-Kinases (RTKs) are the most intensively studied and well 
characterised subfamily, and have many varying functions including control of cell 
division and the cell cycle, cell- cell communication, cell motility and cell survival (Alberts 
2015). A group of RTKs that has been identified to play a prominent role during various 
aspects of development are the erythropoietin-producing hepatocellular carcinoma 
receptors (Eph) with their corresponding eph-receptor-interacting protein (ephrin) ligands. 
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1.1 Eph receptors and ephrin ligands 
Eph receptors and their corresponding ephrin ligands play crucial roles in a great variety 
of different physiological and pathological processes. While traditionally mainly 
implicated in many developmental processes such as cell migration, cell sorting and tissue-
border formation (reviewed in (Batlle & Wilkinson 2012, Klein 2012); it has become 
increasing clear that the Eph-ephrin system is also essential for many functions in the 
developed body in both health and disease (Pasquale 2008, Klein 2009, Pasquale 2010). 
Given their broad and essential roles, the focus of a large body of work has been to elucidate 
the structural properties of Ephs and ephrins, the molecular mechanisms regulating their 
signalling, and how they affect normal and pathological physiology, as described below. 
1.1.1 Domain topology 
Ephs are the largest family of RTKs. They are divided in two subclasses, EphAs and 
EphBs, and each subclass consists of several distinct members, whose number varies 
between different classes of organisms. For example, in mammals there are 9 A-type and 
6 B-type Eph receptors, as well as five ephrinA and three ephrinB ligands (Eph 
Nomenclature Committee 1997), whereas in Caenorhabditis elegans there is only one Eph 
receptor and four different types of ephrins (George et al. 1998, Wang et al. 1999), and in 
Drosophila melanogaster only a single Eph-ephrin pair has been identified (Scully et al. 
1999, Bossing & Brand 2002).  The subdivision of Eph receptors into A- and B-type 
depends on their binding preference for either A-type or B-type ephrins, respectively. 
EphrinAs are tethered to the plasma membrane via a glycosylphosphatidylinositol (GPI) – 
anchor, while ephrinBs contain a single transmembrane (TM) domain and a highly 
conserved cytoplasmic tail. 
Despite their distinct binding preferences, EphAs and EphBs share the same principle 
domain organisation (Fig. 1). The extracellular part of the receptor consists of a globular 
ligand binding domain (LBD), a cysteine-rich region, which itself contains a sushi domain 
and an EGF-like domain, and two fibronectin type-III repeats (FNIII). The TM segment of 
the receptor entails a single-pass -helical domain. The juxtamembrane (JM) region of the 
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receptor is followed by a catalytically active kinase domain, a sterile- motif (SAM) and 
a Psd-95, Dlg and ZO1 (PDZ) domain (Pasquale 2008).   
The extracellular domain topology of ephrinAs and ephrinBs is highly conserved and 
consists of a globular receptor binding domain (RBD) and a short linker of about 40 amino 
acids (aa) in length. EphrinAs are tethered to the plasma membrane by a GPI-anchor and 
lack any intracellular domains, whereas the ephrinBs are TM proteins, whose cytoplasmic 
tail contains a PDZ binding motif as well as five key tyrosine residues that are 
phosphorylated upon activation (Kalo et al. 2001, Song et al. 2002, Pasquale 2008) (Fig.1). 
1.1.2 Signalling from Ephs and ephrins 
Ephs and ephrins are traditionally thought to reside in the membranes of opposing cells 
and trigger a signalling response upon coming into contact via their globular RBDs and 
LBDs, respectively (Labrador et al. 1997, Lackmann et al. 1997, Lackmann et al. 1998, 
Himanen et al. 2001). Nonetheless, more recently, several cases have been described for a 
functional role of cis-interaction of Eph receptors and ephrins being expressed in the same 
cell, in which the ephrins can attenuate the signalling response of the Eph receptor 
(Carvalho et al. 2006, Kao & Kania 2011). 
A unique feature of the Eph-ephrin system is its ability to initiate bidirectional signalling 
(Holland et al. 1996, Bruckner et al. 1997, Kalo et al. 2001, Yu & Bargmann 2001, Davy 
et al. 2004). Signals into the Eph-expressing cell are referred to as forward signalling, while 
signalling in the ephrin-expressing cell is called reverse signalling. Reverse signals can 
either be mediated through co-receptors, as in the case of ephrinAs (Kramer et al. 2006, 
Beg et al. 2007, Lim et al. 2008b, Bonanomi et al. 2012) or through signalling molecules 
binding to the cytoplasmic tail of ephrinBs (Bruckner et al. 1999, Cowan & Henkemeyer 
2001, Palmer et al. 2002). Interestingly, downstream targets of Eph-ephrin signalling differ 
significantly between the forward and reverse directions (Jorgensen et al. 2009). Typically 
Ephs and ephrins are expressed in a complementary pattern and mediate a repulsive signal, 
leading to morphological changes of the cells, thus enabling processes like cell separation 
or growth cone collapse in neurons (Drescher et al. 1995, Gale et al. 1996, Mellitzer et al. 
1999, Mann et al. 2003). Nonetheless a growing number of physiological situations has 
emerged, where Eph-ephrin signalling is primarily adhesive, especially in the context of  
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Figure 1. Domain topology of Eph receptors and ephrins  









synaptic plasticity, but also in some axon guidance decisions (Davy & Robbins 2000, 
Holmberg et al. 2000, Poliakov et al. 2004, Egea & Klein 2007, Klein 2009).  
1.1.2.1 Eph forward signalling 
Many RTKs become catalytically active after ligand binding leads to a dimerization of the 
receptor. Ephs differ from this pattern, as they require higher-order cluster formation to 
initiate signalling (Fig. 1) (Stein et al. 1998, Himanen et al. 2001, Smith et al. 2004, 
Himanen et al. 2010). After the initial hetero-dimer between Eph and ephrin is formed, a 
second receptor-ligand pair is recruited, forming a hetero-tetramer before higher-order 
clusters involving larger numbers of receptors can develop (Smith et al. 2004, Seiradake et 
al. 2010). In the case of EphB2-ephrinB2 signalling, the hetero-tetramer of two receptor 
and ligand molecules each has been reported to be sufficient to induce bidirectional 
signalling (Himanen et al. 2001). Recent publications have highlighted the fact that Eph-
ephrin clusters can elicit different signalling responses depending on their composition. 
One study showed that the number of higher-order complexes versus the number of dimers 
in EphB2 clusters determines the strength of the cellular signalling response in case of cell 
collapse (Schaupp et al. 2014). Additionally, differences in the structural properties of Ephs 
can be responsible for distinguishing between adhesive and repulsive responses upon 
stimulation with the same ligand, as is the case for EphA2 and EphA4 upon ephrinA5 
stimulation (Seiradake et al. 2013). 
The clustering of Ephs can either be induced by membrane-tethered ephrins or by ephrin 
ectodomains that have been pre-clustered and are applied in solution (Davis et al. 1994), a 
fact that has been heavily utilised in subsequent functional studies of the Eph-ephrin system 
(Tanaka et al. 2004, Cowan et al. 2005, Sahin et al. 2005, Tolias et al. 2007, Um et al. 
2014). However, in how far stimulation with pre-clustered ectodomains elicits the same 
signalling responses as cell contact-mediated stimulation is not clear, as the two approaches 
lead to distinct downstream phosphorylation patterns (Jorgensen et al. 2009). The clusters 
can propagate by including a growing number of molecules after their initial formation and 
there is also evidence that Ephs can be recruited into signalling clusters independent of 
ephrin binding (Wimmer-Kleikamp et al. 2004). This ephrin-independent recruitment of 
Ephs could potentially be explained by homotypic interactions between Ephs mediated by 
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their extracellular LBDs, sushi and/or FNII domains, as well as their cytoplasmic SAM 
domain (Lackmann et al. 1998, Himanen & Nikolov 2003, Himanen et al. 2010, Seiradake 
et al. 2010).  
Within their respective subclasses, Ephs are able to bind promiscuously to several ephrins 
and vice versa, but the binding affinities can vary greatly between different ligand-receptor 
pairs (Brambilla et al. 1995, Brambilla et al. 1996, Gale et al. 1996). However, more and 
more evidence has also highlighted the role of cross-subclass binding, as in the examples 
of EphA4, which can bind to ephrinB2 or ephrinB3 in addition to ephrinAs (Smith et al. 
1997, Kullander et al. 2001a, Kullander et al. 2001b, Qin et al. 2010), or EphB2 that can 
bind ephrinA5 (Himanen et al. 2004). This inter-class binding adds a further level of 
complexity to the Eph-ephrin system, thus enabling cells expressing a single type of 
receptor to receive and integrate important signalling cues from environments expressing 
different types of ligands.  
Activity of the Eph receptor kinase domain is required for repulsive signalling in the 
forward direction (Holmberg et al. 2000). After ligand-induced cluster formation, Ephs 
transition from a state that is only weakly catalytically active to high kinase activity in a 
multi-step process (Binns et al. 2000, Kullander et al. 2001b, Wybenga-Groot et al. 2001). 
Firstly, ligand binding and cluster formation lead to phosphorylation of tyrosine residues 
in the JM region, which induces a conformational change that releases the auto-inhibition 
of the kinase domain by electrostatic repulsion (Fig.1) (Wybenga-Groot et al. 2001). 
Secondly, after initial phosphorylation of tyrosines in the JM region, Ephs can 
autophosphorylate several conserved tyrosines within the kinase domain, which further 
increases catalytic activity (Kalo & Pasquale 1999, Binns et al. 2000). Additionally, after 
initial phosphorylation events in the JM region, Ephs can be further phosphorylated by 
members of the sarcoma virus transforming gene product (src) family of kinases (SFK) 
(Ellis et al. 1996, Zisch et al. 1998). The phosphorylation-induced conformational changes 
also allow the docking of src-homology 2 (SH2) domain containing proteins. These 
interactions with SH2 domain containing proteins seem to be dispensable for the principle 
activation of Ephs and may instead rather play a role in fine-tuning or triggering additional, 
separate signalling responses (Zisch et al. 2000). Furthermore, the SAM and PDZ domains 
also play a role in Eph signalling. PDZ-containing interactors can stabilise Eph clusters as 
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scaffolding proteins or initiate distinct signalling pathways themselves (Hsueh & Sheng 
1998, Torres et al. 1998). However, it is not yet completely understood whether, and to 
what extent, the interactions with SAM or PDZ domain-containing proteins are necessary 
for physiological Eph functions, as truncation of these domains does not abolish all 
signalling responses (Kullander et al. 2001b, Park et al. 2004). An interesting study by 
Egea and colleagues employing a mutated, constitutively catalytically active EphA4 
further elucidated the importance of the kinase domain and highlighted the role of 
signalling modulation by interaction with the ephrin ligands. Their experiments show that 
while kinase activity independent of ligand binding is sufficient for axon guidance 
decisions like midline repulsion, correct formation of thalamo-cortical projections requires 
signalling modulation through ephrin ligands (Egea et al. 2005). While these results 
establish the importance of Eph receptor kinase function in forward signalling, the role of 
Ephs acting as ligands for ephrin reverse signalling is independent of their kinase activity 
(Kullander et al. 2001b).  
1.1.2.2 Reverse signalling through ephrins 
In contrast to the EphA and EphB receptors, which share many signalling properties, 
ephrinAs and ephrinBs differ significantly in their signalling mechanisms due to their very 
dissimilar structural architecture.  
EphrinA signalling 
Lacking a cytoplasmic domain and instead being linked to the plasma membrane by a GPI-
anchor, the mechanisms by which ephrinAs translate their signal into the cell are 
particularly interesting. A growing body of evidence supports the theory that they mediate 
their function by recruiting co-receptors after being activated by Ephs. Among the 
receptors reported to function as co-receptors with ephrinAs are the Glia cell line-derived 
neurotrophic factor (GDNF) receptor, proto-oncogene tyrosine-protein kinase receptor 
RET (RET) (Kramer et al. 2006, Dudanova et al. 2010, Bonanomi et al. 2012), and the 
neurotrophin receptors p75 (Lim et al. 2008b) and tropomyosin receptor kinase B (TrkB) 
(Marler et al. 2008). The cross-talk of the neurotrophin and Eph-ephrin signalling systems 
is highly functionally relevant, as can be seen by the varied responses (axon branching 
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versus axon repulsion) downstream of ephrinA6 depending on its association with either 
p75 or TrkB (Poopalasundaram et al. 2011). Another proposed mechanism for ephrinA 
reverse signalling is that ephrinA clusters concentrate in special membrane compartments 
such as rafts or caveloae and trap SFKs such as fyn or other signalling molecules such as 
integrins within to enact their signalling (Davy et al. 1999, Davy & Robbins 2000).  
EphrinB signalling 
B-type ephrins contain a highly conserved cytoplasmic tail that encompasses five tyrosine 
residues, which can become phosphorylated upon binding to Eph receptors, as well as a 
PDZ domain (Bergemann et al. 1998, Torres et al. 1998, Bruckner et al. 1999, Song et al. 
2002). As for Eph receptors, it has been proposed that ephrinBs undergo a conformational 
change in their cytoplasmic tail upon activation, thus facilitating the access of downstream 
signalling effectors (Song et al. 2002, Song 2003). Src family kinases are key mediators of 
ephrin phosphorylation (Kalo et al. 2001, Palmer et al. 2002, Foo et al. 2006, 
Georgakopoulos et al. 2006).  Once phosphorylated, the cytoplasmic tail of ephrinBs can 
bind to SH2/SH3 adaptor proteins such as Grb4 that mediate downstream signalling events, 
for example, actin cytoskeleton rearrangements (Cowan & Henkemeyer 2001, Segura et 
al. 2007, Xu & Henkemeyer 2009).  
In contrast to the Eph receptors, the PDZ domain in ephrinBs has been shown to be of 
crucial importance for several physiological functions. By binding protein tyrosine 
phosphatase PTP-BL, the PDZ domain triggers the dephosphorylation of the tyrosine 
residues in the cytoplasmic tail and thus enables fine tuning of the ephrinB signalling 
response, possibly also switching from phosphorylation-dependent to PDZ adaptor protein-
mediated signalling (Palmer et al. 2002). Another study shows that for the remodelling of 
the vasculature mediated by ephrinB2 the PDZ domain is required, as mice expressing 
mutant ephrinB2 lacking the PDZ domain die within weeks after birth presenting severe 
malformation of lymphatic vasculature. In contrast, mice expressing ephrinB2 lacking all 
five cytoplasmic tyrosine residues exhibit only a very mild phenotype with minor 
malformations and no premature lethality (Makinen et al. 2005). PDZ-containing 
scaffolding proteins also mediate cross-talk to other signalling pathways as in the case of 
PDZ-RGS3, which attenuates signalling downstream of the heterotrimeric G-protein-
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coupled receptor CXCR4 through its GTPase-activating properties (Lu et al. 2001). 
Interaction with the scaffolding proteins of the glutamate receptor interacting protein 
(GRIP) family helps recruit kinases to ephrin clusters (Bruckner et al. 1999) and also 
promotes glutamatergic synapse formation by stabilising α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptors in postsynaptic domains (Aoto et al. 2007, 
Essmann et al. 2008). 
Together, these findings have emphasised the importance of reverse signalling in eliciting 
additional and distinct signalling responses, both through phosphorylation-dependent, and 
PDZ-dependent pathways.  
1.1.2.3 Signal attenuation 
An interesting question in Eph-ephrin signalling is how a high-affinity adhesive reaction 
between receptor and ligand is translated into cellular repulsion. While there is a growing 
number of physiological functions that require adhesive Eph-ephrin signalling, for 
example, the requirement of EphA splice isoforms lacking kinase-mediated repulsive 
signalling properties for neural tube formation (Holmberg et al. 2000), or the involvement 
of Eph receptors and ephrins in synaptic stability and plasticity (reviewed in Klein 2009); 
in the majority of cases the signal mediated by ephrins and Ephs is repulsive. In order to 
achieve repulsion between cells, it is not only necessary that the cytoskeletal architecture 
is re-arranged downstream of Eph-ephrin signalling, but also that the high-affinity ligand-
receptor complex comprising molecules from opposing cell membranes is removed from 
the cell surface.  
Two major pathways for removal of Eph-ephrin complexes from the cell surface have been 
discovered. The first is trans-endocytosis of entire Eph-ephrin complexes into the cell 
(Marston et al. 2003, Zimmer et al. 2003). This process is the main focus of this thesis and 
will be discussed in depth in section 1.3.3. The second mechanism to remove Eph-ephrin 
complexes from the cell surface is by proteolytic cleavage. The metalloprotease A-
Disintegrin-And-metalloprotease 10 (ADAM10) has been reported to be able to cleave 
ephrinAs at their ectodomain in trans after being activated by EphAs and increase contact-
mediated repulsion (Hattori et al. 2000, Janes et al. 2005, Janes et al. 2009). EphA2 can be 
cleaved by membrane type-1 matrix metallo-proteinase (MT1-MMP), triggering cell 
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repulsion in cancer cells (Sugiyama et al. 2013). EphA4 can be cleaved, but the 
physiological relevance for repulsive signalling of EphA4 cleavage is not completely 
understood as mice expressing cleavage-resistant EphA4 receptors show only a mild 
phenotype in axon guidance and EphA4 cleavage was independent of ephrinA activation 
(Gatto et al. 2014). Gatto and colleagues further observed altered levels of EphA4 
expression and thus suggested a role for EphA4 cleavage in the fine-tuning between cis 
and trans signalling from EphA4 receptors. Addtionally, another study proposed EphA4 
cleavage by -secretase to be dependent on synaptic activity (Inoue et al. 2009). 
EphrinBs can be cleaved in cis by metalloproteinases and -secretases (Georgakopoulos et 
al. 2006, Tomita et al. 2006). The work by Georgakopoulos and colleagues further suggests 
that the cleavage of ephrinB2 does not terminate signalling, but rather that the generated 
intracellular fragment possesses distinct signalling capabilities and mediates the activation 
of src kinase downstream of ephrinB2 after activation by EphBs. Similarly, reports of the 
cleavage of EphBs have suggested physiological signalling properties for the cleaved 
intracellular fragments and implicated that cleavage is dependent on calcium influx and 
ligand binding (Litterst et al. 2007), and that the cleaved fragments are involved in 
regulating cell surface expression of NMDA receptors (Xu et al. 2009). However, whether 
these findings represent a general signalling mechanism mediated by cleaved fragments in 
EphB-ephrinB signalling remains unclear, especially, since another report shows EphB 
cleavage after binding to ephrinBs to be required in the more classical role of cell repulsion 
(Lin et al. 2008). 
These studies show that cleavage of Eph receptors and/or ephrins fulfils several important 
physiological roles that might extend beyond enabling cell-cell detachment and signal 
attenuation.  
1.1.3 Physiological functions of Eph‐ephrin signalling 
As alluded to already, the Eph-ephrin signalling system is involved in a plethora of 
physiological functions and plays important roles both in development and adult 
physiology, as well as in health and disease. By giving examples for the roles of Eph-ephrin 
signalling in the nervous system I would like to introduce some of the interesting features 
and common mechanisms of the Eph-ephrin system. Several excellent reviews exist that 
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examine the involvement of Eph-ephrin signalling in vascular development (Adams & 
Eichmann 2010, Klein 2012, Pitulescu & Adams 2014), cell differentiation and 
proliferation (Genander & Frisen 2010, Wilkinson 2014), the immune system (Wu & Luo 
2005, Funk & Orr 2013), glucose homeostasis (Jain & Lammert 2009), bone maintenance 
(Edwards & Mundy 2008), as well as its role in neurodegenerative diseases (Cisse & 
Checler 2015) and cancer (Genander & Frisen 2010, Pasquale 2010), and I will thus refrain 
from discussing these functions in detail here.  
1.1.3.1 Eph‐ephrin signalling in axon guidance 
Probably the most intensely studied and well-established role of Eph-ephrin signalling in 
the nervous system is its involvement in axon guidance during neuronal development. 
Already in the 1990s, a study by Bonhoeffer and colleagues established the ability of the 
Eph-ephrin system to initiate repulsive guidance responses by triggering axonal growth 
cone collapse (Drescher et al. 1995). Since then, a large number of subsequent studies have 
built upon this seminal work (some selected references Wahl et al. 2000, Mann et al. 2003, 
Sahin et al. 2005). Here, I will use two well-studied physiological settings, retinotopic map 
formation and guidance of motor neurons, to illustrate the physiological relevance of Eph-
ephrin signalling in axon guidance. 
Processing of sensory information often depends on the correct topographic mapping of 
sensory inputs onto higher brain centres. One example is the input of visual information 
through the retina. The spatial information of retinal activation patterns is crucial for its 
correct interpretation in higher brain centres. Therefore, the well-defined topographic 
organisation is retained in neurons projecting from the retina to the tectum. Axon guidance 
by the Eph-ephrin system is important for the correct formation of these topographic maps 
in order to relay information from the retina to higher brain centres. EphA-ephrinA 
bidirectional signalling is required to form correct retino-tectal projections and, depending 
on the exact localisation of expression of receptors and ligands, they can be either repulsive 
or attractive cues (Knoll et al. 2001, Knoll & Drescher 2002, Dufour et al. 2003, Marquardt 
et al. 2005). One mechanism important for topographic map formation is a differentiated 
EphA response resulting from gradients of EphA and ephrinA expression between the 
retinal origin and tectal target zones of neurons (Brown et al. 2000). Recent work has 
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shown that the gradient of ephrinA correlates with the target size of the topographic map 
established in the tectum (Tadesse et al. 2013). Topographic map formation also depends 
on the kinase function of EphA4 (Dufour et al. 2006). Marquardt and colleagues propose 
that contrasting repulsive and attractive signalling responses are regulated by EphAs and 
ephrinAs residing in the same neuron, but within distinct membrane domains (Marquardt 
et al. 2005).  Another report suggests that eprhinAs reduce EphA-mediated repulsive 
signalling by acting on EphAs in cis (Carvalho et al. 2006). Reverse signalling from 
ephrinAs in topographic map formation seems to intersect with neurotrophic signalling and 
p75 has been implicated as the responsible co-receptor (Lim et al. 2008b, Grimbert & Cang 
2012). In how far correct map formation also is dependent on neuronal activity in the retinal 
ganglion cells is still a matter of debate, with work supporting an important role of activity 
(Grimbert & Cang 2012) and other results suggesting neuronal activity is dispensable 
(Benjumeda et al. 2013).  
Guidance of motor axons to their correct targeting zones in limbs also relies heavily on 
Eph-ephrin signalling. Motor neurons originating in the motor cortex need to cross the 
midline before forming the corticospinal tract and finally innervating targets on the contra-
lateral side of their origin. This process requires EphA4 signalling in the axons, which are 
repelled by ephrinB3 expressed in cells on the midline of the spinal cord (Dottori et al. 
1998, Coonan et al. 2001, Kullander et al. 2001a, Kullander et al. 2001b). These EphA4-
expressing neurons form a component of the central pattern generator required for 
locomotion and the aberrant crossing of neurons in EphA4-knockout mice leads to a 
distinct hopping phenotype due to abnormal synchronous activation of limbs on both sides 
(Kullander et al. 2003). Three independent studies suggest that one key downstream player 
of EphA4 signalling in this context is the Rac GTPase activating protein (GAP) -
chimaerin, as an -chimaerin knockout mouse phenocopies the EphA4 knockout (Beg et 
al. 2007, Iwasato et al. 2007, Wegmeyer et al. 2007). Correct formation of spinal motor 
circuits has been reported to consist of distinct clustering-dependent and independent 
EphA4 signalling mechanisms (Egea et al. 2005). Recent work from Paixao and colleagues 
has furthermore demonstrated that ephrinB3-EphA4 signalling is required for the correct 
formation of both descending and ascending axon tracts in the spinal cord (Paixao et al. 
2013). Once motor neurons leave the spinal cord, interactions between ephrinAs and 
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EphA4 are crucial for neurons to reach their target areas in the limb musculature (Kramer 
et al. 2006, Dudanova et al. 2010, Kao & Kania 2011, Bonanomi et al. 2012, Dudanova et 
al. 2012). Reverse signalling by ephrinAs is required in this context, and RET functions as 
a co-receptor alongside ephrinAs linking contact-mediated Eph-ephrin interaction to 
signalling by the diffusible neurotrophic guidance cue GDNF (Kramer et al. 2006, 
Dudanova et al. 2010, Bonanomi et al. 2012). The studies from Dudanova and colleagues, 
as well as from Kao and colleagues, have highlighted an intricate interplay between 
repulsive EphA signalling, attractive ephrinA signalling and signal attenuation by cis 
interactions between ephrinAs and EphA receptors. All of these mechanisms are acting on 
the same neuron and are required for the precise spatio-temporal control of axon guidance 
from the spinal cord to the limb muscles (Kao & Kania 2011, Dudanova et al. 2012). 
Cleavage of EphAs is an additional mechanism to fine-tune this process (Gatto et al. 2014).  
The Eph-ephrin system is well established as a key regulator of axon guidance in several 
physiological contexts. The examples given in this short overview illustrate that the role of 
Eph-ephrin signalling is far more complex than providing mere repulsive guidance cues by 
inducing growth cone collapse. Cross-talk between subclasses, regulation by downstream 
effectors, cis signalling and adhesive responses all contribute to the central role of Eph-
ephrin signalling in orchestrating fine-tuned axonal guidance decisions. Despite the 
growing body of work, many details of the underlying molecular mechanism for Eph-
ephrin-mediated axon guidance, especially regarding the process of cell detachment, 
remain to be unravelled. 
1.1.3.2 Eph‐ephrin signalling at synapses 
Eph-ephrin signalling plays a different role at synapses, where it can mediate adhesive 
signals and is involved in the generation of synapses, as well as synaptic maintenance and 
plasticity. 
Eph‐ephrin signalling in synaptogenesis  
Ephs can regulate the formation of excitatory synaptic connections by stabilising NMDA 
receptors at postsynaptic specialisations (Dalva et al. 2000). Another suggested mechanism 
for how Eph receptors contribute to synapse formation is by increasing motility of dendritic 
Introduction 
      15 
filopodia (Kayser et al. 2008). Whether promotion of synaptogenesis by EphBs requires 
their kinase function is still a matter of debate. Recent work from Greenberg and colleagues 
using a chemical genetic approach suggests that the kinase function is not required for 
synaptogenesis (Soskis et al. 2012). However earlier work from the same group suggests 
that excitatory synapse formation is promoted by enhancing degradation of ephexin5 
through its phosphorylation by EphB receptors (Margolis et al. 2010). Excitatory synapses 
often form on dendritic protrusions called spines and EphBs play important roles in 
forming these spines as a step leading up to synapse formation (Henkemeyer et al. 2003, 
Kayser et al. 2006). 
While EphBs have been shown to play a role in postsynaptic development, ephrinBs have 
been implicated in presynaptic development (Kayser et al. 2006, Lim et al. 2008a, 
McClelland et al. 2009). This regulation of synaptic development can depend on interaction 
with syntenin (McClelland et al. 2009). Syntenin itself can bind and stabilise glutamatergic 
receptors at synapses (Hirbec et al. 2002). Nonetheless, other studies, found ephrinBs to 
also be involved in synapse formation on the postsynaptic side (Aoto et al. 2007, Segura et 
al. 2007, Xu et al. 2011). The postsynaptic involvement of ephrinB3 can also be mediated 
through syntenin, an interaction independent of phosphorylation of ephrinB3 (Xu et al. 
2011). Other proteins implicated downstream of ephrinBs in synapse formation are GrB4, 
which in this case would argue for the requirement of ephrinB phosphorylation (Segura et 
al. 2007), and the PDZ domain interactor GRIP1 (Aoto et al. 2007). 
Eph‐ephrin signalling in neuronal plasticity 
Eph-ephrin signalling is not limited to functions in the developing nervous system. An 
increasing body of work underlines the importance of the Eph-ephrin system for plasticity 
in the mature nervous system on both the levels of synapses as well as dendrites and spines. 
One important feature of plasticity on the synaptic level is the activity-dependent change 
in signalling properties and synaptic strength known as long-term potentiation (LTP) (Bliss 
& Lomo 1973, Bliss & Collingridge 1993). EphB receptors can phosphorylate NMDA 
receptors either directly (Dalva et al. 2000) or through src family kinases (Takasu et al. 
2002), and thereby modulate synaptic plasticity. Further studies have identified the 
postsynaptic requirement of EphB receptors for NMDA-mediated LTP generation 
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(Grunwald et al. 2001, Contractor et al. 2002). EphB signalling in LTP is independent of 
its kinase function. Grunwald and colleagues showed that EphB receptors truncated at the 
carboxy-terminus were sufficient to rescue the EphB knockout phenotype (Grunwald et al. 
2001). Potentially, the kinase-independent signalling is promoted by scaffolding proteins 
binding to the PDZ domain of EphB2 like GRIP1, which clusters glutamatergic receptors 
(Contractor et al. 2002). 
Paralleling their requirement in synaptogenesis, ephrin molecules also play reciprocal roles 
in synaptic plasticity and can act on both the presynaptic and postsynaptic sides. Several 
studies showed the involvement of ephrinBs in LTP in the hippocampus (Contractor et al. 
2002, Grunwald et al. 2004, Armstrong et al. 2006, Bouzioukh et al. 2007, Lim et al. 
2008a). The effect of ephrinBs on LTP can be dependent on (Grunwald et al. 2004) or 
independent of the function of NMDA receptors (Armstrong et al. 2006, Lim et al. 2008a). 
LTP downstream of ephrinBs requires phosphorylation of the cytoplasmic tyrosine 
residues in contrast to long-term depression (LTD), which is phosphorylation independent 
(Bouzioukh et al. 2007). Another pathway by which ephrinBs can influence synaptic 
plasticity is by stabilising AMPA receptors at synapses, which requires the phosphorylation 
of a serine residue of ephrinB2 (Essmann et al. 2008). Interestingly, Eph-ephrin signalling 
can also influence LTP in a more indirect route, since an EphA4-ephrinA3 interaction 
between neuronal and glia cells regulates glutamate uptake into astrocytes and thereby the 
induction of LTP at adjacent synapses (Filosa et al. 2009). 
In addition to changes at the synaptic level, plasticity in the mature nervous system is also 
mediated by morphological changes at the level of spines and dendrites (Yuste & 
Bonhoeffer 2001). Eph-ephrin signalling can exert these effects on the cytoskeletal 
architecture of cells, for example via signalling through Rho-family GTPases (see section 
1.2.3 for more details), and is thus also able to effect morphological changes in neuronal 
plasticity. Experiments in cultured neurons have revealed that EphBs regulate the 
morphology of dendritic spines, for example through Cdc42 and its guanine exchange 
factor (GEF) intersectin (ITSN) (Irie & Yamaguchi 2002, Nishimura et al. 2006), or Rac1 
and its GEFs Kalirin (Penzes et al. 2003) or Tiam1 (Tolias et al. 2005, Tolias et al. 2007). 
Ephrin reverse signalling can also facilitate dendritic remodelling in a phosphorylation- 
and PDZ-dependent manner through Grb4, PICK1 and syntenin downstream of eprinB3 
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(Xu et al. 2011). Similar to its relevance for LTP, neuron-glia cross-talk mediated by 
EphA4 and ephrinA3 is also involved in regulating dendritic spine morphology (Murai et 
al. 2003, Carmona et al. 2009). The effects of EphA4 on spine morphology can also be 
mediated by the regulation integrin signalling (Bourgin et al. 2007) or alternatively by 
activating phospholipase gamma and causing actin rearrangement through cofilin (Zhou et 
al. 2007). NMDA-dependent ephrinA2-signalling is required for maintaining spines and 
synapses, as ephrinA2 knockout mice show increased pruning of dendritic synapses (Yu et 
al. 2013). 
The ability of the Eph-ephrin system to employ different downstream effectors, integrate 
information from several signalling pathways, and provide fine-tuned responses into 
opposing cells via bidirectional signalling allows the control of important elements of 
synaptic development and physiology. Still, several molecular details of how specific 
signalling responses can be achieved and how diverse pathways with contrasting effects 
downstream of Eph-ephrin signalling intersect remain to be deciphered. 
 
As demonstrated by the examples from its physiological roles in the nervous system, the 
Eph-ephrin system can act as a versatile regulator of very distinct physiological responses. 
Understanding the molecular mechanisms regulating Eph-ephrin signalling is therefore a 






The Rho family of GTPases is a subgroup of the rat sarcoma viral oncogene homologue 
(Ras) superfamily of GTPases and itself consists of several subfamilies. The Rho GTPases 
are relatively small proteins (21 kDa) with their signature conserved GTPase domain 
residing in their N-terminus. They act as molecular switches and have been associated with 
several essential physiological functions including controlling cell morphology, 
polarisation, adhesion and migration, as well as vesicle trafficking (Ridley 2006, Iden & 
Collard 2008, Friedl & Gilmour 2009, Hall & Lalli 2010, Parsons et al. 2010). Rho family 
GTPases also play an important role in several diseases including neurodevelopmental 
disorders, neurodegeneration and cancer (Sahai & Marshall 2002a, Govek et al. 2005, 
Newey et al. 2005, Parri & Chiarugi 2010, Stankiewicz & Linseman 2014). Already early 
reports on the functions of Rho family GTPases linked their effects on cell morphology 
and motility to rearrangement of the actin cytoskeleton (Ridley & Hall 1992a, Ridley & 
Hall 1992b, Ridley et al. 1992). Subsequent studies revealed further roles for Rho family 
GTPases in controlling gene expression, mitosis, proliferation and secretion (Etienne-
Manneville & Hall 2002, Jaffe & Hall 2002, Heasman & Ridley 2008). Although Rho 
family GTPase activity affects many intracellular processes, shaping the actin cytoskeleton 
has remained the focal point, and is particularly relevant in the context of the regulation of 
neurite morphology and endocytic processes (Ridley 2006, Hall & Lalli 2010). 
Rho-family GTPases function as molecular switches. This ability arises from the distinct 
signalling properties they exhibit when in a guanine diphosphate (GDP)-bound or guanine 
triphosphate (GTP)-bound state. In their inactive, GDP-bound conformation, Rho family 
GTPases are mainly found in the cytosol and unable to bind their effector proteins (Jaffe 
& Hall 2005). When bound to GTP, Rho GTPases are in their active state and localised to 
membranes via a prenyl group connected to a conserved CAAX motif in their C-terminal 
part (Roberts et al. 2008). In their active state they are able to bind their respective effector 
proteins, often protein kinases such as PAK1 or Rho activated kinase (ROCK) (Bishop & 
Hall 2000). The transitioning between active and inactive states of Rho-family GTPases 
relies heavily on the interaction with three different classes of proteins: GEFs, GAPs, and 
guanine nucleotide-dissociation inhibitors (GDIs) (Jaffe & Hall 2005). GDIs can constrain 
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Rho GTPases in their inactive, GDP-bound state and regulate their subcellular location 
(Olofsson 1999). GEFs catalyse the exchange of GDP to GTP, thereby activating Rho 
GTPases (Hart et al. 1991, Schmidt & Hall 2002a), while GAPs greatly enhance the 
intrinsic GTPase activity of Rho GTPases, resulting in a transition to the inactive state 
(Garrett et al. 1989, Lamarche & Hall 1994, Tcherkezian & Lamarche-Vane 2007). The 
activity of both GEFs  and GAPs can be regulated downstream of extracellular cues and 
they are therefore key regulators of Rho GTPase signalling and important mediators of 
cross-talk between different pathways (Bos et al. 2007). The physiological importance of 
GEFs and GAPs is further highlighted by the fact that both groups of proteins outnumber 
the 20 members of the Rho-family of GTPases several fold. The Rho GTPase cycle and 
the role of GEFs and GAPs is summarised in Figure 2A. 
In this chapter I will provide a short overview of the different subfamilies of Rho GTPases 
and their relevant functions, a more detailed description of the properties and functions of 
GEFs and GAPs, as well as an overview of Rho family GTPase signalling downstream of 
Eph-ephrin complexes. 
1.2.1 Rho GTPase subfamilies 
Rho family GTPases are highly conserved in eukaryotes and can be found in organisms 
ranging from yeast to plants to animals. In mammals, a total of 20 Rho family GTPases 
have been described and they can be divided into 6-8 distinct subfamilies according to their 
sequence similarity (see also Fig.2B) (Burridge & Wennerberg 2004, Wennerberg & Der 
2004, Heasman & Ridley 2008). Most studies so far have focussed on the three cardinal 
members of the Rho family GTPases: RhoA, Rac and Cdc42. Rho-family GTPases not 
falling into one of these three subfamilies are therefore often referred to as atypical Rho 
GTPases. 
1.2.1.1 RhoA subfamily 
The eponymous RhoA subfamily consists of RhoA, RhoB and RhoC. Traditionally RhoA 
has been linked to assembly of actin stress fibres and focal adhesions (Ridley & Hall 1992b, 
Nobes & Hall 1995). The effect on stress fibre assembly, however, does not rely on a large 
increase in actin polymerisation downstream of RhoA, but rather on myosin-induced 
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bundling of actin (Machesky & Hall 1997). To this end, RhoA activates ROCK, its most 
commonly studied downstream effector (Leung et al. 1995). One of the chief functions of 
ROCK signalling is phosphorylation of myosin, which thus facilitates the formation of 
stress fibres (Amano et al. 1996, Kimura et al. 1996). ROCK signalling downstream of 
RhoA can also affect the actin cytoskeleton more directly, for example through 
phosphorylation of Lim kinase, which phosphorylates the actin-binding protein cofilin, 
culminating in stress fibre formation. (Maekawa et al. 1999). RhoA subfamily proteins can 
also interact with actin nucleator proteins of the Dia family, which opens up possibilities 
for both shared and distinct signalling pathways with ROCK downstream of RhoA 
(Watanabe et al. 1999, Sahai & Marshall 2002b, Lammers et al. 2008). 
Due to the high degree in sequence homology between the three subfamily members and 
their ability to bind the same effectors, the various Rho family members have overlapping 
and often redundant functions in some physiological contexts. RhoA and RhoB are both 
required for lamellipodia retraction in macrophages, with only double knockout mice 
showing a strong phenotype (Konigs et al. 2014). In differentiation of skin cells, RhoA-
deficient mice displayed only a mild phenotype with increased cell spreading and defective 
cell-cell contacts in vitro, while RhoB expression was increased (Jackson et al. 2011). 
Additional pharmacological inhibition of RhoB and RhoC greatly exacerbated the 
phenotype, suggesting functional overlap between the RhoA subfamily members. 
Nonetheless, differences in the signalling properties of the different subfamily members 
have also emerged. RhoB differs in its subcellular location from RhoA and RhoC and 
seems to mediate different signalling responses, including regulation of vesicular 
trafficking (Adamson et al. 1992, Gampel et al. 1999, Michaelson et al. 2001).  RhoC 
shows higher binding affinity to ROCK when compared with RhoA, enabling the two 
proteins to activate distinct signalling pathways within the same cell (Sahai & Marshall 
2002b). 
Physiologically, signalling from RhoA subfamily members is important for actin 
rearrangement in neuronal development and axon guidance, as it can mediate growth cone 
collapse and regulate neurite growth (Wahl et al. 2000, Shamah et al. 2001, Fournier et al. 
2003, Sahin et al. 2005, Takeuchi et al. 2015). 
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The Rac subfamily consists of Rac1, Rac2, Rac3 and their distant relative RhoG (Figure 2 
B). A further splice variant of Rac1, Rac1b, with very efficient intrinsic GTP-GDP 
exchange and therefore thought to be constitutively active, has also been described (Fiegen 
et al. 2004). Rac was first shown to be an important mediator in the formation of membrane 
ruffles and lamellipodia in response to extracellular signals such as growth factors (Ridley 
et al. 1992, Nobes & Hall 1995). Changes in the cytoskeleton induced by Rac result from 
an increased polymerisation of actin (Machesky & Hall 1997). Later, Rac subfamily 
members have also emerged as key regulators of endocytic processes including 
macropinocytosis (Dharmawardhane et al. 2000, West et al. 2000) and phagocytosis 
(Massol et al. 1998, Castellano et al. 2000, Chimini & Chavrier 2000, Hoppe & Swanson 
2004). The contribution of Rac subfamily signalling to endocytic pathways, and more 
specifically, endocytosis of Eph-ephrin complexes will be explored in greater detail in 
chapter 1.3.  
The separate Rac subfamily members vary in their expression patterns: While Rac1 is 
expressed ubiquitously, Rac2 is mainly found in hematopoietic cells (Roberts et al. 1999) 
and Rac3 is mainly expressed in the nervous system (Haataja et al. 1997). Rac1 and Rac2 
have both overlapping and distinct signalling functions, as Rac1 and Rac2 single knockout 
mice show distinct phenotypes in hematopoietic cell regulation (Gu et al. 2003), while both 
Rac1 and Rac2 are required for B cell development (Walmsley et al. 2003). Rac1 and Rac3 
have been found to have redundant functions in neuronal development (Corbetta et al. 
2009). Finally, the function and role of RhoG signalling is still a matter of debate, but it 
has been proposed to act upstream of Rac1 and Cdc42, positively regulating their activity 
via interaction with GEFs of the DOCK family (Katoh & Negishi 2003, Hiramoto et al. 
2006, Katoh et al. 2006, Kim et al. 2011, Franke et al. 2012). However, other studies 
suggest RhoG can signal in parallel to Cdc42 and Rac, making use of the same downstream 
effectors (Wennerberg et al. 2002). 
One important downstream effector of Rac subfamily GTPases is the p21-activated kinase 
(PAK), a serine/threonine kinase (Manser et al. 1994, Knaus et al. 1998). Via activating 
PAK, Rac can induce changes in the actin cytoskeleton required for cell motility and 
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neurite morphology (Edwards et al. 1999, Sells et al. 1999, Nikolic 2008). However, Rac 
activity can also lead to actin rearrangement independent of PAK by a pathway involving 
the adaptor protein Nck and the Scar/WAVE (WASP-family verpolin homologous protein) 
complex (Eden et al. 2002). 
Interestingly, activity of Rac subfamily GTPases is in many physiological situations 
opposed to the function of RhoA subfamily proteins and in some cases, leads to direct 
inhibition or downregulation of RhoA signalling (Sander et al. 1999, Nimnual et al. 2003). 
In turn, RhoA activity and signalling via ROCK has been shown to lead to a decrease in 
Rac activity, which can be mediated through activation of Rac-specific GAPs (Ohta et al. 
2006). Furthermore, signalling through the same receptor can influence Rac and Rho 
activity in contrasting directions (Driessens et al. 2001, Hu et al. 2001, Sahin et al. 2005). 
More recently, RhoA, Rac1 and Cdc42 have been shown to act synergistically, but in a 
tightly orchestrated manner in the formation of cell protrusions: RhoA is required at the 
leading edge of the cell to initiate actin rearrangement, while Rac1 and Cdc42 show peak 
activity 2 µm from the cell edge and are active with a delay compared to RhoA. This shows 
a spatio-temporally controlled sequence of activity of the respective GTPases and the 
authors speculate that since RhoA and Rac1/Cdc42 activity are temporally and locally 
exclusive, cross-inhibition is important for this tight regulation (Machacek et al. 2009, 
Pertz 2010). It has thus become increasingly obvious that signalling pathways from 
different Rho subfamilies intersect and influence each other (Guilluy et al. 2011). 
1.2.1.3 Cdc42 subfamily 
The Cdc42 subfamily consists of five members: Cdc42, RhoQ (TC10), RhoJ (TCL), RhoU 
(Wrch) and RhoV (Wrch2/Chip) (Figure 2B). However, there is some debate whether 
RhoU and RhoV are actually a distinct subfamily, given that they show unique properties 
when compared to other Cdc42 subfamily proteins, including being potentially 
constitutively active (Shutes et al. 2006). Cdc42 activity induces long, filamentous 
processes called filopodia to be formed in cells (Nobes & Hall 1995). This function is 
shared by the other subfamily members, which can possibly be explained by their shared 
affinity towards some downstream effectors like PAK (Aronheim et al. 1998, Neudauer et 
al. 1998, Murphy et al. 1999, Tao et al. 2001, Aspenstrom et al. 2004). Nonetheless, 
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subsequent studies also revealed distinct signalling pathways and showed that Cdc42 
subfamily members differ in their intracellular localisation, their sensitivity to regulation 
by GDIs and the respective downstream effects mediated (Michaelson et al. 2001, Murphy 
et al. 2001). Furthermore, despite the high level of sequence homology between RhoQ, 
RhoJ and Cdc42, GEFs seem to only marginally increase GTP-GDP exchange rates in 
RhoQ and RhoJ, while some of them are very potent activators of Cdc42 (Jaiswal et al. 
2013a). 
One key downstream effector of Cdc42 signalling to the actin cytoskeleton is Wiskott-
Aldrich syndrome protein (WASP), which mediates actin polymerisation and is involved 
in the formation of Cdc42-induced filopodia (Symons et al. 1996). RhoQ and RhoJ, as well 
as RhoV can also induce filopodia formation via WASP (Aronheim et al. 1998, Abe et al. 
2003). However, a WASP-independent pathway for inducing filopodia by Cdc42 has also 
been described (Peng et al. 2003). WASP mediates rearrangement of the actin cytoskeleton 
via the Arp2/3 complex, which induces actin branching (Stradal & Scita 2006). Another 
important pathway for Cdc42 subfamily GTPases uses PAK to regulate the actin 
cytoskeleton in an analogous fashion to Rac subfamily GTPases (Manser et al. 1995, 
Aronheim et al. 1998, Edwards et al. 1999). 
Signalling from Cdc42 via the WASP signalling pathway has been shown to be involved 
in both regulation of neurite morphology (Wong et al. 2001, Irie & Yamaguchi 2002, Abe 
et al. 2003, Nishimura et al. 2006, Franke et al. 2012) and endocytic processes (Hussain et 
al. 2001, Qualmann & Kessels 2002, Sabharanjak et al. 2002, Chadda et al. 2007), and is 
therefore highly relevant in the context of this study. 
1.2.1.4 Atypical Rho family GTPases 
A more specialised subfamily of Rho GTPases are the Rnd proteins (Rnd1, Rd2, 
Rnd3/RhoE). Despite sequence homology with RhoA, the mechanism of action of the Rnd 
subfamily of proteins seems to differ significantly from the archetypical Rho family 
GTPases (Foster et al. 1996, Fiegen et al. 2002, Garavini et al. 2002, Chardin 2006).  Rnd 
proteins cannot act as molecular switches, since they are GTPase-deficient and are 
constitutively active in their GTP-bound form (Foster et al. 1996, Fiegen et al. 2002, 
Garavini et al. 2002). Nonetheless, Rnd proteins have been shown to regulate the actin 
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cytoskeleton (Nobes et al. 1998, Aspenstrom et al. 2004). They can act as RhoA-
antagonists by activating p190RhoGAP and their activity is regulated by a feedback-loop 
involving RhoA-activated kinase (ROCK) (Wennerberg et al. 2003, Riento et al. 2005, 
Goh & Manser 2012). As RhoA-antagonists, they have been shown to play a role in axon 
guidance, for example downstream of semaphorin signalling (Oinuma et al. 2004a, Oinuma 
et al. 2004b, Pacary et al. 2011).  
Another pair of unusual Rho-family GTPases are RhoD and Rif, in that they seem not to 
be regulated by GEFs, like most other Rho-family GTPases (Jaiswal et al. 2013a). This 
may be because RhoD and Rif display a very high intrinsic exchange rate from GDP to 
GTP and are proposed to thus be constitutively active, similar to the splice variant Rac1b 
(Fiegen et al. 2004, Jaiswal et al. 2013b).Functionally, RhoD and Rif have been shown to 
induce rearrangement of the actin cytoskeleton and be involved in vesicular transport, 
among other functions (Murphy et al. 1996, Gasman et al. 2003, Aspenstrom et al. 2004, 
Gad & Aspenstrom 2010). 
RhoH is an atypical Rho GTPase and just like the Rnd subfamily, it lacks a key residue in 
its GTPase domain, rendering it incapable of GTP hydrolysis (Li et al. 2002). While RhoH 
is not involved in rearrangement of the actin cytoskeleton, in contrast to most other 
members of the Rho family GTPases (Aspenstrom et al. 2004), it has been implicated to 
play an important role in some cancers (Preudhomme et al. 2000). A likely mechanism for 
its function is binding and inhibition of other Rho family GTPases (Li et al. 2002). 
The Rho BTB subfamily, which consists of three members (RhoBTB1-3) differs from other 
Rho family GTPases in that they contain additional domains in their C-terminus, lack the 
CAAX-motif important for membrane localisation, and are also unable to rearrange the 
actin cytoskeleton (Rivero et al. 2001, Aspenstrom et al. 2004). Furthermore, RhoBTB3 
has an atypical GTPase domain and is thought to bind ATP instead of GTP (Espinosa et al. 
2009). 
A final subfamily of Rho GTPases that shows no effects on the cytoskeleton is the Miro 
subfamily, consisting of members Miro1 and Miro2, which have been shown to localise to 
mitochondria and to be involved in regulation of apoptosis (Fransson et al. 2003, 
Aspenstrom et al. 2004). However, due to large sequence divergence from all other Rho 
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family GTPases, it is questionable whether they should be included in the Rho family at 
all (Fransson et al. 2003). 
 
Despite this great variety of GTPases, research so far has mainly focussed on just three 
proteins: RhoA, Rac1 and Cdc42. Given that these three subfamilies have been implicated 
already in Eph-ephrin signalling and endocytic processes (see below) and the fact that their 
regulatory mechanisms are accessible for experimental manipulation, we also focussed on 
their role in EphB-ephrinB endocytosis in this study. When studying the effects of Rho 
GTPases it will be important to bear in mind that there is a degree of physiological 
redundancy within different subfamilies of Rho GTPases, as well as regulatory cross-talk 
within and between subfamilies.  
1.2.2 Regulation of Rho subfamily GTPases by GEFs and GAPs 
1.2.2.1 Regulation through GEFs 
There are two major families of GEFs for Rho family GTPases in eukaryotes: the Diffuse 
B-cell lymphoma oncogene (Dbl) family and the Dedicator of Cytokinesis (DOCK)-
family.  
The Dbl family all share the eponymous Dbl Homology (DH) domain that is crucial for 
mediating guanine nucleotide exchange (Hart et al. 1991). For most Dbl family GEFs, the 
DH domain is paired with a pleckstrin homology (PH) domain, involved in binding the 
target GTPase (Rossman et al. 2002), or membrane localisation of GEFs through lipid 
binding (Ferguson et al. 1995, Lemmon & Ferguson 2000, Razzini et al. 2000). There are 
74 proteins containing a DH encoded by the human genome, but not all of them display 
GEF activity towards Rho-family GTPases (Jaiswal et al. 2013a). In addition to the 
signature DH-PH tandem domains, GEFs can contain a great variety of domains involved 
in signalling or protein-protein interaction, amongst them SH2, SH3, GEF domains for 
other GTPases such as Ras, PDZ or Kinase domains. This assortment of diverse interaction 
sites enables GEFs to integrate signals from, and confer signals to a host of different 
signalling pathways (Schmidt & Hall 2002a). 
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Specificity of GEFs for distinct Rho-family GTPases covers a broad spectrum. A 
comprehensive study by Jaisawal and colleagues tested several GEFs for their catalytic 
activity towards a large number of Rho-family GTPases in vitro. Their results suggested 
that while some Dbl family GEFs do not show any activity towards the tested GTPases, 
others are active on several of them, for example, Prex1 that confers activity to members 
of all three cardinal Rho subfamilies, some are subfamily specific, for example, p190GEF 
for the RhoA subfamily; and yet others are highly specific for a single GTPase, for 
example, ITSN for Cdc42 (Jaiswal et al. 2013a). The study further revealed that the 
catalytic efficiency with which GEFs mediate GDP to GTP-exchange in GTPases can vary 
greatly, as it ranges from 5-fold to 60,000-fold increase over baseline intrinsic exchange 
activity (Jaiswal et al. 2013a). These facts suggest that different GEFs can affect Rho 
GTPase activity at different time scales and with different efficiencies. Interestingly, the 
results reported in this comprehensive study sometimes contradict previous reports in the 
literature regarding the specificity of some GEFs. For example, Prex1 had previously been 
described as a Rac-specific GEF (Welch et al. 2002), whereas Jaiswal and colleagues show 
that it also has significant activity towards members of the RhoA and Cdc42 subfamilies. 
However, some of these discrepancies can potentially be explained by this study relying 
solely on in vitro studies, while posttranslational modifications, interaction with GDIs, or 
subcellular compartmentalisation in vivo may significantly change the activity of GEFs, as 
can be observed in the case of ephexin changing its specificity upon phosphorylation (Sahin 
et al. 2005). 
GEF activity can be regulated in several ways (Schmidt & Hall 2002a). A very important 
regulatory mechanism for GEFs is phosphorylation by protein kinases (Patel & Karginov 
2014). For example, the Vav family of Rho GEFs has been shown to be present in the cell 
in an auto-inhibited confirmation that is relieved upon tyrosine phosphorylation by SFKs 
(Aghazadeh et al. 2000, Yu et al. 2010). Combined with the possibility of Vav proteins 
being de-phosphorylated by phosphatases (Stebbins et al. 2003, Sastry et al. 2006), the 
phosphorylation status of Vav provides tight and transient spatio-temporal control for its 
activity. While phosphorylation by tyrosine kinases correlates with higher GEF activity, 
phosphorylation of serine or threonine residues can be either inhibitory or activating. One 
example of this is GEF-H1 (ArhGEF2) that can be activated upon phosphorylation of a 
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threonine residue by Extracellular signal-Regulated Kinase (ERK), while a different 
phosphorylation event mediated by ERK on a serine residue inhibits its function, as does 
serine phosphorylation by PAK (Zenke et al. 2004, Fujishiro et al. 2008, von Thun et al. 
2013). Finally, a remarkable effect of phosphorylation is observed in ephexin (NGEF), 
downstream of EphA4 receptor signalling, where the preference of GEF activity switches 
from Rac1/Cdc42 to RhoA upon phosphorylation (Sahin et al. 2005). 
Aside from phosphorylation, there are multiple other mechanisms regulating GEF activity. 
One such pathway involves GPCRs. Synaptic GPCR Brain-specific Angiogenesis Inhibitor 
1 (BAI1) is required for restricting Rac-specific GEF Tiam1 to synapses in synaptogenesis 
by direct interaction, thereby leading to the localised Rac activation necessary for 
establishing polarity (Duman et al. 2013). GPCR signalling is not only required for correct 
localisation of GEFs, but can also directly increase GEF activity. Gactivates p63GEF 
(GEFT) by directly binding to the PH domain, which leads to a release of auto-inhibition 
(Rojas et al. 2007). G and phosphatidylinositol signalling can directly and 
synergistically increase GEF-activity of Prex1, which enables Prex1 to act as a coincidence 
detector of these two signalling pathways in neutrophils (Welch et al. 2002). A unique 
feature of GPCR signalling via GEFs can be observed with Trio, a GEF containing two 
separate DH-PH domains showing distinct substrate specificity towards RhoA and 
Rac1/Cdc42, respectively (Debant et al. 1996). The RhoA-specific DH-PH domain of Trio 
shares sequence similarity with the DH-PH domain from p63GEF and accordingly, G-
interaction through the same molecular mechanism leads to increased GEF activity towards 
RhoA and an associate shift away from activity towards Cdc42 and Rac1 (Rojas et al. 
2007). 
The DOCK family of GEFs has been discovered more recently and displays different 
characteristics when compared to Dbl family GEFs (Cote & Vuori 2002). Since they lack 
the DH domain, DOCKs are often referred to as atypical GEFs. Instead of the DH domain, 
DOCK proteins share two separate DOCK homology regions, DHR1 and DHR2, from 
which they mediate lipid binding and induce GEF activity (Laurin & Cote 2014). The 
DOCK family consists of 11 members and interestingly, they all show specificity for either 
Rac or Cdc42 GTPases and are not active towards RhoA (Cote & Vuori 2002, Cote & 
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Vuori 2006). DOCK-family GEFs are also different from Dbl family GEFs in that at least 
some members rely on interaction with members of the Engulfment and cell motility 
protein (ELMO) family in order to exhibit nucleotide exchange activity. This interaction, 
first described between Dock1 (also known as DOCK180) and ELMO1, leads to Rac 
activation (Wu et al. 2001, Brugnera et al. 2002, Grimsley et al. 2004, Lu et al. 2004). 
Dock4 has also been shown to require interaction with an ELMO protein to influence cell 
migration via Rac activation (Hiramoto et al. 2006) and an ELMO2-Dock3 complex is 
required for neurite outgrowth downstream of neurotrophic factor signalling (Namekata et 
al. 2012). However, it is not yet completely understood whether all DOCK proteins require 
complex formation with ELMOs to exhibit GEF activity. Furthermore, activation of Rac 
by the DOCK-ELMO complex on is regulated by another GTPase, RhoG, which seems to 
be important for translocation of the DOCK-Elmo complex to the cell membrane (Katoh 
& Negishi 2003, Hiramoto et al. 2006, Katoh et al. 2006, Namekata et al. 2012). A second 
regulatory mechanism for DOCK proteins is the formation of dimers. Homodimers of 
Dock9 or Dock1 have been reported to display increased GEF activity (Meller et al. 2004). 
Further research has also provided evidence of heterodimers between Dock1 and Dock5 
and suggested ELMO proteins act as scaffold proteins for DOCK-family dimers (Patel et 
al. 2011). Recently DOCK proteins, and the DOCK-ELMO-RhoG signalling axis in 
particular, have emerged as important players in regulating neurite morphology, 
complexity and spine formation through effects on the actin cytoskeleton (Kim et al. 2011, 
Franke et al. 2012, Namekata et al. 2012). Also phagocytic uptake of apoptotic cells in C. 
elegans also employs a DOCK-ELMO complex downstream of RhoG, which is in turn 
activated by the Dbl-GEF Trio (deBakker et al. 2004). 
In conclusion, it has become evident that GEFs are not only key regulators of GTPase 
activity, but due to their ability to interact with and be regulated by different signalling 
pathways also constitute a versatile mediator of signalling cross-talk. 
1.2.2.2 Regulation through GAPs 
GAPs are highly conserved in eukaryotes and can be found in organisms ranging from 
yeast to humans (Peck et al. 2002). Between 60 and 70 different proteins containing a Rho 
GAP domain are encoded in the human genome but not all of them have been functionally 
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described yet (Tcherkezian & Lamarche-Vane 2007). Initially thought of as mere signal 
terminators of Rho GTPase signalling, by now many pivotal roles for GAP proteins have 
been described, including intersection with other signalling pathways as well as signalling 
functions not mediated by the Rho GAP domain. 
The key feature GAP proteins have in common is their signature Rho GAP domain, which 
enhances the intrinsic GTPase activity of Rho GTPases upon binding by the GAP to the 
GTPase (Peck et al. 2002). A conserved arginine residue within the Rho GAP domain is 
essential for its catalytic function, but not mandatory for the initial binding between GAP 
and GTPase (Graham et al. 1999). A notable exception to this rule is the Rac-specific GAP 
oculocerebrorenal syndrome of Lowe (OCRL-1), which displays low GAP activity despite 
lacking the conserved arginine residue in its GAP domain (Faucherre et al. 2003). Apart 
from the common RhoGAP domain, GAPs may contain a great variety of different 
interaction domains including PDZ, SAM, SH2, SH3, BAR and DH-PH domains, thus 
enabling them to make use of, and contribute to, several distinct signalling mechanisms 
and pathways (Peck et al. 2002, Tcherkezian & Lamarche-Vane 2007). An example 
highlighting the importance of GAPs independent of their GAP activity can be found in 
TCGAP, which regulates insulin-dependent glucose uptake via interactions with RhoQ 
despite not being catalytically active in cellulo (Chiang et al. 2003). 
There are significant differences between GAPs regarding their specificity towards single 
Rho family GTPases or subfamilies. Studies have shown that some GAPs are specifically 
active towards single GTPases or at least GTPase subfamilies, for example p190GAP for 
RhoA (Ridley et al. 1993) and ARHGAP15 for Rac (Seoh et al. 2003). Some GAPs display 
an intermediate level of specificity and are active towards members of two of the main Rho 
subfamilies, but not towards the third. For example, CdGAP is active towards Cdc42 and 
Rac1, but not towards RhoA (Tcherkezian et al. 2006). Other GAPs, however, show a 
broad range of activity towards several GTPases, for example RICS and OPHN1 that both 
show activity towards Cdc42, Rac1 and RhoA (Billuart et al. 1998, Nakamura et al. 2002, 
Fauchereau et al. 2003, Moon et al. 2003). Identifying the specificity of GAPs towards 
single GTPases is challenging, as studies often only test the activity towards their GTPase 
of interest, or towards Cdc42, Rac1 and RhoA (being the most-studied Rho GTPases), and 
very few comprehensive studies exist. Furthermore, there seem to be significant differences 
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between the specificity GAPs display in vitro compared to observations in vivo 
(Tcherkezian & Lamarche-Vane 2007). Often there are also conflicting reports about the 
specificity of certain GAPs, as is the case for Slit/ROBO GAP1 (SrGAP1), which was 
originally reported to interact with Cdc42 and RhoA, but not Rac1 in vivo (Wong et al. 
2001), but a more recent study reported activity mainly towards Rac1 (Yamazaki et al. 
2013). Potentially, these contradictory findings can be explained by post-translational 
modifications, which can influence specificity in different cellular contexts ((Minoshima 
et al. 2003). 
A subset of GAPs, but not all of them, show tissue specific expression. One example is 
RICS (also known as Grit), which is only expressed in the brain, where it contributes to 
neurite extension downstream of TrkA (Nakamura et al. 2002, Moon et al. 2003). 
Regulation of GAP activity is often mediated through phosphorylation by protein kinases. 
Kinase-regulated pathways include signalling by SFKs fyn and src (Roof et al. 1998, Liu 
et al. 2006), signalling downstream of synaptic activity through calmodulin-dependent 
protein kinase II (CamKII) (Okabe et al. 2003) and cytokinetic signalling through Aurora 
B (Minoshima et al. 2003). GAPs are also involved in mitogenic signalling. CdGAP is 
phosphorylated at an important regulatory site by ERK1 (Tcherkezian et al. 2005) and 
another GAP, RhoA-specific Gmip, interacts with Ras GTPases, themselves important 
players in mitogenic signalling (Aresta et al. 2002). As with GEFs, phosphorylation can 
have very varied effects on GAP activity: it can lead to an increase in GAP activity (Roof 
et al. 1998, Ohta et al. 2006), it can inhibit activity (Okabe et al. 2003, Tcherkezian et al. 
2005) or very interestingly, lead to a change in substrate specificity, as for example in the 
case of male germ cell Rac GAP (MgcRacGAP), which switches its specificity from Rac1 
and Cdc42 to RhoA after phosphorylation (Minoshima et al. 2003). A similar switch has 
also been reported for SrGAP1 downstream of Roundabout receptor (ROBO) signalling, 
increasing its activity towards Cdc42, while downregulating GAP activity towards RhoA 
(Wong et al. 2001). GAPs are also regulated downstream of Eph-ephrin signalling, as 
detailed in the section below. 
GAPs also provide a target for cross-talk between different subfamilies of Rho GTPases. 
Filamin A –associated Rho GAP (FilGAP) is a Rac GAP that gets phosphorylated 
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downstream of ROCK leading to an increase in its activity (Ohta et al. 2006). CdGAP 
experiences inhibition of its Rac GAP activity when bound by ITSN1, a Cdc42-GEF (Jenna 
et al. 2002). Bcr contains both a Rho GAP and a Rho GEF domain and has been shown to 
simultaneously inhibit Rac1 and promote Cdc42 signalling in vivo (Ridley et al. 1993, 
Korus et al. 2002). Finally, GAPs can also be downregulated by degradation through the 
proteasome after ubiquitination (Su et al. 2003). 
These examples underline the importance of regulation of GTPase activity by GAPs and 
highlight that GAPs play just as central a role as GEFs in integrating information from 
different signalling pathways. 
1.2.3 Eph‐ephrin signalling through Rho‐family GTPases 
Many important functions of Eph-ephrin signalling rely heavily on processes involving 
rearrangement of the cytoskeleton. Therefore it is not surprising that Rho-family GTPases 
and their regulating GEFs and GAPs have emerged as key effectors in Eph-ephrin 
signalling.  
Growth cone collapse in neurons can be initiated by RhoA signalling (Lehmann et al. 1999, 
Dergham et al. 2002). Experiments with retinal ganglion cells (RGCs) have shown that 
RhoA-dependent growth cone collapse is triggered downstream of EphA activation by 
ephrinA5 (Wahl et al. 2000). This signalling pathway uses ROCK downstream of RhoA to 
induce actin-myosin-based contraction and also seems to negatively regulate Rac1 
signalling. Another study, however, showed Rac1 signalling downstream of ephrinA2 in 
RGCs to be crucial for correct formation of retino-tectal projections (Jurney et al. 2002). 
The role of Rac1 in growth cone collapse downstream of ephrinA-EphA signalling is linked 
to its ability to promote endocytic uptake (Fournier et al. 2000, Jurney et al. 2002). Recently 
the RhoA-ROCK pathway has also been shown to be responsible for growth cone collapse 
downstream of ephrinB reverse signalling induced by ectodomains of EphB2 (Takeuchi et 
al. 2015). A very interesting feature of EphA forward signalling mediated by RhoA is the 
effect EphA activation has on the RhoGEF ephexin (NGEF) in neurons. As described 
previously, phosphorylation of ephexin by EphA receptors leads to a change in its catalytic 
specificity - decreasing its ability to activate Cdc42 and Rac1, while increasing its activity 
towards RhoA - thereby activating the RhoA-ROCK pathway and leading to growth cone 
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collapse (Shamah et al. 2001, Sahin et al. 2005). Another GEF that has increased activity 
towards RhoA after phosphorylation by EphA4 is ArhGEF15. It is expressed in vascular 
smooth muscle cells and modulates vascular contractility by contributing to actin stress 
fibre formation (Ogita et al. 2003). Finally, a shift in balance away from Cdc42 and towards 
RhoA activity downstream of ephrinA-EphA signalling is also responsible for inhibiting 
chemotaxis in T-lymphocytes, but whether this signalling pathway also operates through 
phosphorylation of a GEF is not yet known (Sharfe et al. 2002). 
The function of Rho family GTPases is also important for the role of Eph-ephrin signalling 
in the formation of the motor system. EphrinB3-EphA4 signalling in the spinal cord is 
important for the correct formation of central pattern generators. Correct axon guidance 
decisions for the development of this locomotor circuit require growth cone collapse 
mediated by 2-chimaerin, a Rac GAP, which gets activated upon binding to active EphA4 
clusters (Beg et al. 2007, Iwasato et al. 2007, Wegmeyer et al. 2007). This interaction is 
potentially facilitated by the adaptor protein Grb4 (also known as Nck2), as mice deficient 
for Nck1 and Grb4 show the same phenotype as 2-chimaerin or EphA4 knockout mice 
(Fawcett et al. 2007). 
In contrast to 2-chimaerin-induced inhibition of Rac1 activity causing growth cone 
collapse in spinal motor neurons, in RGCs growth cone collapse and correct axon guidance 
occurs after activated Ephs phosphorylate and thereby activate Vav family GEFs, which, 
in turn, activate Rac (Cowan et al. 2005). Moreover, the work of Cowan and colleagues 
presents a potential explanation for the seemingly opposing roles of Eph-Rac signalling 
plays in growth cone collapse: the authors link Vav and Rac function to endocytosis of 
Eph-ephrin clusters, which is thought to be required for cell detachment. The endocytic 
uptake possibly requires localised activation of Rac, whereas the collapse of the actin 
cytoskeleton of the growth cone in general requires a reduction in Rac activity. As the 
mechanisms of Eph-ephrin endocytosis are seminal to this dissertation, they will be 
discussed in greater depth in section X. 
Rac activity has also been implicated in repulsive guidance and axon pruning downstream 
of reverse signalling by ephrinB3. Effective signalling requires phosphorylation of 
ephrinB3, which enables Grb4 to bind to its cytoplasmic tail. Grb4 in turn can bind Dock1 
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and the Rac downstream effector PAK and together, this signalling cascade regulates the 
actin dynamics necessary for growth cone collapse (Xu & Henkemeyer 2009). 
For the effects on dendrite morphology mediated by Eph-eprin signalling, Rac and Cdc42 
signalling downstream of EphB2 has been reported to be important. A signalling axis 
involving EphB2, Cdc42, the Cdc42-specific GEF ITSN and neuronal Wiskott-Aldrich 
syndrome protein (N-WASP), a regulator of actin polymerisation, has been shown to be 
required for the formation and maturation of dendritic spines in cultured hippocampal 
neurons (Irie & Yamaguchi 2002, Nishimura et al. 2006). Experiments indicated that 
Cdc42 activity is required for spine formation and that ITSN displayed greater GEF activity 
when bound by EphB2 or N-WASP. A complex of EphB2, N-WASP and ITSN resulted in 
an even larger increase in GEF activity, which suggests a synergistic effect of N-WASP 
and EphB2 binding on ITSN. Another GEF involved in dendrite morphogenesis is Kalirin 
(Penzes et al. 2000, Penzes et al. 2001). Kalirin localises to EphB2 clusters activated by 
ephrinB1 and is subsequently phosphorylated (Penzes et al. 2003). Rac activity is increased 
by Kalirin and in turn, leads to an increase in the activity of its downstream effector PAK, 
which mediates the localised actin rearrangement required for dendritic spine 
morphogenesis (Penzes et al. 2003). Another pathway employed by both EphA and EphB 
activated by ephrinBs to regulate dendrite morphogenesis uses the Rac-specific GEF 
Tiam1 to induce Rac activity (Tanaka et al. 2004, Tolias et al. 2007). Tiam1 is recruited 
to, and phosphorylated by ephrinB-induced EphB2 receptor clusters, and this activation is 
necessary for spine development (Tolias et al. 2007). The presence of NMDA receptors at 
EphB2 clusters and the previous established link between synaptic activity and Tiam1 
signalling suggests that there is a connection between synaptic activity and EphB2-
regulated dendrite morphogenesis (Tolias et al. 2005, Tolias et al. 2007). More recent work 
proposed that Tiam1 forms a complex with the Rac GAP Bcr in this context, which allows 
precise and tight spatio-temporal regulation of Rac activity to regulate synaptogenesis 
downstream of EphB receptors (Um et al. 2014). A finely tuned balance in Rac activity is 
required, as inhibition of Bcr function leads to both aberrant synaptic overgrowth due to 
increased Tiam1-induced Rac activity and increased spine-loss induced by ephrinB1 due 
to increased internalisation of ephrinB1-EphB clusters. Tiam1 has also been implicated in 
the endocytosis of EphAs and it has been proposed to mediate signalling from Eph receptor 
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clusters residing in endosomal compartments (Yoo et al. 2010, Boissier et al. 2013). A 
detailed description of the mechanisms of Eph-ephrin endocytosis is provided in chapter 
1.3.3. A different role for Tiam1 activity downstream of ephrinB2 reverse signalling has 
been reported by Adams and colleagues for vascular smooth muscle cells. Here, ephrinB2 
reverse signalling regulates Tiam1 activity, as well as localisation towards the cell 
membrane and sites of platelet-derived growth factor receptor (PDGFR) internalisation. 
Both PDGFR internalisation and Tiam1-induced Rac activity are required for correct vessel 
wall formation (Nakayama et al. 2013). 
Spine morphogenesis and synapse formation can also be mediated by ephrinB reverse 
signalling. Experiments in cultured rat hippocampal neurons have shown a signalling 
pathway involving Grb4, GIT1, Pix, Rac and PAK to be required for the formation of 
dendritic spines and synapses downstream of ephrinBs (Zhang et al. 2005, Segura et al. 
2007). Phosphorylation of ephrinBs is required, which in turn leads to localisation of GIT1 
to synaptic compartments and binding of Grb4 (Segura et al. 2007). The GIT1-Grb4 
complex recruits the GEF Pix, which activates Rac1 and thereby PAK. This signalling 
cascade leads to an increase in phosphorylation of myosin light chain II (MLC2), which is 
required for the effects on dendrite morphology (Zhang et al. 2005). 
In conclusion, Rho-family GTPases and their regulatory GEFs and GAPs are well-
established players in Eph-ephrin signalling and are instrumental for actin rearrangement-
driven changes in cell morphology and motility, for example in growth cone collapse and 
spine morphology. Furthermore, they seem to be pivotal elements in Eph-ephrin 
endocytosis, however, their precise contribution still remains to be deciphered. The large 
number of GEFs and GAPs and their overlapping specificities also provide a high level of 
redundancy in the system, as can be seen in the role of Eph-ephrin signalling in dendrite 
morphogenesis, where both a Tiam1-Rac and an ITSN-Cdc42 pathway have been 
described. Studying the involvement of GEFs and GAPs in Eph-ephrin signalling therefore 




The term endocytosis derives from the Greek words endos (into) and cytos (“hollow 
vessel” = cell) and is used to describe the cellular processes that mediate the up-take of 
molecules, membranes, liquids, or larger components into a cell.  Being able to internalise 
external material into a cell is of vital importance for many physiological functions. 
Primarily thought to be required for the regulation of signalling responses and, especially, 
for the downregulation of signalling by the internalisation of cell surface receptors 
(Doherty & McMahon 2009, McMahon & Boucrot 2011), endocytosis is also important in 
the  elimination of pathogens (Flannagan et al. 2012), in mediating changes of cellular 
morphology (Donaldson et al. 2009, Tojima et al. 2011), and in synaptic signalling (Royle 
& Lagnado 2010). Furthermore, endocytic pathways are also used by viruses and other 
pathogens to infect cells and are therefore important in the context of several diseases 
(Marsh & Helenius 2006, Maxfield 2014).  
Internalisation of cargo serves several purposes and can also result in differing outcomes. 
Once internalised, vesicles from several endocytic pathways are considered to first localise 
to the early endosomal compartment. From the early endosomal compartment different 
endocytic routes exist: either cargo is returned to the plasma membrane via recycling 
endosomes, or it is sent for degradation via late endosomal and lysosomal compartments 
(Alberts 2015). The trafficking between these different endosomal compartments is tightly 
regulated by small GTPases of the Rab family (Wandinger-Ness & Zerial 2014). Different 
Rab GTPases are associated with distinct endosomal compartments. The best characterised 
ones are: Rab5 with the early endosome, Rab7 with the late endosome and Rab11 with the 
recycling endosome. 
After the discovery of recycling from endosomal compartments had challenged the original 
notion that endocytosis is only a mechanism for restricting and terminating signalling from 
cell surface receptors, further evidence for a more diverse physiological function of 
endocytosis came from the observation that some receptors remain active and continue 
signalling from inside the endosomal compartment after internalisation. Initially reports 
for epidermal growth factor receptor (EGFR) signalling responses showed that the receptor 
stays active and phosphorylated and bound to its downstream effectors on endosomes (Di 
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Guglielmo et al. 1994, Baass et al. 1995, Burke et al. 2001). By now so-called signalling 
endosomes have also been described to occur after activation of several other RTKs 
including TrkA, TrkB and p75NTR (Grimes et al. 1996, Howe et al. 2001, Barker et al. 
2002, Shao et al. 2002, Saxena et al. 2005). 
Endocytosis is thus a diverse process, which is not only important in many physiological 
contexts, but can also serve multiple purposes depending on the trafficking of cargo 
downstream of the initial internalisation event. 
1.3.1 Endocytic pathways 
The term endocytosis encompasses a host of different processes, which differ significantly 
in their molecular mechanism and the kind of cargo they internalise. The distinction 
between these pathways is based on differences in ultrastructural appearance as revealed 
by electron microscopy, the type of cargo internalised, and the molecular mechanisms 
involved. Here I will provide a short overview of the most commonly described endocytic 
pathways. 
1.3.1.1 Clathrin‐mediated endocytosis 
Perhaps the most intensively studied endocytic pathway is clathrin-mediated endocytosis 
(CME). In most cases CME is required for the uptake of cell surface receptors after binding 
to extracellular ligands, which is also the reason it was formerly called receptor-mediated 
endocytosis. In brief, a host of adaptor proteins can recruit activated receptors and initiate 
the formation of clathrin-coated pits (CCP) (Sorkin 2004, Schmid et al. 2006). Specific 
adaptor proteins are required for the recruitment of specific endocytic cargos within this 
process (Motley et al. 2003). Clathrin itself has the structure of a triskelion and forms a 
lattice around the endocytic pit inducing membrane curvature (Roth & Porter 1964, Schmid 
& McMahon 2007, McMahon & Boucrot 2011). While the clathrin-coat is sufficient to 
induce membrane curvature, scaffolding proteins of the epsin and/or BAR families are 
required to stabilise the curvature in order to form vesicles (Ford et al. 2002, Peter et al. 
2004). For the budding of a vesicle from a CCP, activity of the small GTPase dynamin is 
required, which leads to the scission of the vesicle at its neck connecting it to the plasma 
membrane (De Camilli et al. 1995, Praefcke & McMahon 2004). GTPases of the Rho 
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family have been shown to inhibit CME when constitutively active (Lamaze et al. 1996), 
however it is questionable how physiologically relevant this regulation is, as it is not in the 
focus of the extensive recent literature on clathrin-mediated endocytosis (Ridley 2006, 
Schmid & McMahon 2007, Doherty & McMahon 2009, McMahon & Boucrot 2011). 
1.3.1.2 Caveolae‐mediated endocytosis 
Another pathway important for the internalisation of cell surface receptors is caveolae-
mediated endocytosis. Caveolae are specialised membrane compartments rich in lipids and 
the eponymous protein caveolin that is capable of forming invaginations in the cell 
membrane (Parton & Simons 2007). From these invaginations, endocytic cargo-containing 
vesicles can be cleaved off. This process requires dynamin activity (Henley et al. 1998). 
Endocytic vesicles deriving from caveolae are more stable than clathrin-coated vesicles 
and first reside in compartments termed caveosomes after internalisation (Tagawa et al. 
2005). Nonetheless, subsequently they are trafficked through typical endosomal 
compartments, such as the early endosome, as is the case for several other endocytic 
pathways (Pelkmans et al. 2004). Their stable nature led to the hypothesis that caveolae 
function as signalling platforms (Krajewska & Maslowska 2004). Furthermore, 
recruitment of receptors to caveolae can prohibit their internalisation through other 
pathways, as in the case of EGFR (Park et al. 2000). A process closely related to caveolae-
mediated endocytosis is flotillin-dependent endocytosis, however endocytic cargo and 
flotillin are localised to distinct membrane compartments outside of caveolae (Glebov et 
al. 2006, Frick et al. 2007). 
1.3.1.3 Other clathrin‐independent pathways 
There is a host of further so-called clathrin-independent endocytic pathways and the 
molecular distinction between them is not always clear and varies between studies and 
authors (Sandvig et al. 2008, Doherty & McMahon 2009, Donaldson et al. 2009). One of 
these is the clathrin-independent carrier/GPI-anchored protein-enriched early endocytic 
compartment (CLIC/GEEC) pathway. Endocytosis through the CLIC/GEEC pathway 
mediates uptake of GPI-anchored proteins and extracellular fluids and is tightly regulated 
by Cdc42 and two GAPs: GTPase regulator associated with focal adhesion kinase-1 
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(GRAF1) and ARHGAP10 (Sabharanjak et al. 2002, Kumari & Mayor 2008, Lundmark et 
al. 2008, Doherty & Lundmark 2009). Internalisation through the CLIC/GEEC pathway 
can lead to either recycling back to the membrane or lysosomal degradation (Fivaz et al. 
2002, Sabharanjak et al. 2002). A separate clathrin- and caveolae-independent pathway 
requires the activity of Rac1 and its downstream effector PAK for the internalisation of 
interleukin receptors or nicotinic acetylcholine receptors, respectively (Grassart et al. 2008, 
Kumari et al. 2008). As there is conflicting evidence about whether dynamin is required 
for the internalisation of endocytic cargo, it is not clear whether these two reports refer to 
an identical pathway or whether Rac and PAK, through their effects on the actin 
cytoskeleton, are involved in different endocytic routes. This notion is supported by their 
requirement for macropinocytosis (see below). Another clathrin-independent pathway is 
characterised by the requirement of the small GTPase Arf6 and its independence from 
dynamin activity (Naslavsky et al. 2004, D'Souza-Schorey & Chavrier 2006). 
Internalisation via this Arf6-dependent endocytic pathway is tightly linked to trafficking 
of endocytic cargos through recycling compartments and back to the plasma membrane 
(Donaldson et al. 2009). Strikingly, despite being required for a clathrin-independent 
internalisation pathway, Arf6 has also been shown to have a regulatory role in CME by 
binding to clathrin and recruiting adaptor proteins (Paleotti et al. 2005, Tanabe et al. 2005). 
1.3.1.4 Macropinocytosis and Phagocytosis 
Macropinocytosis is a pathway by which larger patches of membrane are taken up. It 
involves the formation of membrane ruffles, which share a similarity in their composition 
to lipid rafts (Manes et al. 2003). Through this process, large numbers of RTKs can be 
internalised at the same time (Orth et al. 2006, Orth & McNiven 2006). There are several 
proteins implicated in this process. The pinching off of macropinosomes from the cell 
membrane has been reported to not be regulated by dynamin, as in many other endocytic 
processes, but rather employs the activity of ATPase Pincher/EHD4 or brefeldinA-ADP 
ribosylated substrate (BARS) (Shao et al. 2002, Liberali et al. 2008). Rac1 is critical for 
the formation of dorsal membrane ruffles and thus for macropinocytosis (Ridley et al. 1992, 
West et al. 2000). Recruitment of Rac to sites of macropinosome formation requires 
cholesterol and potentially the activity of the small GTPase Arf6 (Grimmer et al. 2002, 
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Cotton et al. 2007). Several protein kinases are involved in macropinocytosis, but the 
complete regulatory network has not yet been deciphered. The downstream effector of 
Rac1, PAK, plays a central role in the regulation of macropinocytosis (Dharmawardhane 
et al. 2000). One of its important functions is the phosphorylation of BARS, which is 
required for BARS-mediated membrane fission to occur (Liberali et al. 2008). 
Furthermore, constitutive phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) activity 
is sufficient to induce membrane ruffling and macropinocytosis (Amyere et al. 2000). The 
same is true for SFK v-Src (Veithen et al. 1996). However, the precise contribution of these 
kinases to the macropinocytosis pathway is not clear yet. 
Phagocytosis is the uptake of large particles, particularly pathogens and cell debris, by 
specialised cells in the immune system (Flannagan et al. 2012). This ‘eating’ of large 
particles (from Greek “phagein” = to devour) requires large scale remodelling of the 
cytoskeleton architecture and the function of Rho family GTPases (Massol et al. 1998, 
Chimini & Chavrier 2000, Hoppe & Swanson 2004).  Activation of Rac1, Rac2 and Cdc42 
in a precisely orchestrated location and temporal sequence is required for the formation of 
the phagocytic cup and for subsequent internalisation to ensue (Hoppe & Swanson 2004). 
A special form of phagocytosis is the uptake of entire living cells into another cell, called 
entosis, which requires RhoA activity and is thought to occur in many forms of cancer 
(Overholtzer et al. 2007). 
1.3.1.5 Trans‐endocytosis of transmembrane molecules 
In rare cases, uptake of receptor-ligand complexes, in which both proteins are membrane-
bound, is observed. The transmembrane ligand bride of sevenless in Drosophila 
melanogaster is internalised into cells expressing the sevenless receptor tyrosine kinase 
(Cagan et al. 1992). Sonic hedgehog is internalised into cells expressing its receptor in a 
dynamin-dependent process, as revealed by experiments in an avian system (Incardona et 
al. 2000). Another transmembrane protein internalised in a dynamin-dependent process is 
notch, however, this requires catalytic cleavage of its ectodomain (Parks et al. 2000). A 
final example of endocytosis of transmembrane proteins into another cell are the Eph 
receptors and their ephrin ligands (Marston et al. 2003, Zimmer et al. 2003). This will be 
discussed in greater depth in the following chapter. 
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In how far the different endocytic pathways described above are completely separate and 
functionally distinct is not completely understood. Given the overlapping molecular 
mechanisms of the different pathways it is possible that there is cross-talk and cross-
regulation between different endocytic routes. An interesting question is to what extent 
cargos such as specific receptors are associated with a specific endocytic pathway. 
Extensive work on EGFR has provided some insight into how the same protein can be 
taken up by multiple pathways and which effects this has on its signalling and function. 
Depending on the concentration of ligand used to stimulate EGFP-expressing cells, EGFRs 
are internalised by a clathrin-dependent (at low doses of EGF) or independent (at high 
doses) pathway (Sigismund et al. 2005, Orth et al. 2006). Interestingly, the various 
endocytic pathways also lead to distinct fates of the internalised EGFR. When endocytosed 
through CME, EGFR can be recycled back to the plasma membrane or continue signalling 
from endosomal compartments, while endocytosis through clathrin-independent 
mechanisms leads to ubiquitination of the receptor and subsequent degradation (Sigismund 
et al. 2008). 
The variety and complexity of different endocytic pathways underscores the biological 
importance for cells to be able to internalise external or membrane-bound substances. As 
more and more characteristics of individual pathways are deciphered, attributing an 
endocytic pathway of a protein of interest to one of the established pathways can potentially 
reveal additional information about its signalling characteristics. However, given that not 
all boundaries between different pathways are clearly defined and the molecular 
mechanisms, at least to some extent, overlap, there might be more of a spectrum of 
interlinked endocytic mechanisms than clearly defined pathways. 
1.3.2 Role of the actin cytoskeleton in endocytosis 
Since all endocytic processes require morphological changes of the cell membrane such as 
the formation of invaginations or protrusion around endocytic sites, it is not surprising that 
rearrangement of the cytoskeleton has emerged as a central element in the control of several 
endocytic pathways (Girao et al. 2008). Actin polymerisation drives the membrane 
extensions required for the engulfment of cargos and also provides an anchor for the force 
required to allow vesicle budding by membrane scission. The processes required for the 
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uptake of larger cargo or large patches of membrane, such as in macropinocytosis 
(Merrifield et al. 1999, Grimmer et al. 2002) and phagocytosis (Swanson et al. 1999, 
Chimini & Chavrier 2000), especially rely heavily on actin rearrangement. To which extent 
the actin cytoskeleton plays a role in CME is still a matter of debate. While there is evidence 
that CME is not dependent on changes in the actin cytoskeleton (Lamaze et al. 1996, 
Fujimoto et al. 2000), other reports show more efficient uptake of CCPs at sites of local 
actin reassembly at least in some physiological contexts (Gottlieb et al. 1993, Merrifield et 
al. 2002). A very recent report using super-resolution live microscopy shed more light on 
the role of actin in CME. In their system, some CCPs co-localised with polymerised actin 
while others did not. Internalisation occurred in the absence of co-localisation, but the rate 
of uptake was higher when CCPs co-localised with polymerised actin (Li et al. 2015). 
The actin cytoskeleton is thus a pivotal element in the control of many endocytic processes 
and likely a key mediator of endocytosis of Eph-ephrin complexes (see below). 
1.3.3 Endocytosis of Eph‐ephrin complexes 
Endocytosis plays an important role in Eph-ephrin signalling. In order to switch from an 
initially adhesive response to a repulsive one, the interlocked Eph-ephrin complexes 
linking opposing cells must be removed from the cell surface. One  mechanism to achieve 
this is by cleavage of either the Eph receptor or the ephrin thus allowing cell detachment, 
as described in section 1.1.2.3 and first shown in the reports by Hattori and colleagues and 
Janes and colleagues (Hattori et al. 2000, Janes et al. 2005). The other option for removing 
Eph-ephrin complexes to allow cell detachment is endocytosis. 
In 2003 both Zimmer and colleagues and Marston and colleagues established that in 
parallel with cell detachment, the entire EphB-ephrinB complex was endocytosed into 
either the receptor or ligand expressing cell, thus mirroring bidirectional signalling 
capability (Marston et al. 2003, Zimmer et al. 2003). In fact, in addition to proving the 
uptake of full-length proteins into the opposing cell by antibody staining against their 
intracellular domains, experiments with membrane stains revealed that the endocytosed 
vesicles also contain portions of the membrane of the opposing cell (Marston et al. 2003). 
Therefore, the process has been termed trans-endocytosis. Both studies show that the 
intracellular domains and, in the case of EphBs, their kinase function is required for 
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endocytosis to occur. Intracellular truncation of either the receptor or the ligand disrupts 
bidirectionality and shifts the direction of endocytosis into the opposite cell. If both 
elements are truncated, endocytosis and cell detachment are inhibited, and the cells adhere 
strongly to each other (Zimmer et al. 2003). In the unperturbed system with full-length 
receptors and ligands, the direction into which more endocytosis occurs depends on the 
cellular context and also on the sequence in which the two different cell types have been 
seeded, suggesting that the state of attachment plays a role. Interestingly, Marston and 
colleagues also showed that Ephs stay phosphorylated after endocytosis, which could allow 
for Eph receptor signalling from endosomal compartments. The two studies also provide 
some insight into the molecular mechanisms underlying the trans-endocytosis process, at 
least in the forward direction. As expected for a process involving reorganisation of cellular 
membranes to the extent needed for internalising whole Eph-ephrin clusters, including 
patches of membrane from the opposing cell, actin dynamics are essential for trans-
endocytosis to occur, as revealed by treatment with the actin-depolymerising drug 
cytochalasin D. The importance of actin reorganisation was further underlined by the 
findings that both activity of the actin-binding Arp 2/3 complex, as well as activity of Rac1 
is required for ephrinB trans-endocytosis into EphB+ cells. Interestingly, no co-localisation 
of internalised EphB with clathrin-coated pits or caveolin was observed, suggesting that 
ephrinB trans-endocytosis into EphB+ cells does not use the CME or caveolae-dependent 
internalisation pathways (Marston et al. 2003). Finally, the internalisation of Eph-ephrin 
clusters is also dependent on the GTPase dynamin, which most likely regulates vesicle 
scission from the membrane. Zimmer and colleagues also showed the physiological 
relevance of trans-endocytosis for axon guidance decisions. Not only does trans-
endocytosis occur between EphB-expressing cells and neurons endogenously expressing 
ephrinBs in culture, but it is also required for contact-mediated growth cone collapse. 
Furthermore, when cells expressing truncated Ephs, which restrict endocytosis to the 
reverse direction, were compared to cells expressing the full-length protein, allowing 
bidirectional endocytosis, the latter were found to induce growth cone collapse more 
effectively. Later work by Lauterbach and Klein indicated that EphB trans-endocytosis into 
ephrinB+ cells is important in astrocyte-neuron communication (Lauterbach & Klein 
2006). Taken together, these papers highlight the importance of the trans-endocytosis 
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process for EphB-ephrinB signalling, in particular, its relevance for transforming initial 
adhesion into repulsion. Further elucidation of the molecular mechanisms governing this 
process will enable a better understanding of the function of Eph-ephrin signalling in many 
relevant physiological contexts, such as axon guidance and tissue border formation.  
After the initial work presented in these papers, several other studies further elucidated the 
molecular mechanisms of Eph-ephrin endocytosis. However, these studies did not examine 
endocytosis in a cell-cell contact-mediated setting, but rather made use of the fact that 
signalling responses can also be elicited by treating cells with pre-clustered soluble 
receptor or ligand ectodomains. In how far the uptake of clusters induced by soluble 
ectodomains uses the same molecular mechanisms is not clear, especially in light of recent 
work that has shown significant differences in phosphorylation patterns downstream of 
cell-contact induced Eph-ephrin signalling when compared to that induced by soluble 
ectodomains (Jorgensen et al. 2009). Still, at least some of the requisite proteins described 
by the Marston and Zimmer studies have also been implicated in regulating endocytosis of 
soluble ephrin ectodomains into Eph+ cells. For example, Rac1 was shown to be involved 
in uptake of EphA and EphB receptors after stimulation with soluble ephrin ectodomains 
(Cowan et al. 2005, Tolias et al. 2007, Yoo et al. 2010, Um et al. 2014). Moreover, Cowan 
and colleagues discovered that growth cone collapse downstream of EphA receptors in 
retinal ganglion cells is dependent on the Rac-GEF Vav. Vav-induced Rac activity leads 
to endocytosis of Eph-ephrin complexes, which is required for growth cone collapse. 
Without Vav-mediated growth cone collapse, retinogeniculate projection neurons show 
aberrant guidance and wiring. While endocytosis of ephrinA1—EphA4 receptor clusters is 
inhibited in neurons cultured from Vav2/3 knockout mice, uptake of transferrin, a protein 
endocytosed via CME, is not altered, suggesting uptake of ephrinA1-EphA4 clusters is 
independent of CME (Cowan et al. 2005). 
The Rac subfamily-specific GEF Tiam1 has been implicated as a regulator of endocytosis 
of both EphAs and EphBs after stimulation with soluble ephrin ectodomains. Initial work 
by Tolias and colleagues revealed an interaction between Tiam1 and EphB receptors in 
dendritic spine development. Upon stimulation with ephrinB1 Tiam1 is recruited to EphB2 
clusters, where it is phosphorylated (Tolias et al. 2007). Phosphorylation of Tiam1 then 
increases its GEF activity towards Rac (Servitja et al. 2003, Miyamoto et al. 2006). Tiam1 
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can also interact with EphAs via their JM region (Yoo et al. 2010, Boissier et al. 2013). 
This interaction is important for the ephrinA5-induced internalisation of EphA8 clusters 
(Yoo et al. 2010). Co-localisation with clathrin heavy chain molecules and transferrin 
suggests that EphA8 is internalised via the clathrin-mediated pathway after stimulation 
with soluble ephrinA5-FC. Subsequent work by the same group provides evidence that a 
mutated EphA8 receptor lacking the Tiam1 interaction domain in the JM region is able to 
negatively affect endocytosis of other EphA receptors and expression of this 
internalisation-deficient mutant leads to aberrant retinocollicular topographic mapping 
(Yoo et al. 2011).   
Tiam1 is also involved in the internalisation of EphB receptors upon stimulation with 
ephrin ectodomains (Um et al. 2014). For the role of EphB receptors in spine development 
and synapse maturation, a fine-tuned balance in Rac activity needs to be achieved, since 
on one hand, Rac activity is required for spine growth and synapse development, while on 
the other hand, excessive Rac activity leads to excessive endocytosis and spine loss. This 
balance is achieved by a regulatory complex formed between Tiam1 and Bcr, which has 
GAP activity towards Rac. This regulatory complex can bind to EphB2 and in the inactive 
state of the receptor, the inhibitory function of Bcr on Rac activity is dominant. Upon 
stimulation with ephrinB1, however, a disruption of the Tiam1-Bcr complex and a transient 
increase of Tiam1 phosphorylation and Rac activity was observed. These events are 
required for ephrinB1-induced spine and synapse formation. Interestingly, experiments 
using neuronal cultures from Bcr knockout mice, or with neurons expressing dominant 
negative isoforms of Bcr, indicate that despite being a negative regulator of Rac activity, 
Bcr function is still required for ephrinB1-induced spine growth, as stimulation with 
ephrinB1 ectodomains in these genetic backgrounds led to a loss of spines and synapses. 
One explanation for these striking results is the effect Bcr exerts on the endocytosis of 
EphB2s. In Bcr knockout mice the level of internalisation of EphB2s after ephrinB1 
stimulation is greatly elevated, which potentially attenuates the signalling required for 
spine growth and synapse development mediated by EphB2-activated Tiam1 and Rac. In 
addition to the requirement of Rac, Tiam1 and the regulating function of BCR, work by 
Um and colleagues also implies that activity of the GTPase dynamin and the CME pathway 
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are required for endocytosis of EphB2 receptors upon stimulation with ephrinB 
ectodomains. 
Interestingly, additional research into the role of Tiam1 in Eph-ephrin signalling and 
endocytosis suggests continuous signalling of EphA-ephrinA complexes from endosomal 
compartments (Boissier et al. 2013). This study confirmed the earlier observation that Ephs 
remain phosphorylated after internalisation and also revealed that Tiam1 remains bound to 
Ephs in endosomes. However, the study does not provide direct evidence of EphA 
signalling from the endosome, so whether the retained phosphorylation and interaction of 
Eph with Tiam1 at the endosome has physiological relevance still remains to be clarified. 
Furthermore, Boissier and colleagues also shed some light on the intracellular trafficking 
of internalised EphAs, which can undergo either lysosomal degradation (about 2/3 of 
internalised clusters) or they can be recycled to the plasma membrane (1/3). Further 
evidence for degradation through the lysosome of internalised Eph receptors comes from 
studies linking EphA2 and EphB1 to the ubiquitin ligase Cbl and subsequent degradation 
(Walker-Daniels et al. 2002, Sharfe et al. 2003, Fasen et al. 2008). After stimulation with 
ephrinA1 or ephinB1 respectively, Ephs phosphorylate Cbl, which in turns ubiquitinates 
the receptors and primes them for degradation. A recent study provides further evidence 
for this by showing that ubiquitination of EphA2s shifts their trafficking away from 
processing through the recycling endosome to degradation in the lysosome (Sabet et al. 
2015). 
While signalling from Rac family GEFs positively regulates Eph receptor endocytosis, 
negative regulators have also been identified. SH2 domain containing inositol 5-
phosphatase 2 (SHIP2) interacts with EphA2 via its SAM domain and negatively regulates 
the activity of PI3K, which in turn is an activator of Rac activity (Zhuang et al. 2007). 
Overexpression of SHIP2 leads to a reduction of ephrinA1-induced EphA2 endocytosis, 
while knockdown of SHIP2 by siRNA results in an increase of Rac activity and 
consequently, an increase of endocytosis. 
Endocytosis of EphAs is not regulated only by small GTPases of the Rho family, but also 
by GTPases of the Rab family. Internalisation of EphA4 in cultured cells and amygdala 
neurons stimulated by pre-clustered ephrinB3 ectodomains requires the Rab5GEF activity 
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of Rin1 and internalised clusters traffic through Rab5-positive compartments (Deininger et 
al. 2008). 
Both EphAs and EphBs interact with caveolin and localise to caveolae upon activation by 
their ligands, however it is unclear whether this results in internalisation through the 
caveolae-dependent endocytic route and whether this is a cell type-specific observation or 
a general feature of Eph-ephrin signalling (Vihanto et al. 2006) This finding is also in 
contrast to the report from Marston an colleagues that could not detect a co-localisation of 
cell contact-induced EphB clusters with caveolae (Marston et al. 2003). 
Only a small number of studies have investigated the mechanisms of endocytosis into 
ephrin-expressing cells. One study suggests that ephrinBs can be internalised via clathrin-
mediated endocytosis, since potassium depletion (a method used for studying CME (Larkin 
et al. 1983)) and abrogation of dynamin function inhibited uptake of ephrinB1 into the cell 
upon stimulation with EphB1 ectodomains (Parker et al. 2004). Work by Mann and 
colleagues shows that endocytosis of soluble EphB2 ectodomains into ephrinB expressing 
cells occurs in the context of growth cone collapse, but the endocytic machinery required 
is not described (Mann et al. 2003). As ephrinB1 has been shown to interact with Tiam1 
and induce an increase in Rac activity, it is possible that endocytosis into ephrinB+ cells is 
also mediated via Tiam1 and Rac, though so far no direct evidence for this has been 
reported (Tanaka et al. 2004). 
In conclusion, the molecular mechanisms underlying Eph-ephrin endocytosis are not yet 
completely understood. For forward endocytosis into Eph-expressing cells the endocytic 
machineries seem to overlap between ephrin trans-endocytosis and stimulation with 
soluble ephrin ectodomains, as well as between EphA+ and EphB+ cells, as all of these 
processes require Rac activity. However, in how far trans-endocytosis and endocytosis 
upon stimulation with soluble ephrin are completely comparable remains questionable as 
is indicated by the conflicting evidence on the involvement of the CME pathway. 
Nonetheless, it is conceivable that the GEFs and GAPs regulating endocytosis of Ephs 
stimulated with soluble ephrin ectodomains are also involved in the regulation of trans-
endocytosis, since they can influence Rac activity. Even less is known about the 
mechanism of reverse endocytosis into ephrin+ cells. So far only very few studies 
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addressed the topic of its molecular mechanisms and if so, not in a systematic fashion. 
Furthermore, whether ephrinA-expressing cells experience reverse endocytosis at all is not 
known to date. Figure 3 summarises the current knowledge of Eph-ephrin endocytosis. 
 
Figure 3. Endocytosis of Eph‐ephrin complexes 
(A)  Forward  endocytosis  of  Eph‐ephrin  complexes  induced  by  soluble  pre‐clustered  ephrin 
ectodomains.  GEFs  activate  Rac  downstream  of  Eph‐receptors.  Tiam1  and  Vav2/3  have  been 
implicated  as GEFs mediating  this process. Evidence  for  the  involvement of  clathrin  exists.  (B) 
Reverse endocytosis of Eph‐ephrin  complexes  induced by  soluble pre‐clustered Eph  receptors. 
Evidence for the involvement of clathrin exists. (C) Ephrin trans‐endocytosis into Eph+ cell (forward 
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While endocytosis of Eph-ephrin complexes plays a central role in Eph-ephrin signalling, 
the Eph-ephrin system in turn can regulate the endocytosis of other molecules.   
In axon guidance, collapse and steering of growth cones are pivotal events that both require 
gross changes in membrane surface area, which can be mediated by endocytosis (Tojima 
et al. 2011). This process can be regulated by Eph-ephrin signalling. In chick retinal axons, 
stimulation with ephrinA2 induces endocytosis required for growth cone collapse by 
activating Rac1 (Jurney et al. 2002). 
At synapses, Eph-ephrin signalling can regulate endocytosis of AMPA receptors and thus 
influence synaptic maturation and plasticity (Irie et al. 2005, Essmann et al. 2008). 
Remarkably, forward and reverse signalling seem to have opposing effects on the 
internalisation of AMPA receptors. Irie and colleagues report that EphB2s can associate 
with the phosphatase synaptojanin and phosphorylate it. Phosphorylation inhibits the 
phosphatase function of synaptojanin and leads to elevated levels of phosphatidylinositol 
4,5-bisphosphate (PIP2). This in turn leads to an increase in CME and, particularly, to an 
increase in the internalisation of AMPA receptors. In contrast to this, postsynaptic ephrinB 
reverse signalling leads to a stabilisation of AMPA receptors at the cell membrane 
(Essmann et al. 2008). In neurons from ephrinB2 knockout mice, increased AMPA 
internalisation results in reduced synaptic transmission and synapse loss. Mechanistically 
the stabilising function of ephrinBs requires phosphorylation of a serine residue and an 
interaction with scaffolding proteins like GRIP1. 
In the vascular system, ephrinB2 reverse signalling can regulate internalisation of vascular 
endothelial growth factor receptors (VEGFRs) and PDGFRs (Sawamiphak et al. 2010, 
Nakayama et al. 2013). Guidance of tip cells is as essential for vascular sprouting and 
development as axon guidance is for neuronal development. VEGFRs help orient tip cells 
by detecting VEGF gradients. VEGFR-mediated guidance requires the internalisation of 
the receptor in order to be effective. EphrinB2 reverse signalling, which requires the PDZ 
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domain of ephrinB2, is necessary for the internalisation of VEGFR2 (Sawamiphak et al. 
2010), whereas, in vascular smooth muscle cells, ephrinB2 reverse signalling controls 
PDGFRbeta internalisation in the opposite fashion (Nakayama et al. 2013). Cells cultured 
from ephrinB2 mutant mice display increased endocytosis of PDGFRbeta, since the 
receptor gets redistributed from caveolae to clathrin-coated membrane components. 
Simultaneously, signalling downstream of PDGFRbeta through MAP kinase and JNK is 
increased, while signalling through Tiam1 and Rac is reduced, which results in decreased 
proliferation. Unfortunately, the study does not comment on any link between Tiam1/Rac 
signalling and endocytosis.  
These studies show that regulation of endocytic processes by Eph-ephrin signalling is an 
important facet of Eph-ephrin function. The studying of the role of Eph-ephrin controlled 
endocytosis is thus complicated by the fact that the same or overlapping signalling 
molecules and mechanisms are involved in downstream signalling of Eph-ephrin 
complexes, the regulation of Eph-ephrin endocytosis itself, or the endocytosis of other 
proteins regulated by Eph-ephrin signalling. This makes it difficult to distinguish between 
direct effects on Eph-ephrin endocytosis and indirect effects by interfering with common 
endocytic pathways for any studied molecule. 
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1.4 Aims of the study 
The Eph-ephrin signalling system is essential for a plethora of physiological functions, 
especially during development, as well as playing an important role in several diseases, 
including cancer. Understanding the precise molecular regulation of the Eph-ephrin system 
is therefore of great interest. An important element of signalling from Eph-ephrin 
complexes, especially with regards to a switch from mediating an adhesive to a repulsive 
signal, is the removal of Eph-ephrin complexes from the cell membrane. In addition to 
cleavage of ephrins (Hattori et al. 2000) or Ephs (Gatto et al. 2014), the key mechanism 
for removing Eph-ephrin complexes form the cell surface is internalisation by trans-
endocytosis (Marston et al. 2003, Zimmer et al. 2003). Internalisation can occur both into 
the receptor-expressing cell (forward direction) or the ligand-expressing cell (reverse 
direction). 
Despite years of study of the underlying molecular mechanisms of this process, it is still 
far from being completely understood (see Fig 3). Thus far, research has mainly focussed 
on forward direction signalling, while little is known about the regulation of the reverse 
direction. One candidate group of proteins are the Rho family of small GTPases and their 
regulating GEFs and GAPs, as their requirement in various endocytic pathways has not 
only been well established (Qualmann & Mellor 2003, Doherty & McMahon 2009), but 
they have also already been implicated in EphB trans-endocytosis into ephrinB+ cells 
(Marston et al. 2003). 
Another potentially limiting factor of many studies conducted to date is their use of 
stimulation with soluble recombinant ligand or receptor ectodomains, whereas in the 
physiological situation, both elements are membrane-tethered and the trans-endocytosis 
process involves entire complexes of full-length proteins, including patches of membrane 
from the opposing cell. It is very conceivable that the internalisation of pre-clustered 
soluble ectodomains makes use of a distinct endocytic machinery compared to the trans-




This study therefore comprises four central aims: 
1. Deciphering the contribution of different Rho-family GTPases in the regulation of 
EphB trans-endocytosis into ephrinB+ cells by systematic experimental analysis. 
2. Identifying key upstream regulators of EphB trans-endocytosis among the Rho-
family GEFs and GAPs using an image-based siRNA screen. 
3. Comparing the molecular mechanisms required for EphB trans-endocytosis into 
ephrinB+ cells to those implicated in ephrinB trans-endocytosis into EphB+ cells, 
and verifying the physiological significance of our findings in primary neuronal 
cultures. 
4. Clarifying the physiological relevance of using soluble recombinant ectodomains 
to study Eph-ephrin endocytosis by analysing whether internalisation of soluble 
ectodomain-induced Eph-ephrin complexes differs in the endocytic machinery 
used from the trans-endocytosis of membrane-tethered complexes. 
Understanding these key points of the molecular mechanisms of Eph-ephrin endocytosis 
will be important in unravelling how the Eph-ephrin system shapes intercellular 
interactions and communication in developmental and disease contexts. 
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The general mechanisms of Eph-ephrin endocytosis can be studied in cultured cells 
originally derived from human cell lines. These cells are easily accessible using light 
microscopy and a considerable toolbox of genetic techniques, such as over-expression of 
selected proteins or knockdown of protein expression by siRNA transfection, can be easily 
utilised. As SKN neuroblastoma cells endogenously express ephrinB1 and ephrinB2 (T. 
Gaitanos, unpublished results), and since we are particularly interested in the mechanisms 
of EphB-ephrinB reverse endocytosis, we chose to employ them as the principal cell line 
to perform our experiments in. For easier identification of the SKN cells, we used a 
subclone stably over-expressing red fluorescent protein (RFP) tagged to histone 2B (H2B-
RFP), which resulted in a fluorescently labelled nucleus. We additionally conducted 
experiments in HeLa cells, a human cell line derived from cervical cancer cells, to confirm 
that results obtained from SKN cells were not cell line-specific, but represented general 
mechanisms in Eph-ephrin endocytosis. Both HeLa and SKN cells are derived from cancer 
cells, which are known to express a variety of Rho-family GTPases (Sahai & Marshall 
2002a), and there is the potential of physiological redundancy, if several members of the 
same subfamily are co-expressed. Therefore we used reverse transcriptase polymerase 
chain reaction (RT-PCR) to identify which GTPases are expressed. We focused on the 
RhoA, Rac and Cdc42 subfamilies, given their well-established role in endocytic processes 
and the atypical characteristics of the other Rho family GTPases (see Introduction section 
1.2.1). Figure 4 depicts results from the RT-PCR with an image from the gel loaded with 
the RT-PCR products (Fig. 4A). As both the primers for RhoJ and RhoC resulted in PCR 
products of the wrong size, we repeated the RT-PCR for these genes with different primer 
sets (Fig. 4B). The table in Figure 4C shows that many of the tested GTPases are expressed 
in both SKN and HeLa cells. SKN cells express RhoA and RhoB, the Rac subfamily 
members Rac1, Rac3 and RhoG, and the Cdc42 subfamily members Cdc42, RhoQ and 
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RhoU. HeLa cells additionally express Rac2 from the Rac subfamily and RhoV from the 
Cdc42 subfamily. This high number of different GTPases expressed in SKN and HeLa 
cells could potentially pose a challenge for studying their involvement in Eph-ephrin 
endocytosis and the possibility of their physiological redundancy was thus addressed in our 
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2.1.2 Establishing siRNA knockdown as a tool for studying the involvement of Rho‐family 
GTPases in Eph‐ephrin endocytosis 
A useful way to study the functional requirements of proteins is knockdown using siRNA. 
We confirmed the effectiveness of the siRNA knockdown of Rho family GTPases by 
Western blot analysis. Since SKN cells express several members of the respective GTPase 
subfamilies (see Fig. 4), we tested siRNA oligos for each of the expressed GTPases. Protein 
expression was detected from total cell lysates using specific antibodies against the protein 
being knocked down, or in the cases of over-expression, tagged proteins with anti-GFP or 
anti-FLAG antibodies, respectively. Tubulin or GAPDH were used as loading controls.  
20 nM was chosen as the maximum working concentration for the siRNA, since it provided 
a good balance between knockdown efficiency and cell toxicity (T. Gaitanos, unpublished 
results). None of the commercially available antibodies for the GTPases RhoQ and RhoU 
detected a specific band at the correct molecular weight. Therefore I first over-expressed 
tagged versions of the proteins, RhoQ-GFP or FLAG-RhoU, and then knocked down 
expression with siRNA. Representative blots show that knockdown of Cdc42 was dose-
dependent and highly effective at 20 nM oligo concentration (Fig. 5A). For RhoQ and 
RhoU, several oligos were tested and those resulting in the most effective knockdown 
(oligo number 19 for RhoQ and number 45 for RhoU) were used for subsequent 
experiments (Fig. 5B and C). Knockdown of Rac subfamily members was not as efficient 
as for Cdc42 subfamily GTPases. Treatment with Rac1-specific siRNA oligos or the 
combination of Rac1- and Rac3-specific oligos did not lead to a very effective knockdown 
of Rac1, as revealed by the amount of protein remaining in the representative blot with 
anti-Rac1 antibody (Fig. 5D, upper panel). Further, knockdown of Rac3 was not one 
hundred percent effective, as revealed by detection using an anti-Rac3 antibody (Fig. 5D, 
lower panel). However, the remaining amount of protein detected could also be due to 
cross-reactivity of the anti-Rac3 antibody with Rac1 protein, as suggested by the visible 
decrease in antibody-binding observed in the cells treated with a Rac1-specific oligo. 
Knockdown of RhoG, on the other hand, was very effective with both of the RhoG-specific 
oligos tested, as shown in the representative blot (Fig. 5E). For the RhoA subfamily 
proteins, we tested the protein-specific oligos at half the maximum concentration (10 nM) 
mixed with scramble oligos in order to resemble the condition of the double knockdown, 
Results   
56 
where the two oligos were also used at 10 nM each. The two representative blots in figure 
5F clearly revealed effective knockdown of both RhoA (upper panel) and RhoB (lower 














Rac1‐  and Rac3‐specific  oligos  and  blotted with  anti‐Rac1  antibody  (upper panel)  or  anti‐Rac3 








as a  loading  control. Representative blots  are  shown  in  all panels. Data  in panels  (D)‐(F) were 
generated by T. Gaitanos. 
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2.1.3 siRNA knockdown or pharmacological inhibition of Rho family GTPases do not alter 
surface expression of ephrinBs 
To study the endocytosis of Eph-ephrin complexes, it is important that the amount of 
available ephrin on the cell surface is unchanged between different experimental conditions 
in order to avoid potentially skewed results. Therefore, I tested the surface expression of 
ephrinBs under siRNA treatment or pharmacological inhibition of Rac family members 
with EHT1864 (Shutes et al. 2007) by incubating SKN H2B-RFP cells with 2 µg/ml of 
pre-clustered EphB2-Fc tagged with a fluorescently labelled antibody. Incubation was 
limited to 2 min at room temperature before transferring cells on ice to prevent endocytosis. 
After fixation, I stained for clusters on the cell surface in non-permeabilising conditions 
with a fluorescently labelled secondary antibody against Fc (Fig. 6A). Images were 
analysed with CellProfilerTM software (Carpenter et al. 2006) and the number of surface 
clusters per cell between the different conditions were compared (for further details, see 
Materials and Methods section 4.2.12). To serve as a positive control, ephrinB itself was 
knocked down in SKN cells, since in cells depleted of ephrinBs, no binding of EphB2-Fc 
at the surface should be expected. Accordingly, surface cluster numbers were significantly 
reduced in cells depleted of both ephrinB1 and ephrinB2 (5.52 clusters/cell) when 
compared to the scramble control (27.63 clusters/cell), while knockdown of ephrinB2 alone 
gave an intermediate response (12.68 clusters/cell) as the cells were still expressing 
ephrinB1 (Fig. 6B). Remaining vesicles in the ephrinB knockdown control were potentially 
due to a less than 100% effectiveness of the transfected siRNA. As an additional control, 
cells were stimulated with hFc instead of Eph2-Fc, which form almost no surface clusters 
as expected. The observed average value of 0.2 clusters per cell treated with hFc very likely 
reflected unspecific debris or artefacts from the automated analysis with CellProfilerTM 
software. Importantly, neither knockdown of all expressed members of the Cdc42, Rac or 
RhoA subfamilies by combination of siRNA oligos (Fig. 6B and D), nor inhibition of Rac 
with EHT1864 (Fig. 6C and E) affected the levels of ephrinBs expressed on the surface of 
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Figure 6. Surface expression of ephrinBs  
(A) Schematic representation of the experimental setup. SKN H2B‐RFP cells treated with siRNA or 
Rac  inhibitor  EHT1864  were  stimulated  with  EphB2‐Fc  pre‐clustered  with  a  Cy2‐conjugated 
antibody (green dots) on ice for 5 min. Cells were subsequently fixed and stained with a dyLight649‐
conjugated antibody against Fc to visualise surface clusters  (red dots).  (B) Quantification of  the 
average number of surface clusters per cell for SKN cell treated with mock transfection, scramble 
siRNA, ephrinB1 and ephrinB2 siRNA or a combination of Rho‐subfamily siRNAs. As an absolute 













One of our primary goals was to understand the trans-endocytosis mechanism of Eph-
ephrin complexes in the context of cell-cell contact and repulsion. To adequately study this 
physiological process, we relied on experiments using co-culture systems, in which cells 
expressing ephrinBs or EphB receptors come into contact with each other. Given the well-
established effects of Rho family GTPases on the actin cytoskeleton and cell motility (Parri 
& Chiarugi 2010), I tested whether siRNA knockdown of entire subfamilies of Rho 
GTPases interfered with cell motility and the ability of SKN cells to contact other cells. 
Live-cell imaging for extended periods of time (up to 6 h) revealed that SKN cells treated 
with siRNA against Rho family GTPases remain mobile and retain their ability to come 
into contact with other cells, while confirming the expected changes in cell morphology 
(Fig. 7). Experiments also demonstrated that over a period of 60 minutes, cells were able 
to form new contacts with other cells and detach from each other. We therefore chose 80 
min as the duration for our co-culture trans-endocytosis experiments, as it allowed cells 
sufficient time to settle, come into contact with neighbouring cells, and engage in Eph-












The trans-endocytosis process of Eph-ephrin complexes containing both full-length ligands 
and receptors was originally described in two studies published 10 years ago (Marston et 
al. 2003, Zimmer et al. 2003).  The work of Marston and colleagues already showed that 
trans-endocytosis in the forward direction is blocked in cells expressing a dominant 
negative version of Rac. For the reverse direction, however, the molecular mechanisms are 
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unknown. We therefore tested whether Rac subfamily GTPases are also required for EphB 
trans-endocytosis into ephrinB+ cells. 
To this end, we performed co-culture experiments with ephrinB+ SKN H2B-RFP (acceptor 
cells) cells previously treated with siRNA against Rac proteins and HeLa cells expressing 
a FLAG-EphB2C-GFP construct (donor cells). Since the C-terminally truncated form of 
the EphB2 receptor expressed in the donor cells is defective for endocytosis in the forward 
direction (Zimmer et al. 2003), trans-endocytosis will only occur in the reverse direction 
in this experimental setup, i.e. from the HeLa cell into SKN cells. The FLAG epitope on 
the extracellular domain of the EphB2 receptor enables staining of Eph-ephrin complexes 
located on the cell surface. The difference between the total number of Eph-ephrin clusters 
in SKN cells and the number of clusters located on the cell surface represents the number 
of internalised clusters (Fig. 8A). To dissect the potential individual contributions of the 
different Rac subfamily GTPases and account for possible redundancies between them, we 
used oligos against Rac1, Rac3 and RhoG separately, as well as all possible combinations 
of any two Rac subfamily GTPases and a knockdown of all three of them. As a negative 
control, cells were treated with scramble oligos and as a positive control, siRNA against 
ephrinB2 or against both ephrinB2 and ephrinB1 was used to prevent cluster formation and 
thus internalisation. After siRNA treatment for 72 h, SKN cells were co-cultured with HeLa 
cells expressing FLAG-EphB2C-GFP for 80 min in order for cell contact, cluster 
formation and trans-endocytosis to occur. Cells were then fixed and stained against the 
FLAG epitope to visualise surface clusters. For each experiment, each condition was tested 
in triplicate in 96-well plates and for each well, 10 images were taken (Fig. 8D). Image 
analysis was performed semi-automatically using CellProfilerTM and is described in detail 
in section 4.2.12 and Fig. 23..  
Knockdown of ephrinBs reduced trans-endocytosis of Eph-ephrin complexes as expected 
and thus validated the experimental approach. In contrast knockdown of single Rac 
subfamily members or a combination of knockdowns of any two Rac subfamily members 
did not result in significant changes in the number of internalised Eph-ephrin clusters when 
compared to the negative control (Fig. 8B). However, when Rac1, Rac3 and RhoG were 
targeted by siRNA oligos simultaneously, the number of internalised clusters was 
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significantly decreased in comparison to treatment with scramble oligos. The observed 
decrease in trans-endocytosis was only partial, though (reduced to 75 % of control levels, 
Fig. 8B), which could potentially be explained by ineffectiveness of the siRNA oligos used 
(compare Fig. 5D). These results indicate that Rac subfamily GTPases are required for the 
efficient trans-endocytosis of EphB into ephrinB+ SKN cells, and that Rac1, Rac3 and 







the  knockdown  of  the  individual  members  of  the  Rac  subfamily  as  well  as  for  all  different 
combinations of oligos. Data shown as mean of the individual means normalised to the median of 
the scramble control. Repeated measures ANOVA with Dunnett’s post‐hoc test was used to test 
for significance. **=p<0.01, ***=p<0.005  (n= 8  independent experiments)  (C) Quantification of 
average  number  of  internalised  clusters  per  cell  in  the  Rac  inhibitor  assay  performed  with 
CellProfilerTM  including data  for both 10 µM and 20 µM EHT1864. Data  shown as mean of  the 
individual means normalised to the median of the vehicle control. Repeated measures ANOVA with 
Dunnett’s  post‐hoc  test  was  used  to  test  for  significance.  **=p<0.01,  ***=p<0.005  (n=  4 
independent  experiments)  (D)  Co‐culture  of  SKN‐H2B‐RFP  cells with HeLa  cells  overexpressing 
EphB2C. SKN H2B‐RFP cells were treated with siRNA (either as scramble sequence, or pools of 
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In order to corroborate these findings, we pharmacologically inhibited Rac activity by 
treatment with the specific Rac inhibitor EHT1864 in the same experimental setup. Instead 
of transfection with siRNA oligos, SKN cells were treated with vehicle control or 
EHT1864 at a concentration of either 10 µM (images not shown) or 20 µM for 4 h before 
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co-culturing with HeLa cells (Fig. 8E). Confirming results from our siRNA experiments, 
treatment with EHT1864 led to a reduction in the number of internalised Eph-ephrin 
clusters in comparison with the control condition in a dose-dependent manner (Fig. 8C). 
The effect on trans-endocytosis was stronger than that observed in siRNA experiments 
(reduced to 25% of control levels with 20 µM EHT1864, Fig. 8C), suggesting that inhibitor 
treatment leads to a more effective reduction of Rac activity than siRNA-mediated knock 
down of protein expression.  
We wanted to rule out that the requirement of Rac subfamily GTPases in EphB trans-
endocytosis into ephrinB+ cells is a cell type-specific effect and thus conducted 
experiments with HeLa cells as both donor and acceptor cells. Since HeLa cells express 
Rac2 in addition to the other three Rac subfamily members expressed in SKN cells, and 
knockdown of a fourth protein by siRNA is technically very challenging, we chose to also 
use EHT1864 for experiments in HeLa cells. HeLa cells expressing ephrinB1-mCherry (as 
acceptor cells) were treated with EHT1864 as described above and co-cultured with HeLa 
cells expressing a FLAG-EphB2C-GFP construct (Fig. 9A). Inhibition of Rac activity 
with EHT1864 resulted in a significant reduction in the number of internalised EphB-
ephrinB clusters compared to vehicle-treated control at concentrations of both 10 µM and 
20 µM (Fig. 9B and C), as determined by manual counting of images acquired and analysed 
blindly. These results confirm the findings in SKN cells and indicate that the requirement 
of Rac activity for EphB trans-endocytosis into ephrinB+ cells represents a general 
mechanism. 
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to  test  for significance. *=p<0.05, **=p<0.01  (n= 4  independent experiments)  (C) Co‐culture of 




without  permeabilisation  (surface  EphB2C,  shown  in  blue).  EphirnB1‐mCherry  expression  is 
shown in red. Internalised vesicles were determined as total EphB2C (green) puncta distinct from 






Trans-endocytosis of EphB receptors from opposing cells into ephrinB positive neurons is 
crucial for allowing efficient cell detachment during the growth cone collapse response 
(Zimmer et al. 2003). I therefore wanted to investigate if Rac activity is also required for 
EphB trans-endocytosis in cultured neurons. Primary cortical neurons endogenously 
express ephrinBs and are thus a very good experimental model (Tanaka et al. 2004). I 
cultured cortical neurons derived from E15.5 mouse embryos overnight in live cell imaging 
chambers. Neurons were stained with CellTracker Green and treated with vehicle control 
or several concentrations of Rac inhibitor EHT1864 prior to co-culturing with HeLa 
(donor) cells transiently over-expressing an EphB2C-mCherry construct. Live cell 
imaging was performed on a spinning disk confocal microscope equipped with an 
incubation chamber to maintain an environment of 5% CO2 and 37 °C. Several positions 
where EphB2C-mCherry expressing HeLa cells settled next to a healthy neuron were 
selected and imaged every three minutes for a total duration of three hours. Resulting 
videos were analysed manually by observing sites of contact between neuron and HeLa 
cell and determining, whether internalisation of EphB2C-mCherry-containing complexes 
into the neurons occurred. To ensure proper detachment had occurred internalisation was 
determined as a vesicle detaching from HeLa cell protrusions for at least three consecutive 
frames. Treatment with 20 µM EHT1864 led to growth cone collapse in the majority of 
neurons (data not shown), thus cells were treated with concentrations of 2.5 µM, 5 µM and 
10 µM. Figure 10A shows frames taken from example movies of vehicle-treated neurons 
exhibiting trans-endocytosis of EphB2C-mCherry-containing complexes (top two 
panels), and prolonged cell adhesion without internalisation of EphB2C-mCherry-
containing complexes in neurons treated with EHT1864 (bottom panel). Quantification of 
the average percentage of contact sites with internalisation events revealed a significant 
reduction of trans-endocytosis of EphB2C-mCherry-containing complexes into neurons 
treated with EHT1864 at all tested concentrations (Fig. 10B). I therefore conclude that Rac 
activity is required for EphB trans-endocytosis into ephrinB+ neurons and the mechanism 
is potentially the same as the one employed by HeLa and SKN cells. 
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Figure 10. Live‐cell imaging of EphB trans‐endocytosis into ephrinB+ cortical neurons  
(A) Neurons were grown  in 8‐well  live‐cell  imaging  chambers overnight and were  stained with 
CellTrackerTM Green (green in overlay). Subsequently they were treated with either vehicle control 






20 µm.  (B) Quantification of  the percentage of  internalisation occurring at contact sites scored 
manually with MetaMorphTM software. Data for all three tested concentrations (2.5 µM, 5 µM and 
10 µM) shown and vehicle control shown as average of n=4  independent experiments +/‐ SEM. 






With very few exceptions (Marston et al. 2003, Zimmer et al. 2003, Lauterbach & Klein 
2006) all studies of Eph-ephrin endocytosis use pre-clustered soluble ligand or receptor 
proteins to elicit internalization, despite the fact that these proteins are typically membrane-
bound in vivo (Parker et al. 2004, Cowan et al. 2005, Yoo et al. 2010). Having established 
the importance of Rac subfamily members for EphB trans-endocytosis into ephrinB+ cells, 
I next examined whether the same mechanisms are employed for the reverse endocytosis 
of soluble EphB ectodomains. I treated SKN H2B-RFP cells with siRNA oligos against 
Rac1 alone or with a combination of oligos against the three Rac subfamily members 
expressed in SKN cells - Rac1, Rac3 and RhoG. The siRNA-treated cells were incubated 
with 2 µg/ml of a fusion protein of the ectodomain of EphB2 and the human Fc fragment 
(EphB2-Fc) pre-clustered with a Cy2-conjugated antibody at 37 °C for 30 minutes to allow 
endocytosis to occur. Subsequently, cells were fixed and stained against Fc without 
permeabilisation to visualise EphB2-ephrinB clusters that had not been internalised (Fig. 
11A). Scrambled siRNA oligo, combined knockdown of ephrinB1 and ephrinB2, and 
incubation with pre-clustered hFc instead of EphB2-Fc were used as controls. As expected, 
only very few endocytosed clusters were observed in knockdown of ephrinBs (Fig. 11D, 
second row of images, and B). Treatment with hFc showed that endocytosis was dependent 
on the presence of the EphB ectodomain and not of the Fc portion of the fusion protein 
(Fig. 11B). When compared to the scramble control, neither treatment with Rac1 oligo 
alone, nor knockdown of the entire Rac subfamily, showed any significant difference in 
the amount of internalised EphB2-ephrinB clusters (Fig. 11B and D).  
Since knockdown of Rac subfamily proteins by siRNA has been shown to be only partial 
(Fig. 5D) and treatment with EHT1864 had resulted in a stronger effect on EphB trans-
endocytosis into ephrinB+ cells (Fig. 8B and C and Fig. 9B), I wanted to confirm the 
siRNA results by pharmacological inhibition of Rac subfamily GTPases. I treated SKN 
cells with either H2O or EHT1864 (at 10 µM or 20 µM) for 4 h before incubating them 
with pre-clustered EphB2-Fc. There was no significant difference in the average number 
of internalised EphB-ephrinB clusters between vehicle treatment and treatment with 
EHT1864 at the tested concentrations (Fig. 11C and E). These data support the results from 
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the siRNA knockdown experiments and argue that Rac subfamily GTPases are not required 
for endocytosis of soluble EphB2 ectodomains into ephrinB+ SKN cells. 
Figure 11. Rac subfamily GTPases are not required for endocytosis of soluble EphB2 
ectodomains into ephrinB+ SKN cells 
(A)  Schematic  representation  of  experimental  setup  for  the  assay  with  soluble  pre‐clustered 
EphB2‐Fc. (B) Quantification of average number of  internalised clusters per SKN cell transfected 
with siRNA performed with CellProfilerTM including the data for the hFC‐treated control. One‐way 




cells  (nuclei  in blue) were  transfected with  siRNA  (scramble oligo, oligos against ephrinB1 and 
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To further support the findings that Rac subfamily GTPases are not required for reverse 
endocytosis of soluble EphB2 receptors, I also carried out experiments in HeLa cells 
transiently expressing ephrinB1-mCherry. Furthermore, working with HeLa cells also 
allowed me to compare the results with forward endocytosis of soluble ephrinB2 by using 
cells transiently over-expressing EphB2-mCherry. In principle, the experiments were 
conducted analogously to the experiments using SKN cells. HeLa cells expressing either 
EphB2-mCherry or ephrinB1-mCherry were pre-treated with vehicle control or EHT1864 
at 10 µM (images not shown) or 20 µM concentrations for 4 h before being incubated with 
2 µg/ml of ephrinB2-Fc or EphB2-Fc pre-clustered with a Cy2-conjugated antibody. After 
an incubation period of 30 min, cells were fixed with PFA and stained with a secondary 
antibody against Fc without permeabilisation to visualise surface clusters (Fig. 12A and 
B). Incubation with hFc instead of the ephrinB2 or EphB2 fusion proteins was used as an 
absolute control and showed only minimal internalisation or surface binding (data not 
shown). For reverse endocytosis, treatment with either 10 µM or 20 µM EHT1864 led to 
no significant difference in the number of internalised Eph-ephrin clusters compared to the 
vehicle control (Fig. 12C). In contrast, EHT1864 treatment led to a significant reduction in 
the amount of internalised Eph-ephrin clusters in the forward direction at concentrations of 
both 10 µM and 20 µM (Fig. 12D). These results are in line with previous reports proposing 
the involvement of Rac in forward endocytosis of Eph receptor clusters induced by soluble 
ephrins (Cowan et al. 2005, Yoo et al. 2010, Um et al. 2014). The data also show that the 
Rac inhibitor EHT1864 successfully generates an effect under our experimental conditions 
and that the lack of an effect of EHT1864 on reverse endocytosis is not due to inefficient 
inhibition of Rac family GTPases.  
In conclusion, the data indicate that the mechanisms of endocytosis of soluble EphB and 
ephrinB ectodomains are different: uptake of ephrinB into EphB+ cells requires Rac 
activity, whereas uptake of EphB into ephrinB does not. Furthermore, the mechanism of 
ephrinB-mediated uptake of EphB critically depends on membrane tethering of EphB: 
trans-endocytosis of full-length EphB from an opposing cell into the ephrinB+ cell requires 











(red/ yellow  in overlay). Scale bar  represents 10 µm.  (B) HeLa  cells expressing EphB2‐mCherry 
(dashed outline) stimulated with ephrinB2Fc (forward endocytosis). HeLa cells expressing EphB2‐
mCherry were  treated with  vehicle  control  (top panel) or EHT1864 at either 10 µM or 20 µM 
concentration (example images only for 20 µM, bottom panel) for 4 h prior to 30 min stimulation 
with ephrinB2‐Fc pre‐clustered with a Cy2‐conjugated antibody (green) for 30 min. Cells were then 
fixed on  ice  and  stained with  a dyLight649‐conjugated  antibody against  Fc  to  visualise  surface 
clusters  (red/ yellow  in overlay). Note  the  lack of  internalise vesicles  in  the EHT‐treated cell as 
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compared to the control). Scale bar represents 10 µm. (B). (C) Quantification of average number 
of internalised clusters per HeLa cell treated with vehicle or EHT1864 in reverse essay. Counting 
performed manually  and  experiments were  performed  blind. One‐way ANOVA with Dunnett’s 
post‐hoc  test  was  used  to  test  for  significance.  (n=  3‐5  independent  experiments).  (D) 
Quantification of average number of  internalised clusters per HeLa cell  treated with vehicle or 
EHT1864 in forward assay. Counting performed manually and experiments were performed blind. 




Cdc42 and the members of its subfamily have already been implicated in the context of 
endocytosis (Sabharanjak et al. 2002, Chadda et al. 2007), and also as downstream effectors 
of Eph-ephrin signalling (Irie & Yamaguchi 2002, Nishimura et al. 2006). They are 
therefore good candidates for being regulators of EphB trans-endocytosis into ephrinB+ 
cells. SKN cells express three members of the Cdc42 subfamily of Rho GTPases: Cdc42, 
RhoQ and RhoU (Fig. 4). To test the role of Cdc42 subfamily members in EphB trans-
endocytosis, I used the trans-endocytosis assay co-culturing siRNA-treated SKN cells with 
HeLa cells expressing an EphB2C-GFP construct as described before. In addition to the 
control conditions described above, knockdown of the expressed Cdc42 subfamily 
members individually, as well as all possible combinations of the three members, was 
performed (Fig. 13A). While knockdown of ephrinBs reduced the number of endocytosed 
EphB-ephrinB clusters as expected, neither knockdown of single Cdc42 subfamily 
GTPases nor any combination of knockdowns showed a significant change in the number 
of endocytosed clusters compared to scramble control condition (Fig. 13C).  
As the data for the Rac subfamily GTPases suggested that different endocytic processes 
are employed in the trans-endocytosis assay and for the internalisation of soluble pre-
clustered Eph ectodomains I also tested whether the Cdc42 subfamily members are 
involved in endocytosis of soluble EphB2 ectodomains into ephrinB+ cells. Combined 
siRNA knockdown of Cdc42, RhoQ and RhoU was performed in SKN cells, which were 
subsequently stimulated with pre-clustered EphB2-Fc (Fig. 13B). Compared with scramble 
control oligos, treatment with oligos against Cdc42 subfamily GTPases showed no 
significant difference in the number of endocytosed EphB-ephrinB clusters (Fig. 13D). 
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Taking into consideration results from both the trans-endocytosis assay and the assay with 
soluble EphB ectodomains, our data suggest that members of the Cdc42 subfamily of Rho 
GTPases do not play a key role for EphB-endocytosis into ephrinB+ cells. 
Figure 13. Knockdown of Cdc42 subfamily GTPases in trans‐endocytosis assay and assay 
with soluble EphB2 ectodomains 








dyLight649‐conjugated  antibody  against  Fc  to  visualise  surface  clusters  (red/appear  yellow  in 
merged  image).  Scale bar  equals 20 µm.  (C) Quantification  of  average number of  internalised 
clusters  per  cell  in  the  cell‐cell  assay  performed with  CellProfilerTM  including  the  data  for  the 
knockdown  of  the  individual  members  of  the  Cdc42  subfamily  as  well  as  for  all  different 
combinations  of  oligos.  One‐way  ANOVA  with  Dunnett’s  post‐hoc  test  was  used  to  test  for 
significance. *=p<0.05 (n= 3 independent experiments). (D) Quantification of average number of 
internalised clusters per cell in the soluble assay performed with CellProfilerTM. Repeated measures 
ANOVA  with  Dunnett’s  post‐hoc  test  was  used  to  test  for  significance.  ***=p<0.005  (n=  6 
independent experiments). 
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The third major subfamily of Rho GTPases is the RhoA subfamily, of which RhoA, RhoB, 
are expressed in both SKN and HeLa cells (Fig. 4). While RhoA has been shown to be 
important for signalling events downstream of Eph-ephrin interactions, especially in the 
context of growth cone collapse (Shamah et al. 2001, Sahin et al. 2005, Takeuchi et al. 
2015), there have been no direct links so far to the endocytosis of Eph-ephrin complexes.  
To study the involvement of Rho subfamily GTPases in EphB trans-endocytosis, we first 
performed siRNA experiments in the trans-endocytosis assay using SKN cells co-cultured 
with HeLa cells expressing EphB2C-GFP as described above. RhoA and RhoB were 
knocked down individually, as well as in combination. In Figure 14 both the example 
images (Fig. 14A) and the quantification (Fig. 14B) revealed that there is no significant 
difference between knockdown of Rho family proteins and scramble oligos, while 
knockdown of ephrinBs significantly reduced the amount of EphB trans-endocytosis into 
ephrinB+ SKN cells. We also performed experiments with HeLa cells as both donor and 
acceptor cells to further confirm that RhoA subfamily GTPases are not relevant in the 
context of EphB trans-endocytosis. As acceptor cells HeLa cells transiently expressing 
ephrinB1-mCherry were treated with siRNA against RhoA, RhoB, a combination of the 
two, or with scramble oligos. They were co-cultured with HeLa cells expressing EphB2C-
GFP to induce EphB trans-endocytosis into the acceptor cells. RhoA single and RhoA and 
RhoB double knockdowns led to a slight increase in the number of internalised Eph-ephrin 
complexes per cell in compared to scramble oligo treatment (47.11 and 47.87, internalised 
vesicles/cell compared to 42.37 internalised vesicles/cell). However, statistical testing with 
= 0.05 revealed these results to be non-significant (Fig. 14C). 
Since the experiments using SKN cells showed no change in the number of internalised 
Eph-ephrin clusters, and the observed difference in HeLa cells is not statistically 
significant, these results indicate that RhoA subfamily GTPases are not involved in the 
regulation of EphB trans-endocytosis into ephrinB+ cells. This conclusion is further 
supported by the high effectiveness of siRNA knockdown of RhoA subfamily GTPases, 
which excludes insufficient knockdown as an explanation for the lack of an effect. 
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or  a  pool  of  oligos  against  RhoA  and  RhoB)  were  then  co‐cultured  with  FLAG‐EphB2C‐GFP‐





significance.  **=p<0.01,  ***=p<0.005  (n=  3‐4  independent  experiments).  (D) Quantification  of 
average number of internalised clusters per cell in the cell‐cell assay in HeLa cells scored manually. 
All experiments performed blind. Repeated measures ANOVA with Dunnett’s post‐hoc  test was 






Although knocking down RhoA and RhoB in either SKN or HeLa cells showed no 
significant change in the EphB trans-endocytosis into ephrinB+ cells, I was also interested 
to see whether the same is true for endocytosis of soluble EphB ectodomains. Therefore, I 
knocked down RhoA, RhoB or a combination of the two proteins in SKN cells, which were 
subsequently incubated with pre-clustered EphB2-Fc as described before (Fig. 15A). 
Strikingly, I observed a very strong increase in the amount of internalised EphB-ephrinB 
clusters after knocking down RhoA subfamily GTPases when compared to scramble 
control oligos (Fig. 15C). For treatment with either siRNA for RhoA or the combination 
of oligos for RhoA and RhoB, the increase was almost two-fold, while for a knockdown of 
RhoB alone the increase was 1.5-fold. Since the combined knockdown of RhoA and RhoB 
did not result in a stronger effect than knockdown of RhoA alone, these results imply that 
RhoA is the main mediator of this physiological function.  
These results further indicate that RhoA subfamily GTPases limit the rate of endocytosis 
of soluble EphB2 ectodomains into ephrinB+ cells. However, a potential alternate 
explanation for the increase in internalised EphB-ephrinB complexes, could be that RhoA 
subfamily GTPases regulate their downstream trafficking. Indeed, RhoB, and to a lesser 
extent RhoA, have been reported to regulate endocytic trafficking (Gampel et al. 1999, 
Fernandez-Borja et al. 2005, Rondanino et al. 2007, Stirling et al. 2009). Disturbing RhoB 
function interferes with transition from early endosomal compartments to later stages of 
endocytic processing such as multivesicular bodies, and results in smaller endocytic 
vesicles (Fernandez-Borja et al. 2005). A blocked fusion of early endosomes with later 
endocytic compartments could explain the higher number of endocytic vesicles observed 
in my experiments. Curiously, I also observed that the endocytic vesicles are also 
significantly smaller on average in the knockdown of RhoA and the combined knockdown 
of RhoA and RhoB compared to control (Fig. 15E), providing further evidence for this 
hypothesis.   
In order to confirm the role of RhoA subfamily proteins in the endocytosis of soluble 
EphB2 ectodomains, I transfected HeLa cells with ephrinB1-mCherry and treated them 
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with siRNA for RhoA subfamily proteins or scramble control oligo (Fig. 15B). While 
knockdown of RhoA subfamily proteins resulted in an increase in the number of 
endocytosed Eph-ephrin clusters (27.98 for RhoA, and 29.24 for RhoA and RhoB, 
compared to 21.3 internalised vesicles/cell for scramble control), statistical testing with 
0.05 as significance level revealed the difference to be non-significant (Fig. 15D). The 
observed increase in endocytosis in HeLa cells (25-50 % for RhoA single and RhoA and 
RhoB double knockdown, 10-20% for RhoB single knockdown compared to control levels) 
is furthermore very modest compared to the substantial increase observed in SKN cells 
(150-200% compared to control levels). A potential explanation for this discrepancy can 
be found in the distinct experimental setups. Given that ephrinB1-mCherry needs to be 
over-expressed in HeLa cells, there is more ephrinB available on the cell surface compared 
to SKN cells, which endogenously express ephrinBs. The higher level of ephrinB 
expression on the cell surface leads to more binding opportunities for EphB2-Fc and in 
consequence, to more clusters forming and being internalised than under control conditions 
(8.1 clusters/cell in SKN cells, 21.3 clusters/cell in HeLa cells). The endocytic machinery 
of the HeLa cell is possibly already working close to its maximum capacity and therefore 
removal of RhoA subfamily proteins cannot exert as substantial an effect on the amount of 
endocytosis as it does in SKN cells. This could result in the difference between scramble 
oligo treatment and treatment with siRNA against RhoA subfamily members being non-














against  RhoA  and  RhoB  respectively)  then  incubated with  EphB2‐Fc  pre‐clustered with  a  Cy2‐
conjugated  antibody  (green)  for  30  min.  Cells  were  subsequently  fixed  and  stained  with  a 
dyLight649‐conjugated antibody against Fc  to  visualise  surface  clusters  (red/yellow  in overlay). 




hoc  test  was  used  to  test  for  significance.  **=p<0.01,  ***=p<0.005  (n=  3  independent 
experiments).  (D) Quantification of average number of  internalised clusters per HeLa cell  in the 
soluble assay performed on blinded samples manually with  ImageJ. Repeated measures ANOVA 
with  Dunnett’s  post‐hoc  test  was  used  to  test  for  significance.  p=0.0765  (n=  4  independent 





Rho family GTPases are regulated in their function by GEFs and GAPs. To further explore 
the regulation of EphB trans-endocytosis into ephrinB+ cells we performed an image-based 
siRNA screen for Rho-family GEFs and GAPs. We bioinformatically identified human 
Rho-family GEFs and GAPs by searching for proteins containing either a RhoGAP, a DH, 
or a DOCK domain. Our search resulted in 61 GAPs, 11 DOCK-family GEFs and 67 Dbl-
family GEFs. For each gene we used four different siRNA oligos with non-overlapping 
sequences. The scheme in Figure 16A provides an overview of the procedure and workflow 
of the screen. In principle, we used the same cell-cell assay as with the siRNA experiments 
with Rho-family GTPases. SKN H2B-RFP cells were seeded into 96-well plates and 
reverse transfected with siRNA oligos. The siRNA library consisted of 4 individual oligos 
per target gene, distributed in individual wells amongst 13 plates. Each plate also contained 
a set of control conditions: one well with siRNA oligo against kiff11 as a control for 
successful transfection (knockdown of kiff11 leads to an inhibition of mitosis and thus, cell 
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death); six wells of scramble oligos as negative controls; two wells with oligos against 
ephrinB2 as a positive control, resulting in partial inhibition of endocytosis; and three wells 
with a combination of oligos against both ephrinB1 and ephrinB2, resulting in an almost 
complete abolition of EphB2 uptake. Two runs with the full set of oligos were performed. 
The co-culture assay and analysis of images with CellProfilerTM software was performed 
as described before and in section 4.2.12. For each well the percentage of cells with more 
than a given number of vesicles was calculated. The number of vesicles for this cut-off was 
adjusted for each plate so that the negative controls showed a value of close to 40% of cells 
above the cut-off, to normalise for inter-plate variations in the levels of endocytosis. The 
value of 40% was chosen, since it allowed for very good discrimination against the two 
positive controls (Fig. 16B and C). From these cut-off values, z-scores were calculated for 
each oligo as described in Figure 16E. We regarded all results with z-scores below -2 as a 
hit for a decrease in endocytosis and all results with a z-score above 2.5 as a hit for an 
increase in endocytosis. The false positive rates for negative controls with these cut-offs 
were 2.9% for a decrease in endocytosis and 0.7% for an increase in endocytosis. 
Furthermore, 12.3% of ephrinB2 single depletions and 1.9% of ephrinB1 and ephrinB2 
double knockdowns resulted in a false negative result (Fig. 16F). Figure 16 D shows a 
graph depicting the z-scores of all oligos tested. With z-score cut-offs at -2 and 2.5 the 
large majority of oligos from the siRNA library (95%) resulted in no significant change in 
the EphB trans-endocytosis into ephrinB+ cells. A list of oligos targeting GEF proteins 
with z-scores above and below the cut-offs is displayed in Figure 16G. Among the proteins 
for which siRNA oligo treatment resulted in a decrease of Eph-ephrin endocytosis, only 
for Dock11 more than one oligo fell below the -2 cut-off. However, these results 
represented three separate oligos, and none of them showed an effect below cut-off in 
repeat runs. Hence, we extended the number of oligos taken into consideration by including 
those barely missing the cut-off with a z-score of -1.9. Both ITSN1 and ELMO3 had one 
oligo each with a z-score of -1.9, in addition to one oligo scoring below the original cut-
off value. For ITSN1, these two values derived from the same oligo in the two separate 
runs, suggesting a robust response. The oligos resulting in an increase of endocytosis did 
not give a clear result, as no candidate showed a z-score above the cut-off value in both 
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Semi‐automated  analysis  with  CellProfileTM.  (B)  Frequency  distribution  of  the  number  of 
internalised Eph‐ephrin clusters averaged  for  the  three control conditions  from all screen data. 
Scramble in red, ephrinB2 single knockdown in blue and ephrinB1+2 double knockdown in green. 
Dotted  line at 4 vesicles  represents  the cut‐off of a  total cumulative value of 40%  in  scramble 
controls used for analysing the screen data. (C) Quantification of control data with a cut‐off of the 
number  of  internal  vesicles  resulting  in  a  value  close  to  40%  for  scramble  controls.  Statistical 
significance  was  tested  with  ANOVA  with  Bonferroni´s  correction  for  multiple  comparisons. 
*=p<0.05,  ***=p<0.005  (D)  All  z‐scores  for  both  siRNA  libraries  and  controls  blotted.  Z‐score 
analysis as normalisation to average of scramble controls from the whole screen. (E) Formula for 
calculation of z‐scores. (F) Fail rates of controls according to analysis from (D). (G) List of candidate 
GEFs resulting  in a significant difference  in the number of  internalised vesicles (z‐score <‐1.9 or 
>2.5). Genes  leading  to a decrease  in endocytosis on  the  left,  those  resulting  in an  increase  in 
endocytosis on  the  right. Colours highlight genes,  for which several oligos showed a significant 
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2.3.1 ITSN1 cannot be confirmed as a regulator of EphB trans‐endocytosis into ephrinB+ 
cells 
The single strongest result from the screen was the effect of one oligo for ITSN1, which 
markedly decreased the amount of observed internalisation of Eph-ephrin complexes into 
ephrinB+ cells (z-scores -3.9 and -1.9, Fig. 17B). Interestingly, ITSN1, a Cdc42-specific 
GEF, has already been implicated as a mediator of Eph-ephrin signalling in the context of 
dendritic spine development (Irie & Yamaguchi 2002, Nishimura et al. 2006). However, 
no direct link had yet been discovered to the endocytosis of Eph-ephrin complexes and 
studies so far have only implicated ITSN1 in forward signalling. I therefore chose ITSN1 
as the first candidate for subsequent follow-up experiments. In order to confirm the 
requirement of ITSN1 in EphB trans-endocytosis into ephrinB+ cells, I repeated the 
experiments using the same setup that was employed for the screen, but increased the 
number of images taken per condition in order to achieve greater accuracy in the analysis. 
Since at least one oligo for ITSN2 also showed a trend to decrease trans-endocytosis of 
EphB2 receptors (z-score -1.53 and -0.24, Fig. 17B), and the high sequence similarity 
between ITSN1 and ITSN2 (Tsyba et al. 2011) suggests a potential redundancy between 
these two proteins, I also included ITSN2 and a combination of oligos for ITSN1 and 
ITSN2 in the experiment. Surprisingly, follow-up experiments could not confirm the role 
of ITSN1 as a regulator of EphB trans-endocytosis into ephrinB+ cells, as there was no 
significant difference between the average number of internalised EphB-ephrinB 
complexes in cells treated with ITSN1 oligo and cells treated with scramble oligo (Fig. 
17A and C). Furthermore, knockdown of ITSN2 did not result in a significant difference 
in the amount of endocytosis either. The combined knockdown of ITSN1 and ITSN2 
showed a trend towards a reduced number of endocytic events, however statistical analysis 
using  = 0.05 as a significance level revealed this difference to be non-significant.  
There are several potential explanations for these results. Of course, the most obvious being 
that the results from the screen were false positives and ITSN proteins are not required for 
Eph-ephrin reverse endocytosis. However, it could also be possible that ITSN proteins are 
involved in regulating the trans-endocytosis of Eph-ephrin complexes, but that they are just 
one component in a highly complex endocytic machinery and that their role can also be 
fulfilled by other proteins. In this case, the physiological redundancy could overcome the 
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effect a knockdown of ITSN proteins has on the regulation of endocytosis of Eph-ephrin 
complexes. I tried to account for at least the possibility of redundancy between ITSN1 and 
ITSN2 by combining the knockdown of both proteins, which, despite showing a trend 
towards fewer endocytic events per cell, did not give a significant result. Still it is possible 
that proteins other than members of the ITSN family can substitute for their potential role 
in Eph-ephrin endocytosis in the absence of ITSN. This possibility was addressed by 
additional experiments (see below). Finally, it is also conceivable that the effectiveness of 
the siRNA transfection and the resulting knockdown varied between experiments and that 
the knockdown effectiveness in the screen experiments was by chance higher than in the 







bar equals 20 µm.  (B) z‐scores  for used oligos  from siRNA screen.  (C) Quantification of average 
number of internalised clusters per cell performed with CellProfilerTM. Repeated measures ANOVA 
with Dunnett’s post‐hoc  test was used  to  test  for  significance.  **= p<0.01  (n= 4  independent 
experiments). 
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As the initial attempts to confirm the strongest candidate from the siRNA screen, ITSN1, 
were not successful, I considered several explanations. One possible explanation is that 
due to redundancy on both the level of the Rho GTPases, as well as at the level of the GEFs 
and GAPs, it is difficult to obtain consistent results. I therefore addressed whether 
combining siRNA knockdown of two proteins that showed a decrease in endocytosis in the 
screen could overcome this redundancy. Two different combinations of oligos, both 
employing a different line of reasoning, were tested. Firstly, our analysis of the screen 
revealed that GEFs, whose knockdown leads to a decrease in EphB trans-endocytosis into 
ephrinB+ cells, are mainly active on GTPases of the Rac and Cdc42 subfamilies, and not 
the RhoA subfamily (Fig. 16G). According to the literature, ITSN1 is mainly active on 
Cdc42, while FARP2 exhibits GEF activity towards both Cdc422 and Rac (Jaiswal et al. 
2013a). For both of these proteins siRNA oligos scored below the z-score cut-off (Fig. 
18B). I therefore combined the oligos for these two genes in order to inhibit Rac and Cdc42 
activity at the same time. Furthermore, the atypical DOCK subfamily of GEFs has been 
proposed to only exhibit its GEF function when acting in a complex with proteins of the 
ELMO family (Laurin & Cote 2014). Since both knockdown of a member of the DOCK 
subfamily of GEFs (Dock11), and knockdown of ELMO3 showed a decrease in the 
endocytosis of EphB2, we also tested a combination of oligos for these two genes. The 
same general experimental setup as for the screen was utilised: HeLa cells stably 
expressing the EphB2C-GFP construct as donor cells and SKN H2B-RFP treated with 
siRNA oligos as acceptor cells. The combination of oligos was used at a concentration of 
10 nM for each oligo (20 nM final concentration), while knockdown of single genes was 
performed using a concentration of 20 nM of each oligo. EphB trans-endocytosis was 
reduced by siRNA treatment for ephrinB2 or both ephrinB1 and ephrinB2 in SKN cells 
(images not shown). Treatment with siRNA for any of the four target genes alone (images 
not shown), or with a combination of oligos for Dock11 and ELMO3 or FARP2 and ITSN1 
did not significantly change the number of internalised Eph-ephrin clusters per cell when 
compared to treatment with scramble oligo (Fig. 18A and C).  
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Taking into consideration all the results from the follow-up analysis which could not 
consistently confirm any of the candidates, we concluded that identifying hits from the 
screen solely by examining strong results from a single oligo did not provide reliable 
candidates for the regulation of EphB trans-endocytosis into ephrinB+ cells. While there 
are still potential explanations for the discrepancy between the screen results and follow-
up experiments, for example, variations in knockdown effectiveness between experiments, 
or a level of redundancy between GEF proteins that cannot be overcome by the combined 
knockdown of only two different proteins; we decided to re-evaluate the criteria for 















Dunnett’s  post‐hoc  test  was  used  to  test  for  significance.  **=  p<0.01,  ***=p<0.005  (n=  3 
independent experiments) 
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2.4 Analysis of GEF/GAP Screen focussing on consistency over strength of 
responses 
As my follow-up experiments could not confirm any candidate proteins obtained from our 
initial evaluation of the screen data as key regulators of EphB trans-endocytosis into 
ephrinB+ cells, we explored alternative criteria for analysing the screen. Our initial 
approach focused on strong z-scores, preferably in two runs for the same oligo, regardless 
of whether the other oligos against the same gene also showed an effect or not. The 
reasoning behind that being that potentially not all siRNA oligos actually result in an 
effective knockdown of the target protein. The alternate approach we subsequently 
employed was to search for consistent responses in the average of all 4 oligos tested, while 
being more lenient with the cut-off of z-scores which were regarded as a hit (-1.25 instead 
of -2, and 1.75 instead of 2.5). Furthermore, to account for high inter-plate variability in 
the results, z-scores were calculated for each plate individually instead of taking the 
average of the controls from the entire screen (Fig. 19B). Figure 19A illustrates all z-scores 
calculated this way and Table 1 and Table 2 show the z-scores listed for all tested proteins. 
With these criteria, 8% of negative controls showed a significant response, while 1% of 
ephrinB2 and 0% of ephrinB1 and ephrinB2 combined knockdowns failed to show a 
significant reduction in trans-endocytosis (Fig. 19C).  
In Figure 19D and E, the tested GEFs and GAPs are displayed, with the average of the two 
runs for each oligo depicted in a colour code and ranked from left to right according to 
their overall average z-scores from lowest to highest. Also with this new approach, the 
majority of tested oligos did not result in a significant alteration of EphB trans-endocytosis 
into ephrinB+ cells. The candidates identified, however, differed from the previous 
analysis (compare Fig. 16). Figure 19F shows example images for the two strongest hits 
that decrease endocytosis (Tiam2 and Vav1), as well as for the strongest candidate that 
increased the amount of internalised Eph-ephrin complexes (Net1). Tiam2 itself has not 
yet been mentioned in the context of Eph-ephrin endocytosis, but it shares high sequence 
homology with Tiam1 (Matsuo et al. 2003), which in turn is a known player in endocytosis 
of soluble ephrinA ectodomains into EphA+ cells (Yoo et al. 2011, Boissier et al. 2013, 
Um et al. 2014). Vav1 is a close homologue of Vav2 and Vav3 (Fujikawa et al. 2003, 
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Pearce et al. 2004), which have already been described to also regulate endocytosis of 
soluble ephrinA ectodomains into EphA+ cells (Cowan et al. 2005).  
The fact that the GEF showing the strongest increase in trans-endocytosis, Net1, is known 
to be specific for RhoA subfamily GTPases (Alberts & Treisman 1998, Srougi & Burridge 
2011) is remarkable for two reasons. Firstly, despite no significant effect being observed 
for RhoA subfamily knockdown in EphB trans-endocytosis into SKN cells, the trend of an 
increase in endocytosis into ephrinB1-expressing HeLa cells (Fig. 14), and even more so, 
the strong increase in endocytosis observed in experiments using soluble EphB2 
ectodomains (Fig. 15), suggest a possible role of RhoA subfamily GTPases as negative 
regulators of Eph-ephrin endocytosis. Secondly, given that the strongest candidates of the 
GEFs resulting in a decrease of trans-endocytosis are either Rac subfamily specific (Tiam2 
(Jaiswal et al. 2013a)) or have been shown for to be active towards Rac in their 
physiological functions (Vav1(Villalba et al. 2001)), the screen data also suggest a 
potential antagonism between Rac subfamily members and RhoA subfamily members in 
the regulation of Eph-ephrin endocytosis. Similar antagonism between these two signalling 





runs of  the  screen  showing all 4 oligos per gene  for all GEFs or GAPs. Specificity  for GTPase  is 


















Gene  A1  B1 C1 D1 A2 B2 C2  D2 A B C D avg
ABR  ‐6.12  ‐5.03 ‐1.78 ‐5.25 ‐3.17 4.00 3.21  0.48 ‐4.64 ‐0.51 0.71 ‐2.39 ‐1.71
AKAP13  ‐2.81  4.32 ‐1.31 1.34 ‐1.37 ‐0.80 ‐0.18  ‐1.06 ‐2.09 1.76 ‐0.74 0.14 ‐0.23
ALS2  ‐0.54  ‐0.47 0.58 0.14 ‐4.44 ‐3.45 0.31  ‐0.82 ‐2.49 ‐1.96 0.44 ‐0.34 ‐1.09
ARHGEF1  2.69  0.81 3.08 ‐0.82 1.86 ‐3.47 0.42  0.01 2.27 ‐1.33 1.75 ‐0.40 0.57
ARHGEF10  ‐0.02  1.28 0.58 3.51 0.24 2.02 2.20  0.54 0.11 1.65 1.39 2.02 1.29
ARHGEF10L  ‐0.66  2.67 0.18 3.10 0.45 3.10 ‐2.27  0.72 ‐0.10 2.89 ‐1.04 1.91 0.91
ARHGEF11  3.21  3.32 ‐0.11 1.10 0.73 ‐0.16 ‐0.80  ‐1.83 1.97 1.58 ‐0.45 ‐0.37 0.68
ARHGEF12  ‐1.10  ‐0.11 0.59 ‐4.71 ‐0.42 1.48 ‐1.21  ‐0.49 ‐0.76 0.69 ‐0.31 ‐2.60 ‐0.75
ARHGEF15  ‐0.32  ‐1.89 0.24 ‐1.16 ‐0.45 ‐0.65 1.32  ‐0.29 ‐0.39 ‐1.27 0.78 ‐0.72 ‐0.40
ARHGEF16  3.52  2.30 0.50 0.72 ‐1.91 ‐1.09 1.81  4.99 0.81 0.61 1.16 2.85 1.36
ARHGEF17  ‐1.28  0.38 0.25 2.27 0.14 ‐0.27 0.00  ‐0.05 ‐0.57 0.05 0.12 1.11 0.18
ARHGEF18  ‐0.81  ‐1.17 ‐0.94 ‐2.68 ‐2.22 0.76 ‐0.74  1.96 ‐1.52 ‐0.20 ‐0.84 ‐0.36 ‐0.73
ARHGEF19  ‐0.35  ‐2.60 ‐0.94 ‐4.12 ‐1.07 0.65 0.38  2.42 ‐0.71 ‐0.97 ‐0.28 ‐0.85 ‐0.70
ARHGEF2  7.34  0.25 1.36 1.41 ‐1.52 ‐1.06 0.98  ‐1.69 2.91 ‐0.41 1.17 ‐0.14 0.88
ARHGEF25  ‐0.02  1.32 ‐0.21 2.09 ‐0.60 0.58 1.85  ‐0.63 ‐0.31 0.95 0.82 0.73 0.55
ARHGEF3  0.53  4.52 0.71 0.84 ‐2.69 0.72 4.50  ‐0.16 ‐1.08 2.62 2.61 0.34 1.12
ARHGEF33  ‐2.72  0.28 ‐1.05 ‐0.23 ‐1.15 0.17 0.64  ‐0.95 ‐1.93 0.22 ‐0.21 ‐0.59 ‐0.63
ARHGEF38  ‐2.38  ‐0.53 0.62 1.03 ‐1.15 0.47 0.16  0.36 ‐1.76 ‐0.03 0.39 0.70 ‐0.18
ARHGEF4  ‐0.69  2.78 ‐0.02 ‐0.74 ‐1.34 ‐0.79 4.04  2.96 ‐1.01 0.99 2.01 1.11 0.78
ARHGEF5  0.57  0.73 0.31 ‐0.71 ‐1.77 ‐2.04 0.03  0.54 ‐0.60 ‐0.66 0.17 ‐0.08 ‐0.29
ARHGEF6  ‐0.12  3.19 ‐0.17 ‐0.57 0.29 0.47 ‐2.52  ‐5.66 0.08 1.83 ‐1.34 ‐3.11 ‐0.64
ARHGEF7  2.11  1.28 0.51 1.68 0.63 0.46 0.69  2.86 1.37 0.87 0.60 2.27 1.28
ARHGEF9  ‐1.74  0.29 0.41 0.20 0.32 ‐0.33 0.60  ‐0.09 ‐0.71 ‐0.02 0.51 0.05 ‐0.04
  
95 
Gene  A1  B1 C1 D1 A2 B2 C2  D2 A B C D avg
C9orf100  3.16  1.19 0.25 ‐0.45 0.06 ‐1.96 ‐0.72  ‐0.48 1.61 ‐0.38 ‐0.24 ‐0.47 0.13
DNMBP  ‐0.32  0.62 ‐1.80 ‐1.20 ‐4.59 2.10 8.42  5.40 ‐2.46 1.36 3.31 2.10 1.08
DOCK1  0.87  1.55 1.25 1.25 1.87 0.61 0.94  ‐0.33 1.37 1.08 1.10 0.46 1.00
DOCK10  3.01  ‐0.04 3.78 3.09 1.73 ‐3.09 ‐0.06  ‐0.22 2.37 ‐1.56 1.86 1.44 1.03
DOCK11  3.65  ‐0.40 4.70 2.43 0.19 ‐2.89 ‐0.88  ‐3.85 1.92 ‐1.64 1.91 ‐0.71 0.37
DOCK2  ‐0.83  ‐0.09 ‐1.45 0.70 ‐0.63 ‐0.71 ‐0.19  ‐0.47 ‐0.73 ‐0.40 ‐0.82 0.11 ‐0.46
DOCK2  0.58  ‐1.40 0.82 1.87 ‐1.83 ‐2.00 0.01  0.24 ‐0.63 ‐1.70 0.42 1.06 ‐0.21
DOCK3  2.61  1.34 1.66 1.51 0.63 0.86 0.18  ‐1.83 1.62 1.10 0.92 ‐0.16 0.87
DOCK4  2.81  1.65 2.74 2.11 ‐1.44 ‐1.79 ‐0.26  0.94 0.69 ‐0.07 1.24 1.53 0.85
DOCK5  ‐0.90  ‐1.30 1.40 0.80 ‐1.18 0.00 0.04  ‐0.76 ‐1.04 ‐0.65 0.72 0.02 ‐0.24
DOCK6  ‐0.26  1.91 ‐1.54 0.77 1.38 2.47 0.29  ‐0.26 0.56 2.19 ‐0.63 0.25 0.59
DOCK7  1.64  ‐3.01 ‐1.15 1.38 0.61 1.02 0.50  1.43 1.13 ‐0.99 ‐0.33 1.41 0.30
DOCK8  ‐0.21  1.33 1.25 3.57 1.17 1.42 1.31  1.49 0.48 1.38 1.28 2.53 1.42
DOCK9  ‐2.42  1.31 4.25 1.49 0.74 0.11 0.50  0.18 ‐0.84 0.71 2.37 0.83 0.77
ECT2  ‐0.18  0.24 ‐0.08 1.40 ‐2.54 1.23 0.04  1.79 ‐1.36 0.73 ‐0.02 1.60 0.24
ECT2L  ‐1.44  ‐0.03 1.74 ‐1.43 ‐1.75 0.38 0.51  ‐0.89 ‐1.60 0.18 1.13 ‐1.16 ‐0.36
ELMO1  0.16  1.40 0.56 ‐0.55 ‐1.40 ‐1.49 ‐0.47  0.12 ‐0.62 ‐0.04 0.05 ‐0.22 ‐0.21
ELMO2  ‐1.94  0.74 0.71 0.73 ‐0.76 1.98 ‐0.15  0.41 ‐1.35 1.36 0.28 0.57 0.22
ELMO3  1.90  1.20 3.06 1.29 0.45 1.29 1.17  0.51 1.17 1.24 2.12 0.90 1.36
FARP1  ‐0.20  ‐1.75 ‐2.24 2.49 2.90 ‐0.98 3.84  6.55 1.35 ‐1.36 0.80 4.52 1.33
FARP2  0.78  ‐0.53 1.56 ‐2.32 ‐1.47 ‐3.38 6.84  2.74 ‐0.35 ‐1.95 4.20 0.21 0.53
FGD1  0.43  1.54 0.87 ‐1.14 ‐0.01 ‐4.00 5.95  ‐0.78 0.21 ‐1.23 3.41 ‐0.96 0.36
FGD2  0.28  0.01 1.91 0.06 3.60 2.24 7.67  1.87 1.94 1.12 4.79 0.96 2.20
FGD3  0.39  1.23 ‐0.76 ‐1.59 ‐1.29 3.74 ‐1.47  1.09 ‐0.45 2.49 ‐1.11 ‐0.25 0.17
FGD4  0.02  0.02 1.70 ‐0.87 0.11 2.31 3.70  2.36 0.07 1.16 2.70 0.74 1.17
FGD5  1.24  1.50 ‐0.84 0.32 0.88 2.49 4.24  6.90 1.06 2.00 1.70 3.61 2.09
FGD6  0.31  0.33 ‐1.43 ‐1.86 ‐2.29 ‐4.60 4.02  5.21 ‐0.99 ‐2.14 1.29 1.68 ‐0.04
ITSN1  ‐3.56  ‐1.10 1.36 2.36 ‐3.99 ‐1.10 ‐0.08  0.33 ‐3.78 ‐1.10 0.64 1.34 ‐0.72
  
96 
Gene  A1  B1 C1 D1 A2 B2 C2  D2 A B C D avg
ITSN2  ‐0.75  ‐2.84 0.14 1.38 ‐0.53 ‐1.16 0.90  ‐0.36 ‐0.64 ‐2.00 0.52 0.51 ‐0.40
MCF2  ‐1.65  0.33 ‐2.49 ‐0.43 0.68 2.21 0.44  2.21 ‐0.49 1.27 ‐1.03 0.89 0.16
MCF2L (ARHGEF14)  3.78  ‐0.41 0.54 ‐0.04 1.27 ‐1.24 0.30  ‐0.56 2.53 ‐0.82 0.42 ‐0.30 0.46
MCF2L2  0.25  0.60 ‐1.19 ‐0.33 ‐1.91 ‐1.12 0.01  1.59 ‐0.83 ‐0.26 ‐0.59 0.63 ‐0.26
NET1  ‐1.64  1.11 ‐0.97 0.53 4.46 10.36 3.31  3.03 1.41 5.73 1.17 1.78 2.52
NGEF  ‐0.48  ‐1.19 ‐0.31 1.71 ‐1.14 ‐2.63 ‐0.12  0.97 ‐0.81 ‐1.91 ‐0.22 1.34 ‐0.40
PLEKHG1  ‐1.37  0.35 ‐0.50 0.24 6.01 5.27 0.05  ‐1.32 2.32 2.81 ‐0.22 ‐0.54 1.09
PLEKHG2 (CLG)  ‐1.60  1.31 ‐0.32 0.43 ‐0.56 ‐0.37 ‐0.71  0.46 ‐1.08 0.47 ‐0.52 0.44 ‐0.17
PLEKHG3 (KIAA0599)  ‐0.63  ‐2.48 ‐0.40 1.14 ‐2.31 0.47 ‐0.45  0.16 ‐1.47 ‐1.01 ‐0.43 0.65 ‐0.56
PLEKHG4  ‐1.75  0.76 ‐0.03 0.74 ‐2.07 ‐1.69 0.03  0.90 ‐1.91 ‐0.47 0.00 0.82 ‐0.39
PLEKHG4B  ‐1.25  1.25 0.05 0.57 0.62 ‐0.39 0.08  0.49 ‐0.32 0.43 0.07 0.53 0.18
PLEKHG5  ‐0.61  ‐0.54 ‐0.11 ‐0.45 2.15 6.25 ‐1.72  ‐1.59 0.77 2.86 ‐0.91 ‐1.02 0.42
PLEKHG6 (FLJ10665)  ‐0.69  0.37 0.29 0.83 1.08 0.57 ‐1.00  0.46 0.20 0.47 ‐0.35 0.64 0.24
PREX1  0.24  ‐0.85 2.03 1.27 4.99 5.20 4.70  ‐1.23 2.61 2.17 3.36 0.02 2.04
PREX2  ‐0.10  ‐1.71 ‐1.33 1.13 ‐0.82 1.53 0.81  1.17 ‐0.46 ‐0.09 ‐0.26 1.15 0.08
RASGRF1  ‐1.71  ‐1.44 1.83 0.14 4.02 ‐0.56 11.14  ‐0.38 1.15 ‐1.00 6.48 ‐0.12 1.63
RASGRF2  ‐1.72  0.76 0.74 ‐0.21 ‐1.22 ‐0.85 0.09  ‐0.08 ‐1.47 ‐0.04 0.41 ‐0.15 ‐0.31
RGNEF  0.67  ‐0.51 0.97 ‐0.11 ‐1.67 ‐1.67 0.20  0.21 ‐0.50 ‐1.09 0.59 0.05 ‐0.24
SGEF  ‐4.93  2.94 ‐4.59 ‐2.91 0.58 ‐0.93 3.62  2.32 ‐2.17 1.00 ‐0.48 ‐0.29 ‐0.49
Solo  ‐0.28  ‐0.41 ‐2.39 1.88 ‐2.14 3.54 1.76  2.53 ‐1.21 1.56 ‐0.31 2.20 0.56
SOS1  ‐0.63  0.55 ‐0.59 0.72 1.65 ‐1.22 ‐2.28  0.10 0.51 ‐0.33 ‐1.44 0.41 ‐0.21
SOS2 (FLJ25596)  ‐0.02  ‐1.74 ‐0.23 0.29 ‐0.14 ‐1.96 ‐0.36  1.55 ‐0.08 ‐1.85 ‐0.30 0.92 ‐0.33
SPATA13  0.17  1.55 ‐0.03 1.15 3.15 ‐2.07 0.17  ‐2.24 1.66 ‐0.26 0.07 ‐0.55 0.23
TIAM1 (FLJ36302)  1.11  0.76 1.38 1.07 ‐0.85 0.52 ‐0.20  0.78 0.13 0.64 0.59 0.93 0.57
TIAM2  ‐1.17  0.38 ‐1.36 ‐1.69 ‐3.30 ‐3.34 ‐3.03  ‐4.95 ‐2.24 ‐1.48 ‐2.20 ‐3.32 ‐2.31
VAV1  1.53  ‐0.15 ‐1.16 ‐0.36 0.11 ‐4.05 ‐6.96  ‐5.21 0.82 ‐2.10 ‐4.06 ‐2.79 ‐2.03
VAV2  ‐0.55  0.14 ‐0.08 ‐1.43 3.54 0.13 2.10  ‐2.19 1.50 0.14 1.01 ‐1.81 0.21







Gene  A1  B1 C1 D1 A2 B2 C2  D2 A B C D avg
ABR  ‐6.12  ‐5.03 ‐1.78 ‐5.25 ‐3.17 4.00  3.21  0.48 ‐4.64 ‐0.51 0.71 ‐2.39 ‐1.71
ARAP1  ‐0.73  0.09 1.93 0.67 1.14 1.60  ‐3.60  ‐1.58 0.20 0.84 ‐0.83 ‐0.45 ‐0.06
ARHGAP1  0.83  1.64 0.18 0.72 1.30 1.98  ‐2.56  ‐0.36 1.06 1.81 ‐1.19 0.18 0.46
ARHGAP10  ‐1.58  3.46 3.34 ‐0.60 0.97 0.30  1.24  ‐1.95 ‐0.30 1.88 2.29 ‐1.28 0.65
ARHGAP11A  0.53  ‐0.49 4.75 2.11 0.08 1.24  ‐0.10  0.96 0.30 0.38 2.32 1.53 1.13
ARHGAP11B  ‐0.09  0.11 3.36 0.28 ‐0.54 ‐1.05  ‐0.44  0.18 ‐0.31 ‐0.47 1.46 0.23 0.23
ARHGAP12  ‐0.79  3.94 3.68 ‐0.52 0.09 ‐0.13  0.98  ‐1.15 ‐0.35 1.91 2.33 ‐0.84 0.76
ARHGAP15  0.10  ‐1.94 0.25 1.76 ‐1.10 ‐0.22  ‐0.59  0.20 ‐0.50 ‐1.08 ‐0.17 0.98 ‐0.19
ARHGAP17  ‐2.84  ‐1.36 2.70 ‐0.03 ‐0.26 ‐3.58  0.51  ‐2.11 ‐1.55 ‐2.47 1.61 ‐1.07 ‐0.87
ARHGAP18  0.15  ‐1.26 ‐0.51 ‐0.99 ‐0.37 2.32  2.05  0.03 ‐0.11 0.53 0.77 ‐0.48 0.18
ARHGAP19  ‐7.95  ‐4.23 2.81 ‐2.78 3.71 2.03  1.65  ‐1.24 ‐2.12 ‐1.10 2.23 ‐2.01 ‐0.75
ARHGAP20  ‐0.99  0.63 5.85 1.24 ‐1.23 ‐1.43  0.41  0.58 ‐1.11 ‐0.40 3.13 0.91 0.63
ARHGAP22  0.27  0.09 4.57 1.63 ‐0.35 ‐0.88  ‐8.80  ‐1.81 ‐0.04 ‐0.39 ‐2.12 ‐0.09 ‐0.66
ARHGAP23  0.47  1.03 ‐1.39 1.18 ‐0.45 ‐2.48  ‐1.38  ‐0.62 0.01 ‐0.73 ‐1.38 0.28 ‐0.46
ARHGAP24  2.67  2.97 2.31 0.82 1.70 ‐0.20  0.29  ‐2.08 2.18 1.38 1.30 ‐0.63 1.06
ARHGAP25  2.58  4.11 5.54 0.49 0.26 ‐0.01  1.64  ‐0.25 1.42 2.05 3.59 0.12 1.79
ARHGAP26  0.42  2.49 1.70 ‐0.71 0.60 ‐3.67  ‐1.49  ‐8.62 0.51 ‐0.59 0.10 ‐4.66 ‐1.16
ARHGAP27  ‐1.25  ‐1.06 3.75 0.02 ‐0.33 0.38  ‐5.57  0.36 ‐0.79 ‐0.34 ‐0.91 0.19 ‐0.46
ARHGAP28  ‐0.36  ‐1.97 6.22 0.77 0.52 0.36  ‐3.78  0.10 0.08 ‐0.81 1.22 0.43 0.23
ARHGAP29  0.03  ‐2.14 0.87 0.32 ‐0.15 1.01  ‐3.19  0.78 ‐0.06 ‐0.57 ‐1.16 0.55 ‐0.31
ARHGAP30  0.01  ‐1.28 ‐2.17 ‐1.01 ‐0.79 0.72  ‐7.14  0.25 ‐0.39 ‐0.28 ‐4.65 ‐0.38 ‐1.43
ARHGAP31  ‐0.08  ‐2.38 2.40 1.72 ‐0.74 0.63  0.71  0.93 ‐0.41 ‐0.88 1.55 1.32 0.40
ARHGAP33  0.46  0.46 2.74 1.18 1.08 0.64  2.29  1.41 0.77 0.55 2.51 1.30 1.28
ARHGAP36  ‐0.41  0.02 ‐0.95 3.11 0.39 1.47  ‐0.46  0.97 ‐0.01 0.74 ‐0.71 2.04 0.52
  
98 
Gene  A1  B1 C1 D1 A2 B2 C2  D2 A B C D avg
ARHGAP39  ‐0.90  ‐1.73 6.35 1.77 0.16 2.08  ‐8.31  ‐1.96 ‐0.37 0.18 ‐0.98 ‐0.09 ‐0.32
ARHGAP4  ‐1.40  ‐0.46 0.97 0.66 ‐1.51 0.16  ‐1.06  ‐2.98 ‐1.45 ‐0.15 ‐0.05 ‐1.16 ‐0.70
ARHGAP40  0.65  ‐1.13 ‐4.99 ‐1.81 ‐1.06 1.46  ‐2.15  ‐0.81 ‐0.20 0.17 ‐3.57 ‐1.31 ‐1.23
ARHGAP42  ‐0.15  ‐1.34 ‐1.45 ‐0.68 ‐1.34 0.79  ‐1.06  ‐0.41 ‐0.74 ‐0.28 ‐1.25 ‐0.55 ‐0.70
ARHGAP5  0.14  ‐1.68 3.74 2.45 ‐0.30 0.52  ‐8.08  0.22 ‐0.08 ‐0.58 ‐2.17 1.33 ‐0.37
ARHGAP6  ‐1.88  ‐0.53 1.61 ‐0.08 1.58 ‐5.52  ‐4.65  ‐2.17 ‐0.15 ‐3.02 ‐1.52 ‐1.13 ‐1.46
ARHGAP8  0.22  0.10 4.26 0.03 ‐0.92 2.08  ‐0.10  ‐0.04 ‐0.35 1.09 2.08 0.00 0.70
ARHGAP9  1.99  2.68 ‐0.38 2.11 ‐0.57 ‐1.86  0.02  ‐0.02 0.71 0.41 ‐0.18 1.05 0.50
CENTD1  1.39  2.40 1.01 ‐1.49 ‐0.76 1.49  ‐4.63  ‐0.85 0.31 1.94 ‐1.81 ‐1.17 ‐0.18
CENTD3  3.64  5.00 ‐0.75 1.37 ‐0.64 ‐0.47  ‐5.75  ‐1.18 1.50 2.27 ‐3.25 0.10 0.15
CHN1  4.41  ‐2.82 0.02 ‐8.27 3.36 3.24  2.24  ‐3.69 3.88 0.21 1.13 ‐5.98 ‐0.19
CHN2  ‐0.25  2.41 0.00 2.06 0.74 1.79  ‐7.25  0.84 0.25 2.10 ‐3.63 1.45 0.04
DEPDC1A  ‐0.53  2.02 ‐0.74 2.28 0.38 ‐0.04  ‐1.83  ‐0.88 ‐0.08 0.99 ‐1.29 0.70 0.08
DEPDC1B  ‐0.89  ‐0.18 4.79 3.05 0.93 0.21  5.72  0.72 0.02 0.01 5.25 1.88 1.79
DLC1  ‐1.64  ‐0.95 2.75 0.62 ‐1.41 ‐0.14  ‐0.24  0.34 ‐1.52 ‐0.54 1.25 0.48 ‐0.08
FAM13A  ‐1.81  ‐0.80 3.28 ‐0.53 ‐0.07 ‐0.39  ‐2.21  1.74 ‐0.94 ‐0.60 0.53 0.60 ‐0.10
FAM13B  0.72  ‐1.94 2.17 0.78 ‐0.81 1.27  ‐1.01  1.10 ‐0.05 ‐0.33 0.58 0.94 0.29
GMIP  0.21  ‐1.15 ‐0.97 2.07 ‐0.62 0.95  ‐2.67  ‐0.60 ‐0.20 ‐0.10 ‐1.82 0.73 ‐0.35
GRLF1  0.01  ‐1.05 ‐0.69 2.47 ‐0.50 1.89  ‐0.64  ‐0.08 ‐0.24 0.42 ‐0.67 1.20 0.18
HMHA1  ‐5.39  ‐7.42 ‐8.23 ‐1.73 ‐2.26 1.72  2.23  1.08 ‐3.83 ‐2.85 ‐3.00 ‐0.33 ‐2.50
MYO9A  0.45  1.64 ‐1.25 ‐0.21 ‐0.24 ‐0.32  ‐3.86  0.05 0.10 0.66 ‐2.55 ‐0.08 ‐0.47
MYO9B  0.07  2.18 ‐1.86 0.05 0.46 0.58  2.20  1.54 0.26 1.38 0.17 0.79 0.65
OPHN1  ‐1.76  ‐2.20 ‐1.89 2.08 8.31 5.25  8.03  5.28 3.28 1.53 3.07 3.68 2.89
PIK3R1  ‐0.89  ‐0.23 ‐0.30 0.36 ‐3.87 1.87  0.40  1.58 ‐2.38 0.82 0.05 0.97 ‐0.13
PIK3R2  ‐1.64  ‐0.47 ‐0.63 ‐2.26 ‐6.88 ‐5.72  ‐1.71  3.27 ‐4.26 ‐3.09 ‐1.17 0.51 ‐2.00
RACGAP1  ‐0.20  ‐0.01 ‐4.99 ‐0.33 8.68 ‐3.45  1.00  0.60 4.24 ‐1.73 ‐2.00 0.14 0.16
RALBP1  ‐0.54  ‐0.37 3.18 1.59 0.61 0.53  1.73  1.39 0.03 0.08 2.46 1.49 1.02
RICH2  ‐1.22  ‐0.29 1.55 2.05 ‐0.58 ‐0.03  1.37  ‐0.43 ‐0.90 ‐0.16 1.46 0.81 0.30
  
99 
Gene  A1  B1 C1 D1 A2 B2 C2  D2 A B C D avg
RICS  0.08  4.39 ‐8.45 ‐11.43 3.24 2.09  0.83  2.56 1.66 3.24 ‐3.81 ‐4.43 ‐0.84
SH3BP1  ‐0.19  ‐1.17 6.52 2.50 ‐0.71 1.33  1.79  ‐1.49 ‐0.45 0.08 4.15 0.50 1.07
SRGAP1  ‐0.42  0.68 2.12 1.19 ‐0.62 0.56  ‐1.62  1.30 ‐0.52 0.62 0.25 1.25 0.40
SRGAP2  ‐1.66  1.87 ‐0.27 ‐0.96 ‐0.83 ‐0.46  4.55  1.51 ‐1.25 0.71 2.14 0.28 0.47
SRGAP3  ‐0.26  ‐0.47 ‐3.71 1.17 0.50 2.00  0.85  0.87 0.12 0.77 ‐1.43 1.02 0.12
STARD13  ‐0.43  ‐1.30 1.40 ‐0.05 1.03 1.88  2.59  1.97 0.30 0.29 2.00 0.96 0.89
STARD8  ‐0.32  ‐0.96 0.44 ‐0.47 0.76 ‐0.28  ‐1.33  1.72 0.22 ‐0.62 ‐0.44 0.63 ‐0.05
SYDE1  ‐0.67  ‐0.08 0.97 1.10 ‐0.45 1.00  4.13  1.69 ‐0.56 0.46 2.55 1.39 0.96
SYDE2  0.23  0.05 ‐2.02 ‐1.52 ‐0.31 0.94  ‐4.28  0.79 ‐0.04 0.49 ‐3.15 ‐0.37 ‐0.77





Tiam2, also known as Stef, is a GEF for Rac subfamily GTPases and shares high sequence 
similarity with Tiam1 (Matsuo et al. 2002, Terawaki et al. 2010). In a study by Tanaka and 
colleagues preliminary data indicated that Tiam2 is able to bind to ephrinB1 in similar 
fashion to Tiam1 (Tanaka et al. 2004). Our screen data revealed that across all four siRNA 
oligos used against Tiam2, the number of internalised Eph-ephrin clusters was reduced 
when compared to scramble control condition. Knockdown of Tiam1, on the other hand, 
which had already been implicated in endocytosis of soluble ephrinA ectodomains into 
EphA+ cells (Yoo et al. 2010, Um et al. 2014), did not show any effect on EphB trans-
endocytosis into SKN cells. In order to confirm the involvement of Tiam2 in EphB trans-
endocytosis into ephrinB+ cells, we repeated the experiments in the same setup used for 
the screen, but for each experiment the treatments were performed in triplicate to improve 
the validity of the results. Since Tiam1 had been previously shown to be involved in 
endocytosis of soluble ephrin ectodomains, we decided to also re-test Tiam1. These follow-
up experiments confirmed the results from the screen. Knockdown of Tiam2 led to a 
significant reduction of EphB trans-endocytosis into SKN cells, while knockdown of 
Tiam1 resulted in no detectable effect (Fig. 20B). 
Next, we wanted to establish, whether Tiam2 was also required for efficient EphB trans-
endocytosis into other ephrinB+ cell lines. We therefore conducted co-culture experiments 
using two types of HeLa cells transiently expressing ephrinB1-mCherry and EphB2C-
GFP respectively. In addition to the siRNA knockdown of Tiam2, we again included 
knockdown of Tiam1 in the experimental conditions (Fig. 20A, top panel). Furthermore, 
to account for potential redundancy between the closely related Tiam proteins, we also 
tested a combined knockdown using oligos against both Tiam1 and Tiam2 (images not 
shown). We observed a significant decrease in trans-endocytosis upon knockdown of 
Tiam2 in HeLa cells, replicating the findings from SKN cells (Fig. 20C). In contrast to the 
results from SKN cells, knockdown of Tiam1 also resulted in a significant decrease of 
EphB trans-endocytosis into ephrinB1-expressing HeLa cells. A combination of oligos 
against Tiam2 and Tiam1 led to a significant reduction in trans-endocytosis as well, 
however, the combined effect was no larger than the effect of single knockdowns of either 
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Tiam2 or Tiam1. The results from the combined knockdown could suggest a combinatorial 
requirement of Tiam1 and Tiam2 for EphB trans-endocytosis into ephrinB1-expressing 
HeLa cells instead of functional redundancy between the two. Another potential 
explanation for not observing an increase in the effect of the combined knockdown as 
compared to the single knockdowns, could be the fact that in the combined knockdown 
only half the concentration of each single oligo is used, potentially decreasing knockdown 
effectiveness and thus weakening the effect.  
Tiam1 had already been reported to be a regulator of Eph-ephrin endocytosis, however 
these experiments were performed with soluble pre-clustered ephrinA ectodomains into 
EphA+ cells and the role of Tiam2 was not addressed (Yoo et al. 2010, Um et al. 2014). 
Thus, to determine whether reverse and forward trans-endocytosis of Eph-ephrin 
complexes make use of the same molecular machinery, we performed co-culture 
experiments with HeLa cells transiently transfected with either EphB2-mCherry or 
ephrinB1C-GFP, thus only allowing endocytosis into the EphB2-expressing cell (forward 
direction). We tested the same siRNA treatments as in the reverse direction (Fig. 20A, 
bottom panel). Indeed, knockdown of Tiam1, Tiam2, or both proteins combined caused a 
reduction in the number of Eph-ephrin complexes internalised into HeLa cells. As in the 
reverse direction, combined knockdown of Tiam1 and Tiam2 did not result in a more 
pronounced effect on the number of internalised vesicles (Fig. 20D).  
Taken together, these results suggest that the molecular mechanism for trans-endocytosis 
of Eph-ephrin complexes is either the same or, at least shares overlapping molecular 
players in the forward and reverse direction. In both directions, activity of Rac subfamily 









forward  trans‐endocytosis  assay  (bottom  panel)  with  HeLa  cells  expressing  EphB2‐mCherry 
(red/red dashed outline) co‐cultured with HeLa cells expressing FLAG‐ephrinB1C‐GFP (green/blue 
dashed outline). Surface ephrinB1  stained with  secondary antibody  (blue/appears white  in  the 
overlay). Treatment with  scramble, Tiam1 or Tiam2  siRNA oligos.  (B) Quantification of average 
number of internalised clusters per cell normalised to the median of the scramble controls in assay 
with SKN cells performed with CellProfilerTM. Results for each gene and the combination of Tiam1 
and  Tiam2  oligos  at  20  nM  total  final  concentration  are  shown. Data  shown  as mean  of  the 
individual  means  normalised  to  the  median  of  the  scramble  control.  Repeated  ANOVA  with 
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2.4.2 Tiam family proteins are not required for the endocytosis of soluble EphB2 
ectodomains into ephrinB+ cells 
Given the differential requirement for Rac subfamily GTPases for endocytosis of 
membrane-tethered and soluble EphBs, I investigated whether the same is true for the Tiam 
family proteins, given their role as Rac-specific GEFs. I knocked down the expression of 
Tiam1 and Tiam2 in SKN cells using siRNA either individually or in combination and 
stimulated the cells with soluble EphB ectodomains described before (Fig. 21A). Neither 
individual knockdown of either Tiam1 or Tiam2, nor combined knockdown of both 
proteins at the same time (images not shown), resulted in a significant change in the number 
of internalised Eph-ephrin clusters (Fig. 21B).  
The differential requirement for Tiam family proteins between the trans-endocytosis assay 
and the stimulation with soluble EphB ectodomains fit nicely with the observation that also 
Rac subfamily GTPases are only required for EphB trans-endocytosis into ephrinB+ cells, 








µm.  (B)  Quantification  of  average  number  of  internalised  clusters  per  cell  performed  with 
CellProfilerTM. Results for one oligo for each gene and the combination of Tiam1 and Tiam2 oligos 
at 20 nM  total  final concentration are  shown. As a positive control  results  for a knockdown of 
ephrinB2 or ephrinB1 and ephrinB2 combined are shown. As absolute control cells were stimulated 
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3 Discussion 
3.1 Molecular mechanisms of Eph‐ephrin endocytosis 
The findings of this study regarding the molecular regulation of Eph-ephrin endocytosis 
are summarised in the cartoon in Figure 22. In brief, trans-endocytosis of Eph-ephrin 
complexes in both the forward (Fig. 22C) and reverse (Fig. 22D) directions requires Tiam-
induced Rac activity, probably in order to drive polymerisation of the actin cytoskeleton to 
allow for the pinching off of whole receptor-ligand complexes including pieces of the 
opposing membrane. Rac activity controls EphB trans-endocytosis into ephrinB+ SKN 
cells (Fig. 8), HeLa cells (Fig. 9), and primary cortical neurons (Fig. 10). These findings 
show that the general mechanism described in this study is not cell-type-specific and 
relevant in physiological contexts, where Eph-ephrin signalling is important.  
For endocytosis of Eph-ephrin complexes induced by soluble ephrin ectodomains (forward 
direction), Tiam-induced Rac activity is also required. However, previous work also 
suggests that these complexes are internalised via Clathrin-mediated endocytosis (CME) 
(Yoo et al. 2010), which can represent either an overlapping or parallel pathway (Fig. 22A). 
The reverse endocytosis of Eph-ephrin complexes induced by stimulation with soluble 
EphB ectodomains does not require Rac or Tiam activity. Curiously, we also found that 
RhoA subfamily GTPases inhibit or at least slow down the rate of internalisation (Fig. 
22B). While also for reverse endocytosis induced by stimulation with soluble Eph 
ectodomains evidence implicating the importance of the CME pathways exists (Parker et 
al. 2004), the exact molecular mechanism underlying this endocytic route still remains to 
be elucidated.  
In the following chapters I will discuss the results from this study in more detail, as well 





(A)  Forward  endocytosis  of  Eph‐ephrin  complexes  induced  by  soluble  pre‐clustered  ephrin 
ectodomains.  GEFs  activate  Rac  downstream  of  Eph‐receptors.  Tiam1  and  Vav2/3  have  been 
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3.1.1 Which endocytic pathway does EphB‐ephrinB internalisation take? 
As discussed in the introduction (section 1.3.1), endocytic processes can be distinguished 
by their underlying molecular machineries (Doherty & McMahon 2009). Our findings 
suggest that Eph-ephrin complexes are internalised via different endocytic pathways, 
depending on whether they originate from stimulation with soluble fusion proteins or from 
cell contact-mediated Eph-ephrin signalling.  
The original work from Marston and co-workers, as well as Zimmer and colleagues showed 
that trans-endocytosis of Eph-ephrin complexes does not occur via the clathrin-mediated 
pathway of endocytosis (CME), at least in the forward direction, as EphB-ephrinB 
complexes internalised by trans-endocytosis do not co-localise with clathrin-coated pits 
(Marston et al. 2003, Zimmer et al. 2003). Since also no co-localisation of Eph-ephrin 
clusters with caveolin could be detected, Eph-ephrin trans-endocytosis should also be 
independent of the caveolae- mediated endocytic pathway.  
Among the well-described endocytic pathways, macropinocytosis and phagocytosis are 
reliant on Rac activity (Doherty & McMahon 2009). These two pathways both involve the 
uptake of relatively large cargo: either only to some extent discriminatively from the 
environment (macropinocytosis) or very selective uptake of pathogens or apoptotic bodies 
that have been primed for internalisation by specialised cells (phagocytosis). Apart from 
being limited to specialised cells in the immune system, phagocytosis has been shown to 
require the orchestrated activity of several Rho family GTPases (Massol et al. 1998, 
deBakker et al. 2004, Flannagan et al. 2012) and should thus be sensitive to disturbance of 
additional Rho subfamilies other than only Rac. As our experiments, however, only show 
the requirement of Rac subfamily GTPases and suggest that other Rho subfamilies are 
dispensable for EphB trans-endocytosis into ephrinB+ cells, and given that the endocytic 
uptake of Eph-ephrin complexes is not limited to the specialised cells traditionally thought 
to exhibit phagocytosis, it can be postulated that EphB trans-endocytosis into ephrinB+ 
cells is not mediated by canonical phagocytosis. Whereas macropinocytosis was originally 
thought to be involved mainly in the indiscriminate uptake of extracellular fluid and its 
content (hence the Greek origin of the name: “large cell drinking”) (Swanson & Watts 
1995), it has later emerged that macropinocytosis also regulates the selective internalisation 
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of large patches of activated RTKs (Orth et al. 2006). Macropinocytosis is characterised 
by the formation of dorsal membrane ruffles, which requires the activity of Rac subfamily 
GTPases (Rac1 and RhoG) and their downstream effector PAK to initiate the 
reorganisation of the actin cytoskeleton required (Swanson & Watts 1995, 
Dharmawardhane et al. 2000, West et al. 2000, Ellerbroek et al. 2004, Doherty & 
McMahon 2009). EphB trans-endocytosis into ephrinB+ cells also requires the uptake of 
large clusters and corresponding patches of membrane and is regulated by Rac subfamily 
GTPases, as shown in this study. Therefore, it is possible that Eph-ephrin trans-endocytosis 
uses the macropinocytic pathway. To clarify whether Eph-ephrin trans-endocytosis truly 
goes through canonical macropinocytosis or whether it simply shares some molecular 
components, further work will be required. Firstly, studies with siRNA or pharmacological 
inhibition of PAK (Rudolph et al. 2015) could elucidate whether PAK is required 
downstream of Rac signalling in this context. Secondly, a unique feature of 
macropinocytosis is its susceptibility to inhibitors of Na+/H+ exchange, such as amiloride 
(West et al. 1989, Veithen et al. 1996, Koivusalo et al. 2010). Thus, inhibition of Eph-
ephrin trans-endocytosis with amiloride might indicate that this process resembles 
macropinocytosis.  
As a preliminary conclusion, I suggest that Eph-ephrin complexes between two opposing 
cells may be internalised via a macropinocytosis-like pathway. 
Experiments performed using stimulation with soluble ectodomains in both the forward 
and reverse direction have provided some evidence for an involvement of the CME-
pathway, as internalised Eph-ephrin complexes co-localised with markers of the CME-
pathway (Parker et al. 2004, Yoo et al. 2010). Nonetheless, the role of CME is still disputed, 
as several studies also postulate that Rac activity is necessary for internalisation into Eph-
expressing cells after stimulation with soluble ephrin ectodomains (Cowan et al. 2005, Yoo 
et al. 2010, Um et al. 2014). Rac activity is traditionally not considered to be obligatory for 
CME to occur (McMahon & Boucrot 2011).Furthermore Cowan and colleagues also 
showed that upon knockout of Vav2 and Vav3, which led to an inhibition of EphA 
endocytosis induced by soluble ephrinA ectodomains, the general CME pathway was still 
intact. Parker and colleagues reported that ephrin reverse endocytosis after stimulation with 
soluble EphB ectodomains is mediated by CME (Parker et al. 2004). They based their 
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claims on a combination of indirect observations (co-localisation with CME-associated 
proteins after internalisation), and experiments not specific for CME (transfection of a 
dominant negative version of dynamin, potassium depletion). Therefore more conclusive 
experiments, for example with direct siRNA knockdown of components of the clathrin-
machinery, would be required to confirm that reverse endocytosis of Eph-ephrin complexes 
induced by soluble Eph ectodomains uses CME. However, as our results only indicate that 
Rac activity is not required for endocytosis of EphB ectodomains into ephrinB+ cells, they 
do not contradict the findings of Parker and colleagues. Additionally, we found in our study 
that depletion of RhoA subfamily GTPases leads to an increase in endocytosis of soluble 
EphB ectodomains into ephrinB+ cells. Since some evidence exists suggesting RhoA 
activity can negatively affect CME in some physiological contexts (Lamaze et al. 1996, 
Kaneko et al. 2005, Khelfaoui et al. 2009), these data are in agreement with the hypothesis 
that Eph-ephrin reverse endocytosis after stimulation with soluble Eph ectodomains occurs 
via CME. However, it should be noted that the literature on the role of RhoA subfamily 
GTPases in CME is contradictory, as positive regulation has also been reported (Malaval 
et al. 2009, Stirling et al. 2009). 
An interesting feature of endocytosis induced by soluble ephrin or Eph ectodomains is the 
differential requirement of Rac activity between the forward and reverse directions. The 
evidence indicating CME is responsible for endocytosis of soluble ephrin ectodomains into 
Eph+ cells is not very strong, as it only derives from co-localisation studies of CME-
associated proteins with Ephs after internalisation (Yoo et al. 2010). Such co-localisation 
after internalisation could, however, also arise from trafficking of Eph-ephrin complexes 
internalised through clathrin-independent pathways into shared endosomal compartments. 
On the other hand, the requirement of Rac activity for endocytosis of soluble ephrin 
ectodomains into Eph+ cells is fairly strong and has been replicated in several independent 
publications (Cowan et al. 2005, Yoo et al. 2010, Yoo et al. 2011, Um et al. 2014), as well 
as in our study presented here (Fig. 12). Furthermore, additional experiments in our group 
revealed differential activation of Rac upon stimulation with either soluble pre-clustered 
ephrin or Eph ectodomains with a Förster resonance energy transfer (FRET)-based probe 
for Rac activity (Itoh et al. 2002), emphasising that Rac is more strongly activated 
downstream of EphB receptors than ephrinBs (T. Gaitanos, unpublished data). There are 
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several other conceivable explanations for the seemingly conflicting evidence regarding 
the involvement of both Rac activity and CME in endocytosis of soluble ephrin 
ectodomains into Eph+ cells. Not only Rac activity, but also explicitly the GEFs Tiam1, 
Vav2 and Vav3 have previously been implicated in Eph-ephrin endocytosis (Cowan et al. 
2005, Yoo et al. 2010, Um et al. 2014), and the same signalling axis has been shown to 
regulate Eph-ephrin trans-endocytosis in both directions in this study. Therefore, it is 
possible that trans-endocytosis and endocytosis of soluble ephrin ectodomains into Eph+ 
cells share the same macropinocytosis-like pathway and CME is of subsidiary relevance. 
Still, there is also another potential explanation. The role of actin reorganisation in CME 
is still a matter of debate (Mooren et al. 2012). However, there are reports that indicate that 
endocytosis of the vesicular stomatitis virus occurs through CCPs and requires 
polymerisation of actin for its full-length form, while an artificially truncated version of 
the viral particle can be internalised via CME independently of actin (Cureton et al. 2009, 
Cureton et al. 2010). Therefore, a difference in the size of Eph-ephrin clusters induced 
between forward and reverse signalling could be a potential explanation for the variance in 
the requirement of Rac activity for endocytosis. Once the initial cluster formation has been 
triggered by stimulation with ephrin, clusters of Eph receptors can propagate in size due to 
cis interactions independent of ephrin-binding (Wimmer-Kleikamp et al. 2004). However, 
no such propagation mechanism has been described for ephrins thus far. Hence, it is 
conceivable that Eph-ephrin clusters formed by stimulation with soluble ephrin 
ectodomains are larger than those formed after stimulation with soluble Eph ectodomains. 
Hence, it is possible that their internalisation requires an “extended” form of CME, which 
is also dependent on reorganisation of the actin cytoskeleton triggered by Rac activity. 
Finally, it is also possible that two separate pathways, one Rac-dependent, the other 
clathrin-dependent, govern the internalisation of soluble ephrin ectodomains into Eph+ 
cells. It would therefore be very informative to inhibit both pathways at the same time. 
Taking both the results presented in this study and previous literature into consideration, 
trans-endocytosis of Eph-ephrin complexes can be linked to a macropinocytosis-(like) 
pathway, while the paradigm for endocytosis of clusters induced by soluble proteins is 
more nuanced and potentially involves CME as either the main, or at least one of several 
pathways. The evidence so far is not conclusive enough to firmly assign the endocytic 
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processes for Eph-ephrin complexes to any specific pathway. To further dissect the 
contribution of the individual endocytic pathways, careful analysis with manipulation of 
known molecular markers for the separate pathways should be conducted. Moreover, the 
possibility that Eph-ephrin endocytosis is governed by several pathways in parallel, or by 
pathways that are novel in their precise composition of regulating proteins and only 
partially overlap with well-characterised pathways, cannot be ruled out at this stage. Also 
the question in how far the endocytic pathways differ between forward and reverse 
directions and between EphA-ephrinA and EphB-ephrinB signalling was not completely 
answered yet. Here we show that for the trans-endocytosis with two opposing cells in 
contact the molecular regulators identified are the same for forward and reverse direction, 
while endocytosis after stimulation with soluble ectodomains differs in their requirement 
of Rac activity. Regarding the differences between the EphA and EphB systems our 
findings indicate that at least in the forward direction EphA and EphB endocytosis shares 
a common regulatory mechanism via Rac activity. While it should be noted that this 
assumption for EphAs is based primarily on data from studies with soluble ectodomains, it 
would also be interesting to examine whether trans-endocytosis also occurs in EphA-
ephrinA signalling, or whether this system only relies on cleavage for cell detachment 
(Hattori et al. 2000, Janes et al. 2005). Finally, another intriguing question is which 
molecular mechanisms govern the decision into which cell trans-endocytosis occurs under 
physiological conditions with both cells coming into contact expressing either wild type 
Eph or ephrin. 
3.1.2 Physiological relevance of Eph‐ephrin endocytosis triggered by stimulation with 
soluble proteins 
In physiological situations both Ephs and ephrins are membrane-tethered when they engage 
in signalling. Therefore, it is reasonable to assume that the trans-endocytosis of Eph-ephrin 
clusters we observe in experiments during cell-contact mediated signalling more truthfully 
represents the endocytic process in vivo. Nonetheless, it is possible that the mechanisms 
for endocytosis upon stimulation with soluble ephrin or Eph ectodomains are also relevant 
in physiological settings. As Ephs and ephrins have been shown to be cleaved by 
metalloproteases (Hattori et al. 2000, Georgakopoulos et al. 2006, Lin et al. 2008, Inoue et 
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al. 2009, Gatto et al. 2014), it is possible that their shed ectodomains can bind to receptors 
or ligands as soluble proteins and elicit signalling, albeit weakly. If this were the case, then 
endocytosis of Eph-ephrin complexes would probably be regulated by the two distinct 
mechanisms in the forward and reverse direction described in this study (Fig. 22A and B). 
However, so far cleavage of ephrins and Eph receptors has been thought of as an alternative 
mechanism for allowing cell detachment after initial adhesion due to receptor-ligand 
interactions, or a mechanism to fine-tune signalling responses by decreasing sensitivity, 
while no evidence for a signal-inducing role of the shed ectodomains has been found. 
Recent work in our laboratory has shown that both Ephs and ephrins are secreted in 
exosomes, which retain their signalling capabilities (J. Gong, unpublished data). Exosome-
induced ephrin signalling probably involves endocytosis and it would be interesting to 
investigate which endocytic mechanism is involved. It is possible that endocytosis of Eph-
positive exosomes resembles Eph trans-endocytosis between two opposing cells, since the 
membranous nature of the exosome is more similar to a living cell than a soluble fusion 
protein. Further work will be required to assess the requirement of Rac activity and actin 
polymerization in this context. 
In conclusion, given our current understanding of Eph-ephrin signalling, the trans-
endocytosis process orchestrated by Rac activity proposed in this study is highly relevant 
for the physiological role of Eph-ephrin signalling in mediating cell repulsion, while the 
divergent pathway for endocytosis of complexes induced by soluble proteins is of lesser 
importance unless a physiological role of soluble Eph or ephrin ectodomains is discovered. 
Therefore, it would be advisable that future studies of EphB endocytosis into ephrinB+ 








Our experiments in SKN cells, HeLa cells and cortical neurons all show the requirement 
of Rac activity for efficient EphB trans-endocytosis into ephrinB+ cells. Interestingly, only 
the simultaneous, combined siRNA knockdown of all three Rac subfamily members 
expressed in the SKN cells used in this study (Rac1, Rac3, and RhoG) resulted in a 
significant reduction of EphB trans-endocytosis, indicating physiological redundancy 
between them. Redundancy between Rac1 and Rac3 has already been established in the 
literature (Corbetta et al. 2009). In contrast, despite its sequence similarity, RhoG has been 
suggested to activate Rac signalling instead of being redundant to it (Katoh & Negishi 
2003, Hiramoto et al. 2006, Katoh et al. 2006). Still, others have found that RhoG has both 
distinct and shared signalling pathways with other Rac subfamily GTPases (Wennerberg 
et al. 2002). In this study, we carefully dissected the individual contributions of the separate 
Rac subfamily members by performing individual siRNA knockdowns, a combination of 
knockdowns of any two proteins, as well as all three at once. Neither depletion of any single 
Rac subfamily GTPase, nor the combined knockdown of any two subfamily members 
significantly reduced EphB trans-endocytosis into ephrinB+ cells. An effect was only 
observed when Rac1, Rac3, and RhoG were knocked down simultaneously. These results 
suggest that for EphB trans-endocytosis into ephrinB+ cells the three Rac subfamily 
GTPases are physiologically redundant. Marston and colleagues had previously implicated 
Rac1 in the regulation of Eph-ephrin trans-endocytosis in the forward direction by 
transfecting cells with a dominant negative mutant of Rac1 (Marston et al. 2003). These 
experiments do not rule out the possibility that in the forward direction activity of different 
Rac subfamily members is also physiologically redundant, since the dominant negative 
mutant potentially inhibits all family members by sequestering shared regulators and 
effectors. 
Notably, despite a significant decrease in the amount of internalised Eph-ephrin complexes 
in cells treated with siRNA against Rac subfamily members or the Rac inhibitor EHT1864, 
EphB trans-endocytosis is not completely abolished (Fig. 8). This is either due to the 
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treatments not sufficiently inhibiting Rac function, or it could be due to the possibility that 
EphB trans-endocytosis into ephrinB+ cells can also be mediated by an alternative Rac-
independent mechanism. 
3.2.2 The role of Cdc42 signalling in Eph‐ephrin endocytosis  
The results in this study indicate that activity of the Cdc42 subfamily of Rho GTPases is 
not involved in both EphB trans-endocytosis and endocytosis of soluble EphB ectodomains 
into ephrinB+ cells (Fig. 13). However, these results do not exclude the possibility that 
Cdc42 plays a minor role in EphB trans-endocytosis, which is masked by redundancy from 
Rac subfamily GTPases. Since both the knockdown of Rac subfamily members and 
pharmacological inhibition of Rac activity with EHT1864 did not completely block EphB 
trans-endocytosis and Rac and Cdc42 signalling has been reported to be redundant in 
certain physiological contexts (Izumi et al. 2004, Watanabe et al. 2004), it is conceivable 
that Cdc42 subfamily GTPases contribute to EphB trans-endocytosis into ephrinB+ cells 
in the absence of Rac activity. One way to address this possibility could be a combination 
of pharmacological inhibition and siRNA knockdown to target both subfamilies 
simultaneously. 
Initial analysis of the GEF/GAP screen resulted in the Cdc42-specific GEF ITSN1 as a 
candidate for regulating EphB trans-endocytosis into ephrinB+ cells. However, both 
follow-up experiments and re-analysis of the screen data with a higher emphasis on 
consistency did not confirm ITSN1 as a regulator of EphB trans-endocytosis. Nonetheless, 
ITSN1 has previously been shown to be an important signalling component downstream 
of EphB receptors in the regulation of dendritic development (Irie & Yamaguchi 2002, 
Nishimura et al. 2006). Moreover, ITSN1 has also been implicated in the regulation of 
axon guidance at the cortical midline (Sengar et al. 2013), a feature it shares with Eph-
ephrin reverse signalling (Kullander et al. 2001a, Mendes et al. 2006, Otal et al. 2006), 
which could imply that ITSN1 is also involved in Eph-ephrin signalling in this context. 
However, these results implicate ITSN1 downstream of Eph-ephrin forward signalling, 
while I examined the regulation of EphB reverse trans-endocytosis into ephrinB+ cells. 
Therefore I cannot exclude that ITSN1 is involved in the regulation of ephrin trans-
endocytosis into Eph+ cells. It is also possible that ITSN1 fulfils functions not linked to 
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regulating Eph-ephrin endocytosis. Due to its nature as a multi-domain protein it could be 
required for the regulation of the endocytosis of target proteins triggered by Eph-ephrin 
signalling, or for the stabilisation of protein complexes as a scaffolding protein, as it has 
been described in other physiological scenarios (Tsyba et al. 2011, Wong et al. 2012). 
3.2.3 The role of RhoA subfamily GTPases in Eph endocytosis into ephrinB+ cells 
RhoA is well established as a downstream effector of Eph-ephrin signalling, especially in 
the contexts of growth cone collapse and cell retraction (Shamah et al. 2001, Sahin et al. 
2005, Groeger & Nobes 2007, Takeuchi et al. 2015). So far, however, RhoA-like GTPases 
have not been described in the context of endocytosis of Eph-ephrin complexes. The results 
of this study reveal a complex picture for their involvement in Eph-ephrin reverse 
endocytosis. 
Experiments with soluble EphB2 ectodomain stimulation in SKN cells showed a very 
strong phenotype for the knockdown of RhoA subfamily GTPases. The observed increase 
in the amount of Eph-ephrin complexes internalised after EphB2-Fc stimulation was highly 
significant in both the knockdown of RhoA or RhoB individually, or in a combination of 
the two. (Fig. 15C). Remarkably, the effect was stronger for the RhoA single and RhoA 
and RhoB double knockdown than for the RhoB single knockdown. Surprisingly, 
analogous experiments in HeLa cells did not result in a statistically significant increase in 
endocytosis, although a trend in the same direction was observed (Fig. 15D). This 
discrepancy either reveals a cell type-specific effect for RhoA subfamily activity on 
endocytosis of EphB ectodomains into ephrinB+ cells, or it could be explained by the 
circumstances of the artificial overexpression system used for the experiments in HeLa 
cells, with the sheer amount of available ephrin protein at the cell surface masking any 
effect resulting in an increase of endocytic events. 
One possible explanation for the effect of the depletion of RhoA subfamily GTPases on 
endocytosis of soluble EphB ectodomains into ephrinB+ cells could be derived from their 
role in inhibiting CME. Previous work by Parker and colleagues suggests that endocytosis 
of EphB ectodomains into ephrinB+ cells is mediated by CME (Parker et al. 2004). RhoA 
activity, often conferred through its effector ROCK, has been shown to negatively regulate 
CME in several cellular contexts (Lamaze et al. 1996, Kaneko et al. 2005, Khelfaoui et al. 
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2009). It should be noted, however, that there are also reports providing evidence for a 
positive role of RhoA signalling in stimulating CME (Malaval et al. 2009, Stirling et al. 
2009). Our findings are in agreement with the first line of evidence and would thus argue 
for a direct involvement of RhoA subfamily GTPases in negatively regulating endocytosis 
of soluble EphB ectodomains into ephrinB+ cells.  
An alternative explanation for the role of RhoA subfamily GTPases in endocytosis of EphB 
ectodomains into ephrinB+ cells is that they do not directly inhibit the internalisation, but 
rather are required for subsequent endocytic trafficking. RhoB is a well-established 
regulator of endosomal trafficking that facilitates the transition of early endosomes towards 
the lysosomal or recycling compartments, while not effecting endocytic uptake per se 
(Gampel et al. 1999, Fernandez-Borja et al. 2005, Rondanino et al. 2007). Endosomes in 
cells with aberrant RhoB function are smaller than those under control condition and are 
observed in unusual cellular locations (Fernandez-Borja et al. 2005). Also in my 
experiments the endocytosed vesicles in SKN cells stimulated with soluble EphB2 
ectodomains are significantly smaller upon knockdown of RhoA or a combined 
knockdown of RhoA and RhoB (Fig. 15E). This could indicate that the RhoA subfamily 
phenotype, at least to some extent, originates from a defect in endosomal trafficking. If the 
effect of RhoA subfamily depletion in Eph-ephrin endocytosis was due to aberrant 
endosomal trafficking, one would expect that knockdown of RhoB results in a stronger 
effect as compared to RhoA. My data, curiously, presents the opposite result. This should 
not be seen as a definitive argument against the hypothesis of an effect on endosomal 
trafficking, as also some evidence for a role of RhoA itself in endosomal trafficking has 
been reported (Nishimura et al. 2002, Stirling et al. 2009). Additionally, the preferential 
requirement of RhoA over RhoB might be a peculiarity of the Eph-ephrin system. 
On the basis of the presented data, several plausible explanations for the role of RhoA 
subfamily GTPases in endocytosis of soluble EphB ectodomains into ephrinB+ cells can 
be given. In order to clarify the mechanisms involved and test for the role of endosomal 
trafficking, the interaction of Eph-ephrin endosomes with members of the Rab family 
GTPases could be studied, which are known regulators of endocytic trafficking events 
(Wandinger-Ness & Zerial 2014). An alternative or complimentary route of inquiry could 
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be the visualisation of the steps of endocytic processing using super resolution live cell-
imaging.   
In contrast to the results from the soluble assay, the trans-endocytosis assay with SKN cells 
resulted in no change in the amount of internalised complexes when compared to the 
control condition. Still, experiments in HeLa cells again displayed a trend towards an 
increase in endocytosis, which tested as statistically insignificant (Fig. 14). Interestingly, 
the trend for an increase in EphB trans-endocytosis into ephrinB-expressing HeLa cells 
was restricted to RhoA knockdown or a combination of RhoA and RhoB, while RhoB 
depletion alone showed trans-endocytosis exactly at control levels. This pattern is 
remarkably similar to the results obtained in the assay with soluble ectodomains (Fig. 15), 
but of course, without being statistically significant. One piece of evidence supporting 
some relevance of RhoA activity, also for EphB trans-endocytosis, can be drawn from the 
results of the GEF/GAP screen. The GEF showing the strongest increase in endocytosis 
when depleted was Net1. Net1 is a RhoA-specific GEF, which has been found to co-
localise with RhoA in the nucleus (Alberts & Treisman 1998, Schmidt & Hall 2002b).  So 
far no reports linking Net1 to endocytosis exist. Interestingly, one study suggests that Rac1 
activity can increase Net1 GEF activity, thus suggesting a positive reinforcement from Rac 
to RhoA signalling (Carr et al. 2013), whereas an earlier study described Rac and PAK-
dependent down-regulation of Net1 activity, which is more in line with the usual 
counteractive role of Rac and RhoA signalling (Alberts et al. 2005). Taken together with 
the well-established antagonistic role of RhoA and Rac signalling (Guilluy et al. 2011), 
these findings could imply that RhoA signalling can have a minor inhibiting effect on EphB 
trans-endocytosis into ephrinB+ cells. However, the evidence for this hypothesis is 
diminished by results from knockdown of RhoGAP OPHN1 in our screen. OPHN1 
regulates RhoA activity in vivo and is reported to release the inhibitory effect of RhoA 
signalling on CME of synaptic receptors, which is required for proper neural development 
(Fauchereau et al. 2003, Govek et al. 2004, Khelfaoui et al. 2009). According to the 
hypothesis of RhoA as a negative regulator of EphB trans-endocytosis into ephrinB+ cells, 
depletion of OPHN1 should increase RhoA activity and thus lead to a decrease in trans-
endocytosis. Our screen data reveals the exact opposite effect, with knockdown of OPHN1 
resulting not only in an increase in trans-endocytosis, but it being one of the strongest 
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candidates (Fig. 19). A suitable explanation for this conflicting result could be that OPHN1 
also possesses GAP activity for Rac1 and Cdc42, at least in vitro (Billuart et al. 1998), 
which could be the mechanism of action preferentially active in the context of EphB trans-
endocytosis. In any case, more work, also addressing the validity of the tools used (for 
example, confirmation of siRNA knockdown effectiveness), would need to be conducted 
before final conclusions on the role of RhoA subfamily GTPases in trans-endocytosis of 
Eph-ephrin complexes can be drawn.  
Another potential explanation for the discrepancy between the results from the trans-
endocytosis assay and the assay with soluble EphB ectodomains could be that the two 
assays operate at different levels of sensitivity. Since trans-endocytosis can only occur at 
sites of cell contact, this could be a rate-limiting factor and mask effects a putative 
disinhibition of trans-endocytosis by knockdown of RhoA subfamily GTPases could exert. 
In contrast when saturated with soluble EphB ectodomains no such limitations exist and a 
knockdown of RhoA subfamily GTPases leads to an increase in endocytosis.  
In this study we did not investigate the role of RhoA subfamily GTPases in endocytic 
processes in the forward direction. As the trans-endocytosis of Eph-ephrin complexes in 
both directions seem to share the same endocytic pathway and knockdown of RhoA 
subfamily GTPases did not significantly alter the amount of endocytosis observed for EphB 
trans-endocytosis into ephrinB+ cells, it would be reasonable that the same is true in the 
forward direction. Nonetheless, experiments confirming this assumption would give 
further support to the hypothesis that trans-endocytosis of Eph-ephrin complexes uses the 
same endocytic machinery in both the forward and reverse directions. Considering the 
differential requirements for Rac activity in the soluble endocytosis assays with either 
ephrin or Eph ectodomains, and that CME has been implicated in the forward direction 
(Yoo et al. 2010), it would be intriguing to address the question of whether RhoA subfamily 
GTPases also exhibit an inhibitory function towards endocytosis of soluble ephrin 
ectodomains into Eph+ cells. 
Taken together, these results suggest that RhoA subfamily GTPases negatively regulate 
Eph-ephrin reverse endocytosis upon stimulation with soluble EphB2 ectodomains, while 
they do not have a crucial function in EphB trans-endocytosis into ephrinB+ cells. Given 
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the complex nature of the role that RhoA subfamily GTPases play in endocytic processes, 
further experimentation is required to elucidate the exact molecular mechanism of RhoA 
function in this context, and at which state of the endocytic process RhoA subfamily 
members exert their effect. 
3.3 Polymerisation of actin in Eph‐ephrin trans‐endocytosis 
Endocytic processes for the uptake of large cargoes are in most cases dependent on the 
rearrangement of the actin cytoskeleton (Girao et al. 2008, Doherty & McMahon 2009). 
Moreover, for ephrinB trans-endocytosis into Eph+ cells, the requirement of the actin 
cytoskeleton has already been demonstrated (Marston et al. 2003). 
The work in this study, which implicates the activity of Rac-family GTPases, well-known 
regulators of the actin cytoskeleton in endocytic contexts, in the control of EphB trans-
endocytosis into ephrinB+ cells indicates that the requirement for actin reorganisation is 
shared by the forward and reverse pathways. Supporting this hypothesis, recent results 
from our group directly link actin reorganisation to EphB trans-endocytosis into ephrinB+ 
cells (Gaitanos, unpublished data). SKN cells over-expressing LifeAct, a small peptide 
marker that allows the visualisation of F-actin (Riedl et al. 2008), were co-cultured with 
HeLa cells expressing EphB2C-GFP. Live cell-imaging revealed strong co-localisation 
of polymerised actin with EphB2-containing clusters at sites of cell contact, as well as 
during the initial steps of internalisation of clusters including their pinching off from the 
membrane. Strikingly, co-localisation with polymerised actin is lost rapidly after 
internalisation (within 3 min). As a control experiment, cells were treated with EHT1864, 
which resulted in drastically reduced dynamics of the actin cytoskeleton and subsequently 
no co-localisation of polymerised actin with EphB2-containing clusters at sites of cell 
contact. These results indicate that rearrangement of the actin cytoskeleton is induced by 
Rac activity and occurs during the early steps of internalisation in EphB trans-endocytosis 
into ephrinB+ cells, but is dispensable for further endocytic trafficking.  
Interestingly, the time scale for Tiam1 and Rac activation downstream of EphA signalling 
observed by Boissier and co-workers fits very nicely with timing observed in the LifeAct 
experiments, as they reported a peak in activation 3-5 min after stimulation (Boissier et al. 
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2013). Even though these results were obtained in a different experimental setup (forward 
direction and stimulation with soluble ectodomains), it still supports the idea that Tiam-
induced Rac activity drives the actin polymerisation observed during the initial steps of 
Eph-ephrin internalisation. 
It is difficult to further clarify the precise nature of the interaction of the actin cytoskeleton 
with the trans-endocytosis of Eph-ephrin complexes, because of the limitations in 
conventional light microscopy regarding spatial resolution. Electron microscopy or similar 
approaches allowing for a higher resolution are also inadequate for studying such short-
lived and transient processes. Therefore, to gain a better understanding of which steps actin 
is required for during the trans-endocytic process, it would be very insightful to apply live 
cell imaging with super-resolution techniques. A recent example of the benefits of such an 
approach is the work by Li and colleagues that provided valuable insights into the 
molecular interaction of actin with endocytic processes at a resolution not previously 
attainable (Li et al. 2015).  
In summary, the recent discoveries in our group support the central role of actin in the 
trans-endocytosis process proposed by both previous work and the findings in this study. 
Recent technological advances might open novel avenues to decipher the exact mechanism 




In this study I presented two separate ways of analysing the data obtained from the image-
based siRNA screen for the function of Rho family GEFs and GAPs in EphB trans-
endocytosis into ephrinB+ cells. Initially, we scored the effect of each siRNA oligo 
compared to the average of all negative controls from the whole screen. We then selected 
candidates on the basis of a single oligo showing a strong response in average over the two 
separate repetitions conducted (Fig. 16). However, the follow-up analysis of the strongest 
candidate determined this way, ITSN1 (Fig. 17), as well as a combination of oligos for 
different candidate genes to account for potential redundancy (Fig. 18), could not confirm 
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the results. In a second approach, we normalised the effect of each oligo not against the 
combined negative controls from the whole screen, but against the negative controls tested 
in the same plate in order to account for potential inter-plate variations in the baseline 
amount of endocytosis observed. Furthermore, we then examined the average from all four 
separate oligos for each gene to safeguard against potential false positive results derived 
from outliers or off-target effects of specific single oligos (Fig. 19). With this approach we 
identified Tiam2 as the candidate with the strongest effect on EphB trans-endocytosis into 
ephrinB+ cells and subsequent experiments replicated these results. Moreover, the 
importance of Tiam2 was also confirmed by additional experiments in HeLa cells (Fig. 
20). The downside of the analysis taking the average over all tested siRNA oligos for a 
given protein is that it can mask potential effects and lead to false negative results, if some 
oligos do not result in a sufficient knockdown of the protein of interest. However, as our 
initial approach relying on single oligos proved unsuccessful in obtaining verifiable 
candidates, we were willing to accept this limitation. 
We therefore found, at least for the presented study, basing the analysis of screen data on 
the consistency of responses to be superior to an analysis based on the size of an effect in 
single observations.  
3.4.2 Regulation of Eph‐ephrin trans‐endocytosis by Tiam1/2 
In this study we found that the Rac activity required for trans-endocytosis of Eph-ephrin 
complexes is induced by GEFs of the Tiam family. Already identified as a hit in our image-
based siRNA screen, subsequent experiments confirmed the requirement of Tiam2 for 
efficient EphB trans-endocytosis into ephrinB+ SKN and HeLa cells (Fig. 20). 
Interestingly, knockdown of Tiam1 did not result in a significant change in the amount of 
EphB trans-endocytosis into SKN cells, but it showed a comparable effect to Tiam2 
knockdown in HeLa cells (Fig. 20B and C). A combined knockdown of the two proteins 
also reduced trans-endocytosis in HeLa cells, but the effect was no larger than that seen in 
the single knockdowns. The close similarity between Tiam1 and Tiam2 suggests the 
possibility of physiological redundancy between the two (Matsuo et al. 2003). However, if 
physiological redundancy between Tiam1 and Tiam2 was assumed, one would expect a 
larger effect in the double knockdown. There are three possible explanations for the 
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absence of this expected increase in our observations: firstly, the reduced concentration of 
each specific siRNA oligo used in the combined knockdown could lead to an inefficient 
ablation of protein expression, and the remaining level of Tiam proteins decreases the 
observed effect; or, secondly, Tiam1 and Tiam2 are not physiologically redundant, but are 
co-operating in regulating trans-endocytosis of Eph-ephrin complexes in some cellular 
contexts, but not in others. Finally it is also possible that the expression levels of Tiam1 
differ between SKN and HeLa cells and assuming a high expression of Tiam in SKN cells 
the knockdown with siRNA could not be sufficient Additional experiments in other cell 
lines, and, especially, in neuronal cells could help clarify the individual contribution of the 
two Tiam proteins to the endocytosis of Eph-ephrin complexes. 
Previous work has established a role for Tiam1 in the regulation of endocytosis into Eph+ 
cells induced by stimulation with soluble ephrin ectodomains (Yoo et al. 2010, Boissier et 
al. 2013, Um et al. 2014). In agreement with these results, we also show a requirement for 
Tiam family proteins in ephrinB trans-endocytosis into EphB-expressing HeLa cells (Fig. 
20C). 
An unanswered question is how Eph-ephrin signalling is linked to the Tiam proteins 
molecularly. Previous work by Tanaka and colleagues has shown that both Tiam1 and 
Tiam2 bind to ephrinB1 via their N-terminal PH-CC-Ex domain (Tanaka et al. 2004). The 
binding and co-localisation with ephrinB1 of Tiam1 is increased after stimulation with 
soluble EphB2-Fc fusion proteins and leads to a rise in Rac activity. Evidence for the 
interaction of Tiam2 with ephrinBs in the context of EphB trans-endocytosis into ephrinB+ 
cells was provided by recent work from our group, which has demonstrated co-localisation 
of EphB-ephrinB clusters with Tiam2 (T. Gaitanos, unpublished data). However, which 
protein domains are involved in the potential interaction remains unknown. 
Overexpression of the Tiam PH-CC-Ex domain alone has shown a dominant negative 
effect in several studies (Tanaka et al. 2004, Tolias et al. 2007, Terawaki et al. 2010). Thus, 
overexpressing the Tiam PH-CC-Ex domain in trans-endocytosis experiments could 
elucidate whether binding via this domain is required for regulation of EphB-ephrinB trans-
endocytosis by Tiam family proteins. Furthermore, it will also be valuable to map the exact 
interaction site within ephrinB molecules, since it might be possible to generate specific 
point mutations that interrupt Tiam-ephrinB binding. This could potentially result in a 
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version of ephrinB that is endocytosis-deficient, while unperturbed in its other signalling 
capabilities, which would be a very valuable tool in dissecting the individual contributions 
of endocytosis and other signalling mechanisms employed downstream of ephrinBs. 
While several studies provide evidence for enhancement of Tiam1 activity after tyrosine 
phosphorylation (Servitja et al. 2003, Miyamoto et al. 2006, Tolias et al. 2007), Tanaka 
and colleagues found only weak phosphorylation of Tiam1 downstream of ephrinB1, even 
though they report a concomitant increase in Rac activity (Tanaka et al. 2004). In Eph-
ephrin forward signalling, Tiam1 is directly phosphorylated by Eph receptors (Tanaka et 
al. 2004, Tolias et al. 2007, Boissier et al. 2013). Since ephrin ligands lack kinase activity 
of their own, phosphorylation of Tiam proteins in the reverse direction would require an 
intermediary kinase. Tiam1 can be phosphorylated by SFKs (Servitja et al. 2003) and SFKs 
are activated downstream of ephrinBs (Palmer et al. 2002, Georgakopoulos et al. 2006). 
Thus, SFKs are possible candidates to mediate phosphorylation of Tiam1 and Tiam2 
downstream of ephrinBs, if phosphorylation is required for their function in regulating 
EphB-ephrinB endocytosis. Visualising and possibly interfering with the phosphorylation 
status of Tiam proteins, for example, by immunofluorescence with phospho-specific 
antibodies, or the transfection of phospho-mimetic or phosphorylation-deficient point 
mutants of Tiam proteins, would help elucidate the mechanisms of Tiam proteins in Eph-
ephrin trans-endocytosis. A complimentary approach could clarify whether SFKs are 
involved by employing siRNA-mediated knockdown or treatment with pharmacological 
inhibitors.  
Results from my experiments could not detect a requirement for Tiam1, Tiam2, or Rac 
activity for reverse endocytosis of soluble EphB ectodomains into ephrinB+ cells (Fig. 21). 
As the experiments by Tanaka and colleagues were also performed with stimulation by 
soluble EphB2 ectodomains and led to an increase in Rac activity induced by Tiam1 
(Tanaka et al. 2004), these results could be viewed as contradictory to my findings. The 
two most plausible explanations for these contrasting results would be that either Tiam1-
mediated Rac activity downstream of ephrinBs might serve a purpose other than regulating 
endocytosis, or it represents a cell type-specific phenomenon. 
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In summary, our work builds on the existing literature linking Tiam family proteins to Eph-
ephrin signalling and firmly establishes their role as regulators of Eph-ephrin trans-
endocytosis. Further work will be necessary to decipher the exact molecular mechanisms 
governing the interaction between Tiam proteins and Eph-ephrin complexes in this context.  
3.4.3 The siRNA screen of Rho family GEFs and GAPs has provided further interesting 
candidates for the regulation of Eph‐ephrin trans‐endocytosis 
Our image-based siRNA screen revealed several candidate genes that could regulate EphB 
trans-endocytosis into ephrinB+ cells. In line with our findings that EphB trans-endocytosis 
requires Rac activity, three out of the four strongest hits that decreased endocytosis upon 
siRNA knockdown were GEFs that show activity towards Rac (Tiam2, Vav1, Als2). Our 
follow-up experiments confirmed Tiam2 as a regulator of EphB trans-endocytosis into 
ephrinB+ cells, thus demonstrating the reliability of the results obtained from the screen. 
As depletion of Tiam proteins does not result in a complete inhibition of Eph-ephrin trans-
endocytosis, it is possible that other GEFs take over its role in increasing Rac activity and 
promoting actin polymerisation downstream of Eph-ephrin signalling to some extent.  
In our screen, among the GEFs whose depletion led to a decrease in trans-endocytosis, 
Vav1 showed the second strongest result when comparing the average z-scores of all 4 
tested siRNA oligos. Vav1 is one of three closely related GEFs making up the Vav family, 
the other two being Vav2 and Vav3 (Bustelo 2014). Vav family GEFs exhibit activity 
towards GTPases from the RhoA, Rac1 and Cdc42-like subfamilies, but their catalytic 
activity is several folds higher towards Rac1 as compared to other GTPases, at least for 
Vav2 (Jaiswal et al. 2013a). This is in agreement with the majority of the literature on Vav-
family proteins describing the relevance of their signalling through Rac (Bustelo 2014). 
The Vav-family GEFs differ in their expression patterns, as Vav2 and Vav3 are expressed 
ubiquitously, while Vav1 is mainly found in the hematopoietic system in the healthy body 
and is upregulated during many types of cancer (Bustelo 2000, Katzav 2015). Interestingly, 
Vav family GEFs have previously been implicated in Eph-ephrin signalling and 
endocytosis (Cowan et al. 2005). Vav2 interacts with, and is phosphorylated downstream 
of, EphA receptors and experiments with neuronal cultures from Vav2/Vav3 double 
knockout mice demonstrated the requirement of Vav family members for Eph-ephrin 
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signalling-induced growth cone collapse and the internalisation of Eph-ephrin complexes. 
However, the requirement for endocytosis was only tested by stimulation with soluble 
ephrinA ectodomains and not in a cell contact-mediated context. Unfortunately, the study 
also did not compare results from the double knockout to single knockout of Vav2 and/or 
Vav3, so it is not possible to infer whether the two proteins are redundant. In general, 
evidence for both redundant and non-redundant functions of Vav-family GEFs exists 
(Fujikawa et al. 2003, Pearce et al. 2004, Bustelo 2014). Knockdown of Vav2 and Vav3 
did not result in significant changes to EphB trans-endocytosis into ephrinB+ cells in our 
screen. A possible explanation for these findings is, of course, the possibility that SKN 
cells do not express Vav2 or Vav3. Further evidence for mechanistic redundancy between 
Vav proteins and Tiam, as could be the case in the trans-endocytosis of Eph-ephrin 
complexes, derives from the work of Servitja and colleagues (Servitja et al. 2003). They 
show that both Vav2 and Tiam1 are phosphorylated downstream of c-src and in turn 
increase Rac activity. While in their study, phosphorylation of either GEF was dependent 
on the type of stimulation by different pathways, it is conceivable that both could also be 
activated by a common pathway, and assume the function of each other, especially, in the 
absence of one of the proteins. Furthermore, the fact that both proteins get phosphorylated 
by src fits very well in the context of Eph-ephrin trans-endocytosis, since SFKs are key 
signalling mediators in both Eph-ephrin forward and reverse signalling (Ellis et al. 1996, 
Holland et al. 1996, Zisch et al. 1998, Davy et al. 1999, Palmer et al. 2002). Therefore, 
future experiments, firstly confirming the relevance of Vav family GEFs, and secondly, 
exploring the possible redundancy between Vav and Tiam family GEFs, for example, by 
simultaneous siRNA knockdown, could provide valuable information on the molecular 
mechanisms governing Eph-ephrin trans-endocytosis. 
A third candidate GEF that showed a decrease in trans-endocytosis upon siRNA 
knockdown is Alsin (ALS2). Its name derives from its implication in motor neuron diseases 
such as amyotrophic lateral sclerosis (ALS) (Hadano et al. 2001, Yang et al. 2001). ALS2 
contains GEF domains for and binding affinity towards both Rab5 and Rac1 (Topp et al. 
2004). In how far ALS2 actually displays GEF activity towards Rac, however, is still a 
matter of debate, as  studies showing activity towards Rac1 (Otomo et al. 2008), and those 
showing no increase in Rac activity resulting from ALS2 overexpression have both been 
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published (Topp et al. 2004, Tudor et al. 2005). Their possible regulatory function in EphB 
trans-endocytosis into ephrinB+ cells is supported by their role in Rac-dependent 
macropinocytosis and endocytic trafficking, as well as in axonal growth dynamics (Tudor 
et al. 2005, Devon et al. 2006, Hadano et al. 2007, Kunita et al. 2007, Otomo et al. 2008). 
The discrepancy between the involvement of ALS2 in Rac-dependent macropinocytosis 
and its lack of catalytic activity towards Rac1 reported in some studies can be resolved by 
the role of ALS2 suggested in endocytic trafficking. In particular, ALS localises to active 
Rac1 at macropinocytic sites and mediates the fusion of macropinosomes with early 
endosomes via its Rab5GEF activity (Devon et al. 2006, Kunita et al. 2007, Otomo et al. 
2008, Otomo et al. 2011).  Nonetheless, the fact that another study showed increased Rac 
and PAK activity stimulated by ALS2 allows for the possibility that ALS2 directly 
regulates macropinocytosis, at least in some physiological contexts (Tudor et al. 2005). 
This idea has been supported by the finding that the function of ALS2 is probably cell-type 
specific, since macropinocytosis was decreased in ALS2-deficient neurons, but not 
fibroblasts (Otomo et al. 2008).Although the exact contribution of ALS2 to 
macropinocytosis has not yet been completely unravelled, it represents an interesting 
candidate for the regulation of Eph-ephrin trans-endocytosis. ALS2 could fulfil this role 
by either acting as an additional, potentially redundant, RacGEF required for the initiation 
of Rac activity and trans-endocytosis, or by affecting the subsequent trafficking of 
endosomes. In order to further decipher the precise role of ALS2 in Eph-ephrin trans-
endocytosis, it would be necessary to confirm the original results of our screen and 
subsequently dissect out potential redundancies, as already suggested for the Vav family 
GEFs, by performing simultaneous siRNA knockdowns. Additionally, given its role as a 
Rab5GEF, and in light of previous work implicating Rab5 in the endocytosis of EphA 
receptors (Deininger et al. 2008), further analysis of the contribution of Rab5 to the trans-
endocytosis process could prove insightful. 
Of the four strongest candidates among the GEFs resulting in a decrease of endocytosis, I 
have so far omitted Active breakpoint cluster region-related protein (Abr) from the 
discussion, although it showed the third strongest effect when z-scores were averaged over 
all 4 tested oligos. Abr is a complex protein containing both a GAP and a GEF domain 
(Tan et al. 1993) and the literature on the specificity and relevance of the GEF and GAP 
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domains of Abr is very contradictory. Initial reports showed a broad specificity for the GEF 
domain with activity towards Cdc42, RhoA, and Rac subfamily members with highest 
catalytic activity on Cdc42, whereas GAP activity was limited to Cdc42 and the Rac 
subfamily GTPases (Chuang et al. 1995). In contradiction to these observations a later 
study, systematically analysing Rho family GEFs, found no catalytic GEF activity of Abr 
in vitro (Jaiswal et al. 2013a). In the more physiological context of single cell wound 
healing, however, Abr increases RhoA activity, suggesting that Abr is an active GEF 
(Vaughan et al. 2011). In contrast, GAP activity on Rac and/or Cdc42 has been well 
documented by several independent studies (Cho et al. 2007, Oh et al. 2010, Vaughan et 
al. 2011). Additionally, Abr shares high sequence similarity with Bcr (Chuang et al. 1995), 
another GEF and GAP domain-containing protein recently described to be important in 
Eph-ephrin signalling in the context of synapse development (Um et al. 2014). Abr and 
Bcr have both overlapping and distinct signalling functions (Cho et al. 2007, Cunnick et 
al. 2009), and many studies of their physiological function use mice deficient for both 
proteins (Cho et al. 2007, Cunnick et al. 2009, Um et al. 2014). Expression of a GAP-
deficient Bcr variant and experiments with Bcr and Abr double deficient cells resulted in 
an increase in endocytosis of Eph stimulated by soluble ephrin ectodomains in the work by 
Um and colleagues (Um et al. 2014). These results are in disagreement to our findings of 
a decrease in EphB trans-endocytosis into ephrinB+ cells upon knockdown of Abr. 
However, these differences could derive from the quite varied GEF activities reported for 
Abr and might be cell-type specific. While we did not follow-up on the possible relevance 
of Abr in this study, future experiments analysing the role of Abr and possibly also Bcr in 
Eph-ephrin trans-endocytosis could prove very informative, but will have to address 
carefully the respective contribution of its GEF and GAP functions. 
So far, I have mainly discussed candidates from the screen containing GEF domains and 
neglected the candidate proteins for regulation of EphB trans-endocytosis into ephrinB+ 
cells among the GAPs. Apart from Abr, which is discussed above, the depletion of two 
GAPs resulted in a significant reduction in the amount of internalised Eph-ephrin 
complexes: Human Minor Histocompatibility Antigen1 (HMHA1) and 
Phosphatidylinositol 3-kinase regulatory subunit beta (PIK3R2). HMHA1 has only 
recently been shown to exhibit broad GAP activity towards RhoA, Cdc42 and Rac1 in 
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vitro, and to decrease RhoA and, especially, Rac1 activity resulting in changes in actin 
dynamics in mammalian cell lines (de Kreuk et al. 2013). There are no reports about the 
GAP activity of PIK3R2 to date. PIK3R1, a very close homologue, however, displays GAP 
activity towards Rab5, as well as towards Rac and Cdc42, but to the Rho GTPases only at 
a lesser extent and only in vitro (Chamberlain et al. 2004, Runyan et al. 2012). These 
studies demonstrated that PIK3R1 modulates endocytic trafficking via the interaction with 
Rab5. Interestingly, a large scale proteomic screen conducted very recently revealed an 
interaction between ephrinB2 and PIK3R2 (Huttlin et al. 2015). In light of this finding, 
PIK3R2 constitutes a valid candidate for further follow-up analysis. 
Our screen also identified a candidate GEF (Net1) and a candidate GAP (OPHN1), whose 
depletion resulted in an increase in EphB trans-endocytosis into ephrinB+ cells. As we 
were lacking a reliable positive control leading to an increase in endocytosis, we were not 
certain which magnitudes of effect to expect, which complicated evaluation of the screen 
data. Furthermore, the fact that Net1 is a GEF specific for RhoA subfamily GTPases 
(Alberts & Treisman 1998), while OPHN1, although it shows a broad tuning of GAP 
activity in vitro (Billuart et al. 1998), mediates its physiological function via inhibition of 
RhoA signalling (Govek et al. 2004, Khelfaoui et al. 2009), appears contradictory, as this 
suggests they should have opposing functions. In one of these studies it was also 
specifically proposed that the GAP activity of OPHN1 counteracts the inhibitory effect on 
endocytosis enacted by RhoA signalling (Khelfaoui et al. 2009), which would imply that 
siRNA knockdown of OPHN1 leads to a decrease of endocytosis instead of the observed 
increase. In light of these conflicting results, and the difficulties in evaluating candidates 
resulting in an increase of endocytosis, we focussed our follow-up analysis first on proteins 
whose depletion resulted in a decrease of endocytosis. Nonetheless, future work on the 
mentioned candidates could explain the contradicting result of a RhoA-specific GEF and 
GAP showing the same effect, and improve our understanding of the regulation of Eph-
ephrin trans-endocytosis. 
We focussed our follow-up analysis to a single candidate, Tiam2, which we successfully 
confirmed as a key regulator of Eph-ephrin trans-endocytosis. With this proof-of-principle 
validating our screen approach, it stands to reason that analysis of the other candidate 
proteins found in the screen will advance our understanding of the regulation of Eph-ephrin 
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trans-endocytosis and potentially also reveal redundancy or cross-talk between different 
Rho GTPase-regulating proteins. 
3.5 Physiological role of Eph‐ephrin endocytosis  
3.5.1 Trafficking of Eph‐ephrin complexes and the “signalling endosome” hypothesis 
The discovery that Eph receptors remain phosphorylated after internalisation allows for the 
possibility of sustained Eph-ephrin signalling from the endosomal compartment (Marston 
et al. 2003). The idea of “signalling endosomes” derives from original work with EGFRs, 
which has proven that the signalling machinery stays attached to EGFRs on endosomes 
and that continued signalling from endosomal compartments is crucial for effective EGF 
signalling (Di Guglielmo et al. 1994, Bergeron et al. 1995, Burke et al. 2001). Several other 
cell surface receptors have since been shown to exhibit continued signalling after 
internalisation, including neurotrophic factor receptors TrkA, TrkB and p75NTR, as well 
as the NoGo receptor (Grimes et al. 1996, Heerssen et al. 2004, Saxena et al. 2005, Joset 
et al. 2010). Not only does signalling from endosomes extend signalling responses from 
cell surface receptors, but it can also serve to localise signalling by trafficking of 
endosomes to specific cellular locations, such as in the vicinity of the cell membrane for 
Rac1 during cell migration (Palamidessi et al. 2008), or to the nucleus for changes in 
transcription by retrograde transport of neurotrophic factor receptors (Riccio et al. 1997). 
In several described cases, the formation of signalling endosomes has been linked to 
macropinocytosis-like endocytic events that are regulated by Rac (Valdez et al. 2007, Joset 
et al. 2010). Additionally, membrane scission for the formation of signalling endosomes 
can be controlled by the ATPase Pincher and not by dynamin as in many other endocytic 
processes (Shao et al. 2002, Joset et al. 2010). However, whether this is a general rule, and 
whether dynamin might not still be involved in the formation of some signalling 
endosomes, is still a matter of debate (Winckler & Yap 2011). As Eph-ephrin trans-
endocytosis seems to resemble at least some aspects of the endocytic process described in 
these works and also requires Rac activity, it would be interesting to investigate whether 
the pathways are the same. Experiments with a dominant negative version of Pincher, as 
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described by Shao and colleagues (Shao et al. 2002), or, alternatively, knockdown with 
siRNA in an Eph-ephrin trans-endocytosis assay could shed some light on this question. 
After the initial finding that Eph receptors remain phosphorylated after internalisation 
(Marston et al. 2003), work by Boissier and colleagues expanded on the notion that Eph-
ephrin signalling could continue after endocytosis (Boissier et al. 2013). In their 
experiments with EphA2-expressing cells stimulated with soluble ephrinA1 ectodomains 
they observed association of Tiam1 with activated EphA2 after internalisation and 
concluded that this was evidence for Eph-ephrin signalling through Tiam1 and Rac from 
the endosomal compartment. Closer examination of their data, however, suggests that since 
peak activity of Tiam1 and Rac after stimulation with ephrinA1 occurred during the earliest 
observed time points, these findings only confirm the importance of Tiam-induced Rac 
activity in the endocytosis of Eph-ephrin complexes and are not necessarily substantial 
evidence for signalling from endosomes. Nonetheless, while the evidence presented in the 
study by Boissier and colleagues does not provide conclusive evidence for Eph-ephrin 
signalling from the endosomal compartment, it would be sensible to expand on their work 
and test whether interference with endosomal trafficking affects the signalling. Another 
unanswered question is in how far there is also the potential for signalling from the 
endosomal compartment in the reverse direction. EphrinBs have been shown to be de-
phosphorylated shortly after their activation and could thus lose their signalling capacity 
by the time they arrive in endosomal compartments (Palmer et al. 2002). On the other hand, 
several features of ephrinB reverse signalling are independent of tyrosine phosphorylation, 
for example, the interaction with PDZ-binding proteins (Bruckner et al. 1999, Makinen et 
al. 2005). Hence, also the reverse direction of Eph-ephrin endocytosis merits investigation 
into whether signalling from endosomes takes place. A first step could be the extraction of 
endosomes followed by biochemical analysis of binding partners of Eph-ephrin clusters 
analogously to the work by Boissier and colleagues for the forward direction (Boissier et 
al. 2013). 
Continued signalling from endosomal compartments only presents one possibility for the 
fate of Eph-ephrin complexes after internalisation. The two further alternative trafficking 
pathways, which are not necessarily mutually exclusive of continued signalling, are 
degradation and recycling back to the plasma membrane. Work by Boissier and colleagues 
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also quantified the relative amount of Eph-ephrin complexes routed toward degradation in 
lysosomes (two thirds) and recycled to the plasma membrane (one third) (Boissier et al. 
2013). Several other studies also described the trafficking of Eph receptors into lysosomes, 
which was reported to be dependent on their ubiquitination by Cbl (Walker-Daniels et al. 
2002, Sharfe et al. 2003, Fasen et al. 2008, Sabet et al. 2015). Unfortunately, these studies 
were performed solely using stimulation with soluble ephrin ectodomains and only 
focussed on the forward direction. Since there are very distinct downstream signalling 
patterns between forward and reverse direction, as well as cell-contact or soluble protein-
induced signalling (Jorgensen et al. 2009), and since this study has further expanded on 
some of these differences in the context of endocytosis, it is not obvious, whether the same 
endocytic fate is shared between Eph-ephrin complexes in these distinct scenarios. Further 
work unravelling the endocytic fate of Eph-ephrin complexes is therefore needed. One 
possible approach in this context would be studying the role of Rab family GTPases 
downstream of Eph-ephrin signalling. 
3.5.2 Endocytosis and growth cone collapse 
One pivotal role of Eph-ephrin signalling is its function in axon guidance during neuronal 
development. In contexts ranging from retinotopic map formation to midline guidance in 
spinal projections of the motor system, Eph-ephrin signalling provides repulsive guidance 
cues crucial for the correct development of the nervous system (see also section 1.1.3). The 
repulsive signal mediated by the Eph-ephrin interaction originates from the induction of 
growth cone collapse, which allows the axon to re-sprout and continue growing in a 
different direction (Yu & Bargmann 2001, Egea & Klein 2007). Since the interaction 
between Ephs and ephrins initially leads to high affinity adhesion between the two cells in 
contact, Eph-ephrin complexes must be removed from the cell surface to allow cell 
detachment to occur. Trans-endocytosis of Eph-ephrin complexes enables cell detachment 
as a general mechanism and is particularly relevant in the context of growth cone collapse 
(Marston et al. 2003, Zimmer et al. 2003). The endocytosis of Eph-ephrin complexes 
required for efficient growth cone collapse has been shown to be governed by Rac, at least 
for signalling in the forward direction (Marston et al. 2003, Cowan et al. 2005). 
Additionally, the growth cone collapse response downstream of Eph-ephrin signalling in 
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both directions requires the activity of RhoA (Wahl et al. 2000, Sahin et al. 2005, Takeuchi 
et al. 2015). This differential requirement of both Rac and RhoA for growth cone collapse 
is interesting given that the two GTPases often fulfil contrasting physiological functions 
and their signalling pathways can inhibit each other (Guilluy et al. 2011). 
Here, we show that EphB trans-endocytosis into ephrinB+ cells also requires Rac activity 
and that this mechanism is also employed by neurons (Fig. 10). Apart from its role in 
regulating the trans-endocytosis of Eph-ephrin complexes, Rac1 activity downstream of 
Eph-ephrin signalling has also been shown to induce endocytosis of large patches of the 
plasma membrane, which is required for growth cone collapse in addition to the 
rearrangement of the actin cytoskeleton (Jurney et al. 2002). 
The question now arises of how the Rac-mediated regulation of endocytic processes by 
Eph-ephrin signalling is related to the requirement of RhoA activity in Eph-ephrin-induced 
growth cone collapse. The data presented in this thesis combined with findings from the 
extensive literature on Eph-ephrin signalling in growth cone collapse allow for the 
following model integrating the separate elements. Growth cone collapse induced by Eph-
ephrin signalling consists of two or three distinct steps differentially regulated by Rho 
GTPases. To allow the cell detachment necessary for growth cone collapse, Eph-ephrin 
complexes need to be internalised, a process that is controlled by Rac activity. 
Additionally, Rac activity downstream of Eph-ephrin signalling also leads to the 
endocytosis of plasma membrane patches, reducing the surface of the growth cone. The 
third step is disassembly of the filamentous actin structures making up the cytoskeleton, 
which is orchestrated by Eph-ephrin signalling-induced RhoA activity. Possibly, the 
activation of RhoA can occur from Eph-ephrin complexes residing in endosomal 
compartments, and these signalling endosomes could control locally restricted RhoA 
activity, in a similar fashion to what has been reported for Rac signalling from endosomes 
in cell migration (Palamidessi et al. 2008). This hypothesis for the spatio-temporal control 
of actin reorganisation requiring a shift from Rac signalling to a RhoA-based signalling 
response could be mediated by proteins already implicated in Eph-ephrin induced growth 
cone collapse. The GEF ephexin is phosphorylated by Eph receptors, which changes its 
specificity by increasing activity towards RhoA, while decreasing its activity towards Rac 
and Cdc42 (Shamah et al. 2001, Sahin et al. 2005). Thus, it represents a valid candidate to 
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mediate a shift from Rac-induced endocytosis to RhoA-induced actin disassembly in the 
course of growth cone collapse. A second GTPase regulating protein shown to be important 
for growth cone collapse and axon guidance downstream of EphA4 signalling is the 
RacGAP chimaerin (Beg et al. 2007, Wegmeyer et al. 2007). Since it localises to 
activated Eph receptors, it could potentially mediate a down-regulation of Rac activity after 
its initial requirement for the endocytosis of Eph-ephrin complexes. The down-regulation 
of Rac activity then in turn could lead to a disinhibition of RhoA signalling (Guilluy et al. 
2011). Another possibility for switching signalling properties has been described for 
ephrinB reverse signalling. Here recruitment of SFK to activated Eph-ephrin clusters first 
leads to phosphorylation-dependent signalling events, while subsequent dephosphorylation 
by PTP-BL switches the response to PDZ-dependent signalling (Palmer et al. 2002). 
Furthermore, a study of the role of Eph-ephrin signalling in dendritic spine development 
and synapse formation has shown an example where tight regulation of Rac activity by a 
complex consisting of Tiam1 and Bcr, a Rac-specific GEF and GAP respectively, is 
required to mediate Eph-ephrin function (Um et al. 2014). 
A very similar model has been proposed for the regulation of repulsive axon guidance by 
the NoGo receptor (Joset et al. 2010). Also in this case, endocytosis of activated receptors 
requires Rac activity and the induction of growth cone collapse depends on both 
endocytosis of the receptors and localised activation of RhoA signalling from NoGo 
receptors in the endosomal compartment. 
This proposed model for sequential activation of Rac and Rho subfamily GTPases by Eph-
ephrin complexes in mediating growth cone collapse in a multi-step process requiring 
localised signalling from endosomes is, of course, at this point still highly speculative, 
although it is solidly grounded in the findings of this thesis and the existing literature. 
Providing evidence for this model being physiologically relevant will be challenging, since 
the overlapping roles and functions of Rho family GTPases and their regulators are difficult 
to decipher. In order to gain further insights into the precise spatio-temporal regulation of 
and the cross-talk between Rho family GTPases downstream of Eph-ephrin signalling, 
experimental approaches suited to both visualise and perturb Rho GTPase activity at a very 
high spatio-temporal resolution are required. The challenges of achieving this level of 
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understanding of Rho GTPase signalling networks are summarised in an informative 
commentary (Pertz 2010). One way to overcome the challenge of affecting several 
physiological processes simultaneously due to interference with Rho GTPase activity is to 
target regulating proteins specific for the function of interest. By identifying a Rac-specific 
GEF, Tiam2, to be required for Eph-ephrin trans-endocytosis this study provides one 
candidate for such specific regulation. 
3.6 Conclusion and Outlook 
The presented thesis puts forward the first comprehensive analysis of the regulation of 
EphB trans-endocytosis into ephrinB+ cells by Rho family GTPases. We describe an 
endocytic pathway that is regulated by Rac subfamily GTPases and their activation by 
GEFs of the Tiam family, which requires reorganisation of the actin cytoskeleton. Tiam-
induced Rac activity is also required for ephrinB trans-endocytosis into EphB+ cells. The 
physiological relevance of this pathway is underlined by the observation that cortical 
neurons require the same molecular regulation for EphB trans-endocytosis. While the 
forward endocytosis of Eph-ephrin complexes induced by soluble ephrins ectodomains 
probably uses the same endocytic machinery as the trans-endocytosis observed upon cell-
cell contact, reverse endocytosis triggered by soluble EphB ectodomains uses a different 
mechanism that is affected by the activity of RhoA, but not Rac subfamily GTPases. 
The distinct molecular pathways employed between EphB trans-endocytosis after cell 
contact and reverse endocytosis after stimulation with soluble EphB ectodomains, indicates 
that future investigations into the trans-endocytosis of Eph-ephrin complexes should be 
conducted in settings that replicate the contact between Eph- and ephrin-expressing cells 
in order to remain as close as possible to the relevant physiological processes.  
The results of the siRNA screen could still be further exploited. Since the follow-up 
analysis of the strongest candidate, Tiam2, confirmed its significance in the regulation of 
the trans-endocytosis of Eph-ephrin complexes, it is plausible to assume that further 
investigations based on the results of the screen will yield additional insights into the 
molecular regulation of Eph-ephrin endocytosis.  
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One goal for the analysis of Eph-ephrin signalling is the uncoupling of the endocytosis of 
Eph-ephrin complexes from other downstream signalling events. One challenge that must 
be overcome is the fact that both the trans-endocytosis of Eph-ephrin complexes, as well 
as the cellular responses traditionally associated with many physiological functions of Eph-
ephrin signalling, such as growth cone collapse or cell rounding, require reorganisation of 
the actin cytoskeleton. Therefore the use of experimental techniques allowing for very tight 
spatio-temporal manipulation and analysis would be prudent. Approaching this challenge 
on the levels of the specific GEFs identified in this study might prove beneficial, as 
compared to approaches affecting, for example, the actin cytoskeleton as a whole or the 
Rho family GTPases themselves, since they are bound to have a more wide-spread 
physiological effect. 
Taking all of this into consideration, this study represents a valuable expansion of our 
knowledge of the Eph-ephrin signalling system by describing a molecular regulatory 
mechanism of Eph-ephrin endocytosis, which is relevant in physiological contexts. 
Additionally, it provides a solid foundation for further analysis of the endocytic processes 
in the Eph-ephrin system and their contribution to signalling responses. Further unravelling 
these mechanisms will greatly benefit our understanding of the Eph-ephrin system and its 







All chemicals and reagents were purchased from GE Healthcare GmbH (Solingen, 
Germany), Life Technologies (Carlsbad, United States), Merck KgaA, (Darmstadt, 
Germany), Sigma-Aldrich Chemie GmbH (München, Germany), Roche Diagnostics 
GmbH (Mannheim, Germany) and VWR International LLC (Radnor, United States), 
unless stated otherwise in the methods section. Water used for buffers, solutions and 
reactions mixes was filtered using a Milli-Q-Water System (Merck KgaA, Darmstadt, 
Germany) and autoclaved afterwards. Plasmid preparations were done using the Macherey-
Nagel NucleoBond® Xtra Maxi kit (Macherey-Nagel GmbH & Co. KG, Düren, Germany). 
4.1.2 Buffers 
PBS (phosphate‐buffered saline), pH 7.3 
137 mM NaCl 
2.7 mM KCl 
4.3 mM Na2HPO4·7H2O 
1.4 mM KH2PO4 
Lysis buffer for Western blotting 
50 mM Tris, pH 7.4 
150 mM NaCl 
2mM EDTA 
1% TritonX - 100 (vol/vol) 
Protease inhibitor cocktail (Roche) 
Phosphatase inhibitor cocktail (Roche) 
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6x Protein loading buffer (reducing) 
300 mM Tris - HCl, pH 6.8 






4.5 g/l D-Glucose 
1% L-Glutamine 
10% Fetal Bovine Serum (FBS) (GE Healthcare)  
1% Penicillin/Streptomycin (Life Technologies) 
OptiMEM (Gibco, Life Technologies) 
4.5 g/l D-Glucose 
1% L-Glutamine 
10% FBS (GE Healthcare) 
1% Penicillin/Streptomycin (Life Technologies) 
Dissection medium 
HBSS (Gibco, Life Technologies) 
1% Penicillin/Streptomycin (Life Technologies) 
10 mM HEPES 
10 mM MgSo4 
Neuronal maintenance medium 
Neurobasal medium (Gibco, Life Technologies) 
1x B27 supplement (Life Technologies) 
10 mM L-Glutamine (GE Healthcare) 




A full list of all oligonucleotide sequences used in the siRNA screen are available upon 
request. Oligos for the screen library were purchased from either Life Technologies or the 
Max-Planck-institute of Molecular Cell Biology and Genetics, Dresden. Specific oligos 
listed below were purchased from Life Technologies.  
siRNA oligonucleotides 
ephrinB1   5’ – GAAGGGCUUGGUGAUCUAUCCGAAA – 3’ 
ephrinB2   5’ – ACUAUACCCACAGAUAGGAGACAAA – 3’ 
RhoA    5’ – GCCUGUGGAAAGACAUGCUUGCUCA – 3’ 
RhoB    5’ – ACACCGACGUCAUUCUCAUGUGCUU – 3’ 
Rac1    5’ – CCGGUGAAUCUGGGCUUAUGGGAUA – 3’ 
Rac3    5’ – CCUCCGCGACGACAAGGACACCAUU– 3’ 
RhoG 05   5’ – CAGGAGGAGUAUGACCGCCUCCGUA – 3’ 
RhoG 67   5’ – UCGUCAUCUGUUUCUCCAUUGCCAG – 3’ 
Cdc42    5’ – CACAACAAACAAAUUUCCAUCGGAA – 3’ 
RhoQ 06   5’ – GGUCCCUAAGUGAAAGGCUCUGCUU – 3’ 
RhoQ 18    5’ – CCAAUGACCGAUGUCUUCCUUAUAU – 3’ 
RhoQ 19    5’ – AAGAGGAGUGGGUACCGGAACUUAA – 3’ 
RhoU 44    5’ – UCAGUGAUGCCGGAGAUGAAAUGGG – 3’ 
RhoU 45   5’ – CCUCAUUGAGUUGGACAAAUGCAAA – 3’ 
ITSN1    5’ – CCUUUGAAUCCAGAAGCCAUGAUGA – 3’ 
ITSN2    5’ – CAACACACAGCAGUUAGCCCUUGAA – 3’ 
FARP2   5’ – UCGGAAAUAGGAGAUUACGAUGAAA – 3’ 
ELMO3   5’ – AGGUGGUGUGCUACGUGAACAUGAA – 3 ‘ 
Dock11   5’ – CACCCGAAUCUUACAUUCAUGGAAU – 3’ 
Tiam1    5’ – CAGCACAACCCUGACUGCGACAUUU – 3’ 
Tiam2     5’ – GGGAGAACUUCAGGCGUCACAUAAA – 3’ 
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4.1.5 Plasmids 























Antigen  Species  Supplier  Dilution  Application 




FLAG  rabbit  Sigma  1:1000  IF,WB 








All secondary antibodies were purchased from Jackson Immunoresearch (West Grove, 
United States). For Western blots, Horseradish Peroxidase (HRP)-coupled secondary 
antibodies and for immunostainings, fluorescently labelled secondary antibodies were 
used. Antibodies were diluted 1:5000 for Western blotting and 1:1000 for staining of cells. 
4.2 Methods 
4.2.1 Cell culture 
All experiments used either HeLa cells, HeLa cells stably expressing EphB2C-GFP 
(previously generated in our group) or SKN cells expressing histone2B tagged with red 
fluorescent protein (SKN H2B-RFP) (generated by T. Gaitanos). In general, cells were 
cultured in Falcon dishes according to ATCC’s (American Type Culture Collection) 
recommendations concerning splitting ratios and media requirements. HeLa cells were 
cultured in DMEM, which was supplemented with the selective antibiotic Geneticin in the 
case of the cells stably expressing EphB2C-GFP. SKN cells were cultivated in OptiMEM. 
4.2.2 Plasmid transfections 
Cell lines were transfected using Lipofectamine 2000 reagent (Life Technologies) 
according to the instructions provided by the manufacturer. Briefly, cells were transfected 
at a confluency of 50-70%. On the day of transfection, Lipofectamine 2000 was added to 
OptiMEM not containing serum or antibiotics. After 5 min incubation at room temperature 
(RT), DNA was added and the transfection mix was incubated at RT for 15 to 30 min and 
then added directly into the cell medium. Cells were left in the incubator for 24 h to 48 h 
for protein expression depending on the assay. A transfection reagent:DNA ratio of 3:1 
(v/mass) was used for all experiments. 0.5 to 1 μg of total DNA was used to transfect one 
well of a 6-well plate, 1 µg to 2µg were used to transfect one 6 cm dish. 
4.2.3 siRNA transfections 
Cells were transfected with siRNA oligos using Lipofectamine RNAiMax (Life 
Technologies) transfection reagent. Unless otherwise stated cells were reverse transfected 
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at the moment of seeding. Lipofectamine RNAiMax was added to an appropriate volume 
of OptiMEM not containing serum or antibiotics so that the final dilution was 1:1000 for 5 
min at RT. siRNA oligos were pre-incubated with transfection reagent for 30 min at RT. If 
not otherwise stated siRNA was used at a final working concentration of 20 nM. Cells were 
incubated for either 48 h (HeLa cells) or 72 h (SKN cells) at 37 °C for effective knockdown 
to occur. 
4.2.4 Inhibitor treatment 
Rac-specific inhibitor EHT1864 (Tocris Bioscience, Bristol, United Kingdom) was diluted 
in H2O for storage at 4 °C. At the day of experiment a pre-dilution in serum-free OptiMEM 
was prepared and added straight to the respective culture medium to obtain the final 
concentrations specified in each experiment. Cells were incubated with EHT1864 for 4 h 
at 37 °C before subsequent experiments were performed. As a control cell were treated 
with the equivalent volume of H2O in parallel. 
4.2.5 Western blots 
Cell lysates were prepared using a standard protocol in Lysis Buffer (see above) 
complemented with protease and phosphatase inhibitor cocktails (Roche). Protein 
concentration was measured using a DC protein assay (BioRad Hercules, United States). 
Samples were prepared in SDS sample buffer and equal amount of samples (20-50 µg) 
were loaded onto SDS-PAGE gels for separation with 4% acrylamide stacking gel and 
7.5% - 12% acrylamide running gel depending on size of protein of interest. After 
separation proteins were blotted onto a protran nitrocellulose membrane (GE Healthcare) 
using a semi-dry blot chamber (Trans-blot SD, BioRad) and 60 mA per gel for 1 - 2 h. 
Successful transfer of protein was confirmed by PonceauS staining. Membranes were 
blocked in 5% non-fat milk in PBS with 0.1% Tween (PBT) for 30 min at room 
temperature. If not stated otherwise, membranes were incubated overnight with primary 
antibody solution (diluted in 5% non-fat milk in PBT, complemented with 0.02% NaNH3 
at 4°C. Membranes were washed in large quantities of PBT for at least 30 min with at least 
one change of PBT before applying secondary antibodies (HRP-coupled, specific for the 
respective species of the primary antibody, Jackson Immunoresearch) for 1 h at room 
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temperature. After another washing step (30 min, PBT) protein bands were detected with 
either Amersham ECL Western Blot reagent (GE Healthcare) or SuperSignal Femto 
Maximum Sensitivity Substrate (Life Technologies) in the Fusion FX7 chemiluminescence 
imaging chamber (PeqLab GmbH, Erlangen, Germany). Either tubulin or GAPDH were 
used as loading controls and membranes were incubated with primary antibody solution 
for 1-2 h, followed by PBT washes, secondary antibody and detection as described above. 
Representative blots are shown. If blots were quantified, the gel analysis feature of ImageJ 
(http://rsb.info.nih.gov/ij/index.html) was used for densiometric measurements. 
4.2.6 Image acquisition 
Imaging was performed on a Zeiss Axioobserver Z1 inverted microscope (Zeiss, 
Göttingen, Germany) equipped with a CSU-X1 spinning disc confocal unit (Yokogawa 
Electric, Tokyo, Japna) controlled by VisiView software (Visitron Systems, Puchheim, 
Germany) and a temperature-controlled CO2 incubation chamber when required (Pecon 
GmbH, Erbach, Germany). Illumination was provided by Lasers of 405 nm, 488 nm, 561 
nm or 640 nm wavelength for spinning disc confocal imaging (Visitron Systems,) or by an 
X-cite lamp (Excelitas Technologies GmbH & Co. KG, Wiesbaden, Germany) for 
epifluorescence imaging. All fixed samples were imaged using the confocal option. All 
live cell-imaging was performed with the incubation chamber set to maintain 37 °C 
ambient temperature and CO2 concentration of 5 %. For the live-cell imaging of SKN cells 
a 20x air objective was used. Imaging of experiments in 96-well plates, as well as the 
neuron trans-endocytosis experiments were imaged with a 40x air objective. Experiments 
with HeLa cells on coverslips were imaged with a 63x oil immersion objective. 
4.2.7 Endocytosis assay with soluble Eph or ephrin ectodomains 
SKN-H2B-RFP cells or HeLa cells were cultured in 96-well plates (Greiner Bio One 
GmbH, Frickenhausen, Germany) or on cover slips in 6-well plates in OptiMEM or DMEM 
complemented as above at 37 °C and 5% CO2. HeLa cells were transfected with either 
EphB2-mCherry (for forward direction experiments) or ephrinB1-mcherry (for reverse 
direction experiments) as described above. Cells were starved in serum-free OptiMEM 
overnight before stimulation. Fusion proteins of the ectodomain of either EphB2 (for 
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reverse direction experiments) or ephrinB2 (for forward direction experiments) fused to 
human Fc (R&D Systems, Minneapolis, United States) were pre-clustered with dylight488 
dye-coupled anti-Fc antibodies (Jackson Immunoresearch) in volume ratio 5:1 for 45 min 
at room temperature. Human IgG-Fc (Jackson Immunoresearch) was used as a negative 
control and prepared in the same fashion. Cells were incubated with the clustered proteins 
at a final concentration of 2 µg/ml for 30 min at 37 °C. Cells were then fixed immediately 
on ice with 4% PFA (complemented with 4% sucrose). 3 washing steps with PBS were 
followed by blocking with 3% Bovine Serum Albumin (BSA) (Sigma Aldrich) for 30 min 
at room temperature. Staining for surface clusters was performed with a 1:1000 dilution of 
dyLight649 anti-human Fc antibodies (Jackson Immunoresearch) in 3% BSA at room 
temperature. HeLa cells were furthermore permeabilised with 0.1% Triton in PBS for 5 
min and stained with CellMaskTM Blue (1:2000) and DAPI (1:5000) dissolved in PBS for 
10 min. Afterwards cells were washed three times with PBS and, in case of experiments 
on cover slips, mounted with ProLong Gold antifade reagent (Life Technologies) and 
stored in the dark at 4 °C until imaging. Imaging of SKN experiments in 96-well plates 
was performed with a 40x air objective. For each well 10-20 positions were selected and 
stacks of 8 planes with 1 µm step size were taken. Experiments with HeLa cells on 
coverslips were imaged with a 63x oil immersion objective. For each cover slip 10-20 
positions were selected and stacks of 15 planes with 0.5 µm as step size were taken. Image 
analysis is described below. 
4.2.8 Assay to determine cell surface expression of ephrinBs 
The assay was adapted from that above. SKN cells in 96-well plates were stimulated with 
EphB2-Fc, which had been pre-clustered with a dylight488-coupled antibody for 45 min 
at room temperature. In contrast to the endocytosis assay, stimulation took place at room 
temperature for only 2 min before cells were transferred to ice to prevent internalisation. 
Subsequent staining and image acquisition was performed as above. 
4.2.9 Trans‐endocytosis assay 
SKN-H2B-RFP cells or HeLa cells transfected with either EphB2-mCherry (for forward 
direction experiments) or ephrinB1-mCherry (for reverse direction experiments) as 
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described above, were used as acceptor cells. SKN cells were cultured in 96-well plates 
(Greiner Bio One) in OptiMEM, while HeLa cells were cultured on cover slips in 6-well 
plates in DMEM. HeLa cells stably expressing EphB2C-GFP or HeLa cells transiently 
transfected with either EphB2C-GFP (for reverse direction experiments) or ephrinB1C-
GFP (for forward direction experiments) were used as donor cells. Acceptor cells were 
starved in serum-free OptiMEM overnight before stimulation. Donor cells were gently 
dissociated from the surface of the cell culture dish by treatment with 2 mM EDTA in PBS. 
Donor cells were seeded on top of acceptor cells and incubation for 80 min at 37 °C allowed 
for trans-endocytosis to occur. Cells were fixed with ice cold 4% PFA, 4% sucrose for 15 
min, before 3 washes with PBS and blocking with 3% BSA in PBS for 30 min at RT. 
Staining for surface clusters was performed with a 1:1000 dilution of anti-FLAG antibodies 
in 3% BSA at room temperature for 1 h. After 3 washes with PBS FLAG signal was 
detected with dylight649-coupled secondary anti-rabbit antibodies for 1 h at RT. HeLa 
cells were additionally permeabilised with 0.1% Triton in PBS for 5 min and stained with 
CellMaskTM Blue (1:2000) and DAPI (1:5000) dissolved in PBS for 10 min. Cells were 
then washed three times with PBS and, in case of experiments on cover slips, mounted with 
ProLong Gold antifade reagent (Life Technologies). Experiments were stored in the dark 
at 4°C until imaging. Imaging of SKN experiments in 96-well plates was performed with 
a 40x air objective. For each well 10-20 positions were selected and stacks of 8 planes with 
1 µm step size were taken. Experiments with HeLa cells on coverslips were imaged with a 
63x oil immersion objective. For each cover slip 10-20 positions were selected and stacks 
of 15 planes with 0.5 µm as step size were taken. Image analysis is described below. 
4.2.10 Image‐based siRNA screen of Rho GEFs and GAPs 
A list of all human proteins containing either a Dbl-homology or DOCK homology domain 
(GEFs), as well as those containing a RhoGAP domain (GAPs) was generated by 
bioinformatic analysis of the UniProt database (www.uniprot.org). For every gene a set of 
four separate siRNA oligonucleotides with non-overlapping sequences was purchased. 
siRNA was applied to SKN cells in 96-well plates as described above. Each unique oligo 
was tested in a separate well and the whole set of experiments was repeated once. The 
trans-endocytosis assay was performed as described above and image acquisition and 
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analysis with CellProfilerTM software is detailed below. From the resulting quantification 
of the number of internalised clusters per cell several cut-offs representing a minimum 
number of internalised clusters were calculated. Subsequently, the percentage of cells 
containing more than the given number of internalised cluster was calculated for each cut-
off and each treatment. Then the cut-off for which the negative scramble control was 
closest to a value of 40% cells above cut-off was taken for further analysis. From these 
values z-scores were calculated by subtracting the average control value from the observed 
value and dividing the result by the standard deviation of the controls. The average of the 
controls was either calculated from all values of the entire screen or only from the controls 
of a specific plate. Genes were ranked according to their z-scores and candidates identified 
by either examining results for single oligos or by calculating the average over the z-scores 
for all 4 oligos. 
4.2.11 Trans‐endocytosis assay with primary cortical neurons 
Primary dissociated cultures of cortical neurons were generated from E 15.5 mouse 
embryos of wild type CD1 mice. On the day of the experiment mice were sacrificed and 
embryos transferred into PBS on ice. Brains were removed, followed by microdissection 
of the cortices in dissection medium on ice. Cortices from several embryos were 
dissociated in trypsin at 37 °C for 30 min, followed by further mechanical dissociation. 
Neurons were seeded into 8-well imaging chambers (Ibidi, Planegg, Germany) coated with 
Poly-D-lysin (1 mg/ml) and laminin (5 µg/ml) at 105 cells/well and incubated overnight at 
37 °C and 5% CO2. Neurons were stained with 1 µM CellTracker Green in in serum free 
Neurobasal medium for 30 min. Staining solution was then aspirated and replaced by 
neuronal maintenance medium. Subsequently, EHT1864 diluted in H2O was added to the 
medium to produce final concentrations of either 2.5 µM, 5 µM or 10 µM. The control 
wells were treated with a volume of H2O equal to the one used for the 10 µM EHT1864 
treatment. Neurons were incubated at 37 °C and 5% CO2 for 4 h before being transferred 
to a microscope equipped with a temperature-controlled CO2 incubation chamber 
(Pecon/VisiTron systems). After acclimatisation to the imaging chamber HeLa cells over-
expressing EphB2C-mCherry were seeded on top of the cortical neurons at 2x104 
cells/well. HeLa cells were allowed to settle for several minutes before imaging. Imaging 
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was performed with a 40x air objective and images of a single focal plane with brightfleld 
illumination, as well as illumination with the 488 nm (CellTracker Green in neurons) and 
561 nm (EphB2C-mCherry) lasers were taken at each position at three minute intervals 
for a total duration of 3 h. Experiments were analysed with MetaMorphTM (Molecular 
Devices) software. Contact points between neurons and HeLa cell over-expressing 
EphB2C-mCherry were identified and subsequently scored for whether internalisation 
occurred or not. For being scored an internalised cluster had to be visible within in the 
neuron and properly detached from any protrusions of the HeLa cell for at least three 
consecutive frames  
4.2.12 Image analysis with CellProfilerTM 
All endocytosis experiments performed in SKN cells were analyses with CellProfilerTM 
software (Carpenter et al. 2006). The pipeline for analysing trans-endocytosis experiments 
is depicted in Figure 23 and the key steps are shown with example images. First, maximum 
projection images of the image stacks for the three separate channels are loaded. The 561 
nm channel contained the signal from the H2B-RFP labelled SKN nuclei, the 488 nm 
channel contained the signal from the total EphB2DC-GFP, and the 641 nm channel 
contained the signal from the anti-FLAG staining for visualising surface EphB2 receptors. 
Images were first corrected for differences in background illumination signal by 
subtracting a blank image - taken with the same imaging setup - from the image of interest 
and then thresholded to further reduce signal noise. From the 561 nm channel the software 
identified the outlines of the SKN nuclei. In the next step the boundaries of the nuclei were 
expanded by 50 pixels to get an estimate of individual SKN cells (acceptor cells). The 
outline of the HeLa cell was identified from the 488 nm channel (donor cell). To exclude 
SKN cells from the analysis that were too far from the HeLa cells to experience cell 
contact-induced trans-endocytosis, only SKN cells in the vicinity of the HeLa cells were 
retained. These SKN cells were then used as a mask for the identification of total EphB2C 
clusters. Subsequently, the total EphB2C clusters were used as a mask for the 
identification of surface clusters in the 641 nm channel. For each cell and cluster identified 
the software measured several features including size and shape. Furthermore the clusters 
were also related to which SKN cell they had been identified in. The number of identified 
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cluster for each cell was then displayed on an image of the cell outlines. Additionally, all 
data on the identified objects was exported to excel files for subsequent analysis.  
Analysis of experiments with soluble EphB ectodomains was performed with a similar 
pipeline. Instead of identifying the donor cells and restricting analysis to SKN acceptor 
cells in the vicinity, all SKN cells are identified and taken as a mask to then identify total 
and surface clusters. 
4.2.13 Analysis of experiments with HeLa cells in ImageJ 
Images from endocytosis experiments in HeLa cells were deconvolved with MetaMorphTM 
(Molecular Devices) software. Subsequent analysis was performed manually in Fiji 
(Schindelin et al. 2012) on blinded images. Overlay images of the maximum projections 
of image stacks for the three channels of total EphB2 (or ephrinB2 respectively), surface 
staining and CellMask Blue/DAPI were generated. Internalised vesicles were identified as 




three  channels: SKN‐H2B‐RFP makes up  the blue  channel,  total EphB2C‐GFP  signal  the green 
channel and surface EphB2C‐GFP detected by anti‐FLAG staining the red channel. The example 
image on the top shows an overlay with all three channels merged. For subsequent analysis both 
the  outline  of  the  HeLa  cell  (1)  and  the  outline  of  the  SKN  nuclei  (2)  are  detected.  For  the 
subsequent analysis only  the SKN cells  (coloured objects)  in  the vicinity of  the HeLa cell  (green 
outline) are taken into account (3). In those selected SKN cells the total EphB2C‐GFP clusters are 









Data were analysed using Prism (GraphPad) software. Data are shown as average of the 
mean +/- standard error of the mean (SEM) unless stated otherwise. Statistical significance 
was tested for with ANOVA and Dunnett’s post hoc test or with repeated measures 
ANOVA followed by Dunnett’s post hoc test where appropriate. Significance levels are 
denoted with asterisks (P<0.05=*, P<0.01=**, P<0.005=***). 
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